data_2lbn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 111.359 0.133 . . . . 2.8300000000000001 111.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.9700000000000002 110.488 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.26 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68000000000000005 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.93999999999999995 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.98999999999999999 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.93000000000000005 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.8700000000000001 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.97999999999999998 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 3.6299999999999999 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.5600000000000001 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 2.3799999999999999 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.3700000000000001 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.3899999999999999 113.922 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 1.21 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 1.47 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.92000000000000004 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.1799999999999999 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.514 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.0700000000000001 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.2200000000000002 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.5800000000000001 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 1.29 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.22 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 1.1100000000000001 110.986 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 1.04 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 1.51 110.317 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.94999999999999996 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.8700000000000001 110.905 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.6499999999999999 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 1.3400000000000001 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.6599999999999999 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 3.1600000000000001 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.5099999999999998 110.346 178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.3199999999999998 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.3100000000000001 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.5599999999999996 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.6200000000000001 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.9500000000000002 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 4.1200000000000001 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 4.6299999999999999 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.9500000000000002 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.661 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.7400000000000002 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.607 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.8700000000000001 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 3.3500000000000001 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 5.1699999999999999 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.815 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 5.0499999999999998 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 2.1400000000000001 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.97999999999999998 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.5600000000000001 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.25 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.77 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.28 113.634 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 3.3300000000000001 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.3100000000000001 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 1.27 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.6000000000000001 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.3999999999999999 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.869 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 1.22 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.58999999999999997 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.407 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.83999999999999997 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.5700000000000001 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.46 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.1699999999999999 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.1299999999999999 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 72' ' ' ILE . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.83999999999999997 110.798 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HB2' ' HG2' ' A' ' 87' ' ' PRO . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.26 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.6200000000000001 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.869 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.857 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.1599999999999999 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.8600000000000001 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.5900000000000001 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.6299999999999999 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 5.4500000000000002 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.435 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 1.133 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.59 HD22 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.754 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.091 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.622 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.091 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.834 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.716 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.855 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.676 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HG ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.855 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.933 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.986 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.986 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA2' ' HG ' ' A' ' 25' ' ' SER . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.886 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.707 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.5 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.59 ' OE2' HD22 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.423 ' C ' HD21 ' A' ' 50' ' ' LEU . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 50' ' ' LEU . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.723 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.723 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 1.133 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.743 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 1.038 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.635 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.965 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.882 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.965 HG23 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 1.038 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.865 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.979 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.663 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.042 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.716 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.716 ' C ' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.042 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 90' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.72 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.838 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.835 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.856 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.591 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.797 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.919 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.797 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.662 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.835 HD12 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG22 HD12 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.858 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.838 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.552 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.673 ' OE1' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.653 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.653 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.627 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.925 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.894 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.858 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.953 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.919 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.719 HG22 ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.858 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.049 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.049 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD1' ' HA2' ' A' ' 71' ' ' GLY . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.895 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.81 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.895 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.748 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.589 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.941 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.762 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.815 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.785 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.802 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.868 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.91 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.785 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.915 HG23 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.915 ' H ' HG23 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.941 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.529 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.631 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.631 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.802 ' HG2' ' NE ' ' A' ' 20' ' ' ARG . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.611 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.898 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 1.001 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.898 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.936 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.041 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.078 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.936 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.014 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.014 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.755 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.772 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.046 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.654 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.078 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.046 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.668 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.708 0.289 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.812 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.891 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.812 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.7 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.662 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.7 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 1.022 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.022 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.562 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.597 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.76 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.953 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.946 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 66' ' ' ARG . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.856 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.769 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.93 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.946 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.738 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.859 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.851 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.023 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.023 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.777 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.677 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.839 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.839 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.971 HD13 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.747 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.782 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.851 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 1.005 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.971 HG21 HD13 ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.859 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.454 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.735 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.731 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.97 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.939 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.015 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.987 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.847 HG23 ' HB1' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.939 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.962 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.962 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.721 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.85 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HA2' ' A' ' 71' ' ' GLY . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.079 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.706 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.015 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.079 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.628 ' HD1' ' H ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.41 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 1.026 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.763 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.72 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.839 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.619 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.848 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.771 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.026 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 36' ' ' VAL . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.771 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.458 ' CB ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.824 HG23 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.824 ' H ' HG23 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 52' ' ' SER . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.742 ' HG2' HH12 ' A' ' 20' ' ' ARG . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.522 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.72 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.978 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.833 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 1.035 ' HB1' HG23 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.993 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.017 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.035 HG23 ' HB1' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.978 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.988 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.988 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.749 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.843 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.752 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.706 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.017 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.572 ' HG ' ' N ' ' A' ' 85' ' ' CYS . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.652 0.263 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.431 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.824 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.591 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.752 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.628 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.531 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.824 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.75 ' HB2' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.979 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.626 ' H ' HG21 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.979 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.56 ' HE1' ' HG2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.542 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.736 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.823 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.942 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.823 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.832 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.942 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.686 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.851 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.844 ' CA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.853 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.69 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' CA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.754 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.894 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.744 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.84 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.851 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.652 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.84 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.771 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.894 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.847 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.801 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.73 HG21 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' N ' HG21 ' A' ' 38' ' ' THR . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.771 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.727 ' HG3' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.701 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.727 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 1.127 HD23 ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 1.127 ' HG3' HD23 ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.582 ' CD ' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.582 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.565 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.979 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.872 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.935 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.739 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.872 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.979 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB3' HG21 ' A' ' 72' ' ' ILE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' N ' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.948 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.015 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.935 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.918 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.918 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 1.015 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.811 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.838 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.997 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.013 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.81 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.838 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.865 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.974 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.798 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 1.024 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.798 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.795 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.889 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.809 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.849 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 1.02 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.024 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 26' ' ' ILE . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.776 HG21 ' H ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.776 ' H ' HG21 ' A' ' 38' ' ' THR . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.871 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.653 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.749 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.974 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.664 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.802 ' NE2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.871 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.94 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.802 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.889 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.877 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.096 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.94 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.818 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.873 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.744 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.423 ' HB3' HG22 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.735 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.089 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 1.096 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.882 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.008 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.951 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.738 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.996 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.869 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.615 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.941 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.783 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.738 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HG23 ' A' ' 36' ' ' VAL . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.856 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.941 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.941 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG23 HD12 ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.903 HG23 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.409 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.996 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.43 HE21 ' N ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.43 ' N ' HE21 ' A' ' 55' ' ' GLN . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.822 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.817 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.988 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.844 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 1.03 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.608 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.918 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.911 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.03 HG21 ' HB2' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.988 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.935 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.995 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.752 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.756 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.039 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.742 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.918 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.039 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 90' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.813 0.34 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.813 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.76 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.867 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.777 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.798 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.785 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.777 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.8 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 39' ' ' ALA . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.626 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.813 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' OE2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.732 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.788 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.959 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.834 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.898 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.827 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.959 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.023 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.023 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.828 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.805 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.856 ' CD ' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.653 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.805 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 120.656 0.265 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.727 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.75 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.828 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.823 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.75 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.867 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.684 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.714 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.859 HD13 HG13 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.636 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.962 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.714 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.735 HG23 ' N ' ' A' ' 39' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.735 ' N ' HG23 ' A' ' 38' ' ' THR . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.847 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.657 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.634 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.702 HD11 ' HD2' ' A' ' 51' ' ' PRO . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD2' HD11 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.72 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.867 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.999 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.882 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.901 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.038 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.038 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.769 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.901 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.882 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.829 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.903 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.999 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.684 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.903 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.894 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.67 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' HG2' ' A' ' 47' ' ' GLU . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.609 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' HD13 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.791 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.931 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.473 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.931 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.886 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.929 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 HD12 ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.686 HG21 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG21 ' A' ' 38' ' ' THR . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.845 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.609 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.2 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.638 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.996 ' HG2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' CD ' ' HB3' ' A' ' 52' ' ' SER . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 56' ' ' SER . 14.7 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.788 ' HG ' ' H ' ' A' ' 57' ' ' GLY . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.859 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.994 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.879 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.934 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.994 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.795 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.999 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.874 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.934 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.043 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.043 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.724 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.663 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.719 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.857 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.671 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.889 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.999 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.671 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.669 ' H ' ' C ' ' A' ' 87' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.749 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.539 0.209 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD11 ' OG ' ' A' ' 52' ' ' SER . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.844 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.945 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.621 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.078 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.866 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.752 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.856 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.856 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.714 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.945 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.905 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 HD13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.874 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.844 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.733 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 1.029 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.869 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 1.003 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.868 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 1.029 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' CB ' HG23 ' A' ' 72' ' ' ILE . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.958 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.776 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.733 HG23 ' CB ' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 1.003 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.817 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.096 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.096 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.767 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.75 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.078 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.776 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.078 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.852 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 90' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.158 0.504 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.884 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 1.08 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.884 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.832 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.736 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.87 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.662 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 36' ' ' VAL . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.826 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.08 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.95 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 26' ' ' ILE . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.662 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.732 ' HG1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.826 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.707 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.683 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.489 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.722 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.889 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.894 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.722 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.951 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' CB ' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.973 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.072 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.029 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.894 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.951 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.973 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.799 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.631 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 1.052 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.718 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.027 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.889 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 1.072 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.894 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.052 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.027 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.876 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.584 0.23 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.843 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.848 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 1.012 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.531 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.629 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 1.012 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.797 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.875 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.822 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.884 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.861 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.716 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.797 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.945 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.861 HG21 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.93 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.843 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.843 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.75 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 46' ' ' GLU . 5.3 p30 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' N ' HD21 ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.81 ' HG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.81 ' HD3' ' HG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.875 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.814 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 1.016 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.847 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.933 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.012 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.025 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.907 HG21 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 1.016 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.933 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.053 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.053 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.749 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.814 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.138 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.56 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.702 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.025 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.138 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.56 ' HG ' ' C ' ' A' ' 84' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.743 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.795 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.763 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.858 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.734 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.784 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.765 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.035 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 1.03 HD13 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.759 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.832 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD12 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.03 HG22 HD13 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.93 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.759 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.817 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.817 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.547 ' C ' HD21 ' A' ' 50' ' ' LEU . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.685 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.79 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 1.039 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.568 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.874 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.907 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.986 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.776 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.026 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 1.039 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.907 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 1.042 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.042 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.785 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 1.026 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.666 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 1.139 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.776 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.986 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 1.139 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.63 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.7 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.703 ' CB ' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.973 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.49 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 35' ' ' PHE . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.973 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.781 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.775 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' ' OD1' ' A' ' 48' ' ' ASN . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.444 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.783 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 70' ' ' ALA . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.884 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.848 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.84 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.84 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.848 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.884 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.641 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.634 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 90' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.583 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.962 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.767 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.767 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.727 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.983 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.983 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 26' ' ' ILE . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.506 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.671 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.982 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.84 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.928 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.753 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.639 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.753 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.711 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.84 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.585 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.728 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 26' ' ' ILE . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.695 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 1.01 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 1.01 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.812 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 3.2 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 55' ' ' GLN . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLN . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.573 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.73 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.92 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.735 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.824 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.853 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.92 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.817 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.561 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.757 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.853 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.963 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.637 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.842 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.842 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.745 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.675 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.963 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' C ' HG21 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.427 0.158 . . . . 8.0899999999999999 111.427 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 42.77 -157.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.564 -0.902 . . . . 7.0800000000000001 108.564 -178.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -87.63 25.09 1.54 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.83 -1.174 . . . . 4.4299999999999997 107.83 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 43.4 t0 100.02 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 126.216 2.912 . . . . 6.04 103.767 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -160.35 -28.22 0.06 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 110.552 -3.022 . . . . 6.5899999999999999 110.204 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 5' ' ' LEU . 14.0 t70 168.04 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.355 0.805 0 N-CA-C 113.809 1.04 . . . . 7.5199999999999996 113.809 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG22 ' NH1' ' A' ' 8' ' ' ARG . 5.9 m -152.53 8.55 0.05 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.438 0 N-CA-C 117.691 2.478 . . . . 6.4400000000000004 117.691 -175.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.523 ' O ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.46 157.77 23.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.152 1.342 . . . . 8.6400000000000006 112.538 -175.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.532 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 81.3 p -112.27 84.57 1.99 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.136 -0.484 . . . . 3.6000000000000001 112.29 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t 45.03 -144.0 0.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.937 -0.574 . . . . 2.8300000000000001 111.359 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.9700000000000002 110.488 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.26 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68000000000000005 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.93999999999999995 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.98999999999999999 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.93000000000000005 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.8700000000000001 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.97999999999999998 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 3.6299999999999999 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.5600000000000001 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 2.3799999999999999 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.3700000000000001 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.3899999999999999 113.922 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 1.21 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 1.47 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.92000000000000004 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.1799999999999999 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.514 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.0700000000000001 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.2200000000000002 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.5800000000000001 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 1.29 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.22 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 1.1100000000000001 110.986 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 1.04 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 1.51 110.317 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.94999999999999996 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.8700000000000001 110.905 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.6200000000000001 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.6499999999999999 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 1.3400000000000001 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.6599999999999999 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 3.1600000000000001 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.5099999999999998 110.346 178.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.3199999999999998 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.3100000000000001 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.5599999999999996 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.6200000000000001 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.9500000000000002 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 4.1200000000000001 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 4.6299999999999999 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.9500000000000002 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.753 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.7400000000000002 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.607 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.8700000000000001 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 3.3500000000000001 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 5.1699999999999999 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.815 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 5.0499999999999998 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 2.1400000000000001 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.97999999999999998 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.5600000000000001 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.467 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.25 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.77 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.28 113.634 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 3.3300000000000001 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.3100000000000001 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 1.27 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.6000000000000001 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.3999999999999999 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.869 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 1.22 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.58999999999999997 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.407 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.83999999999999997 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.5700000000000001 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.46 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.1699999999999999 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.1299999999999999 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 72' ' ' ILE . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.83999999999999997 110.798 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HB2' ' HG2' ' A' ' 87' ' ' PRO . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.26 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.6200000000000001 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.869 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.857 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.1599999999999999 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.8600000000000001 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.5900000000000001 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.6299999999999999 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 5.4500000000000002 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.435 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.731 0.301 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 53' ' ' PRO . 18.4 m -64.9 124.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.901 ' HG ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -90.98 150.42 21.47 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.054 0.93 . . . . 0.0 112.449 179.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.611 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 27.1 t70 -112.21 -33.44 6.22 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.687 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.112 HD12 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.42 -150.97 0.09 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' H ' HD21 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -85.56 -12.9 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.926 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.112 HG12 HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -81.43 8.9 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 122.362 1.077 . . . . 0.0 108.546 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.804 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 75.6 mtt180 -64.6 155.42 33.26 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.066 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.1 75.38 0.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 1.133 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER -46.86 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.909 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 HD22 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.746 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.754 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.091 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.622 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.091 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.834 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.716 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.855 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.676 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HG ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.855 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.933 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.941 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.986 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.986 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.709 HG21 HD13 ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.655 ' HA2' ' HG ' ' A' ' 25' ' ' SER . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.476 HG22 ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.886 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.707 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.5 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.59 ' OE2' HD22 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.423 ' C ' HD21 ' A' ' 50' ' ' LEU . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 50' ' ' LEU . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.723 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.723 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 1.133 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.629 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.743 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.755 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.038 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.635 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.965 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.556 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.882 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.965 HG23 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 1.038 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.865 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.979 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.663 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.71 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.042 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.716 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' C ' ' HB3' ' A' ' 89' ' ' ALA . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.042 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 91' ' ' PHE . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 90' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.776 0.322 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 m -158.47 -168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.678 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.23 165.8 24.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.59 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 7.1 t70 -80.12 -76.7 0.21 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.174 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.99 HD11 ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -72.96 -79.12 0.08 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.642 177.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.887 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.06 -60.1 0.11 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.59 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.581 ' H ' HD21 ' A' ' 5' ' ' LEU . 12.9 m -120.05 -6.09 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.99 ' H ' HD11 ' A' ' 5' ' ' LEU . 50.7 mtt85 -90.99 -169.15 2.26 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.318 0.58 . . . . 0.0 111.951 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.674 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -89.71 -173.84 4.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.773 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 2.5 t -60.02 -93.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.362 -0.211 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.72 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.838 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.835 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.856 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.856 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.674 ' HE ' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.797 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.919 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.797 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.662 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.835 HD12 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG22 HD12 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.561 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.858 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.838 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.552 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.673 ' OE1' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.653 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.653 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.678 ' HG3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.627 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.925 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.894 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.858 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.953 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.919 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.719 HG22 ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.858 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.049 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.049 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD1' ' HA2' ' A' ' 71' ' ' GLY . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.895 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.81 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.895 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.748 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.589 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.759 0.314 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.721 HG11 ' H ' ' A' ' 3' ' ' LEU . 6.3 t -81.34 165.56 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.721 ' H ' HG11 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -73.64 175.02 7.52 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.041 0.924 . . . . 0.0 113.12 -178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.88 ' HB2' ' CA ' ' A' ' 55' ' ' GLN . 33.9 t70 -72.11 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.108 -1.406 . . . . 0.0 107.784 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.045 HD23 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.78 -82.48 0.14 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.816 0.817 . . . . 0.0 111.158 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.786 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -158.41 -28.9 0.08 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.914 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.045 ' H ' HD23 ' A' ' 5' ' ' LEU . 33.4 m -108.82 -1.89 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.831 ' HD3' ' HA ' ' A' ' 54' ' ' CYS . 55.0 mtt85 -79.33 153.85 29.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.84 89.1 0.28 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m -76.01 -168.87 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.941 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.762 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.815 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.815 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.785 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.802 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.868 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.91 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.785 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.915 HG23 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.915 ' H ' HG23 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.89 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.941 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.529 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.631 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.831 ' HA ' ' HD3' ' A' ' 8' ' ' ARG . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.88 ' CA ' ' HB2' ' A' ' 4' ' ' ASP . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.611 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.898 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.001 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.898 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.936 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.041 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.078 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.936 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.014 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.014 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.762 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.755 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.772 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.046 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.654 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.078 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.046 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.668 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.774 0.321 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 3' ' ' LEU . 3.0 t 65.81 164.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.756 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -68.99 167.42 15.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.332 0.587 . . . . 0.0 112.523 -178.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.535 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 15.0 t0 -81.21 -74.76 0.31 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.006 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -75.69 -80.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.178 178.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 1.006 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -158.62 -58.51 0.07 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.197 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.591 ' H ' HD23 ' A' ' 5' ' ' LEU . 17.1 m -120.33 -3.98 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.784 ' H ' HD11 ' A' ' 5' ' ' LEU . 57.7 mtt-85 -82.25 173.18 12.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.218 0.532 . . . . 0.0 112.236 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.58 -169.86 2.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m -147.16 -46.96 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.375 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.812 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.891 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.812 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.609 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.7 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.662 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.7 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 1.022 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.022 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.716 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.626 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.652 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.597 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.76 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.822 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB1' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.953 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.946 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.708 ' N ' ' O ' ' A' ' 66' ' ' ARG . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.856 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.769 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.93 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.946 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.738 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.69 0.281 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 t -58.87 169.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.93 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.81 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.14 153.02 41.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 35.1 t70 -67.17 -127.61 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.799 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.094 HD11 ' H ' ' A' ' 7' ' ' VAL . 3.0 pp -91.97 -137.49 0.16 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -72.41 -15.73 61.84 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.353 0.597 . . . . 0.0 109.608 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.094 ' H ' HD11 ' A' ' 5' ' ' LEU . 27.6 m -86.81 46.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.895 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.81 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 33.9 mtt180 -61.96 139.47 58.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.3 m 66.74 96.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m -42.54 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.859 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.851 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.023 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.023 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.777 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.677 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.839 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.839 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.971 HD13 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.747 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.782 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.851 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 79' ' ' CYS . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 1.005 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.971 HG21 HD13 ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.717 HG23 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.878 ' N ' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.859 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.454 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.735 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.731 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.97 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA3' ' HG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.851 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.939 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.015 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.987 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.847 HG23 ' HB1' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.97 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.939 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.962 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.962 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.721 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.85 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD1' ' HA2' ' A' ' 71' ' ' GLY . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.079 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.706 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.015 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.079 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.817 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.628 ' H ' ' HD1' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.41 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.821 ' O ' ' HB3' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.42 0.153 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.42 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 17.6 m -56.66 162.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.66 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.04 HD22 ' HG2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -70.77 152.48 43.74 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.067 0.936 . . . . 0.0 112.104 -177.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.78 -72.58 0.59 Allowed 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.344 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.037 HD21 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -91.75 -158.51 0.58 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 1.007 ' HA ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -93.27 -16.75 24.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.037 ' H ' HD21 ' A' ' 5' ' ' LEU . 17.2 m -84.19 -2.6 7.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.947 0.403 . . . . 0.0 111.718 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.857 ' HB3' HD13 ' A' ' 3' ' ' LEU . 32.7 mtt180 -119.88 -23.19 6.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.939 1.352 . . . . 0.0 113.159 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 1.007 HG23 ' HA ' ' A' ' 6' ' ' ASP . 8.3 p -27.51 162.41 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.286 -2.688 . . . . 0.0 115.65 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 1.026 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m -44.9 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.739 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.763 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.72 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.839 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.619 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.848 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.771 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.026 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 36' ' ' VAL . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.771 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.458 ' CB ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.824 HG23 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.824 ' H ' HG23 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.04 ' HG2' HD22 ' A' ' 3' ' ' LEU . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.97 ' H ' ' HB2' ' A' ' 3' ' ' LEU . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.522 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.72 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.978 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.833 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 1.035 ' HB1' HG23 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.993 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.017 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.035 HG23 ' HB1' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.978 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.988 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.988 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.749 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.843 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.752 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.706 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.017 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.572 ' HG ' ' N ' ' A' ' 85' ' ' CYS . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.512 ' H2 ' HD13 ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.809 0.338 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 m -70.72 144.89 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 112.239 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.733 HD11 ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -68.51 -147.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.335 1.064 . . . . 0.0 113.844 -177.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.569 ' CG ' ' HA ' ' A' ' 55' ' ' GLN . 15.0 t0 -157.12 -12.46 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.547 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.764 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -18.13 -77.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.794 -1.548 . . . . 0.0 113.97 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.764 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.5 -28.12 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.19 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.759 ' H ' HD23 ' A' ' 5' ' ' LEU . 19.3 m -97.71 -2.92 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.631 ' HG3' ' C ' ' A' ' 7' ' ' VAL . 84.4 mtt180 -149.47 -164.94 2.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.29 -173.53 4.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.038 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t -65.73 -173.33 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.512 HD13 ' H2 ' ' A' ' 1' ' ' ALA . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.824 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.591 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.752 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.628 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.531 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.824 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.75 ' HB2' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.979 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.626 HG21 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' H ' HG21 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.979 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.542 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.56 ' HE1' ' HG2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.542 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.736 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.823 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.942 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.823 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.806 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.832 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.942 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.793 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.686 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.851 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.844 ' CA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.853 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.853 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.69 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' CA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.322 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 m -69.32 149.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 111.225 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.077 HD23 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -56.37 -177.59 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.689 ' HA ' ' N ' ' A' ' 55' ' ' GLN . 13.3 t70 -144.81 -25.28 0.5 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 111.646 -2.524 . . . . 0.0 109.62 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.052 HD23 HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -67.1 -135.84 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.014 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.729 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -97.73 -18.77 18.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.052 HG12 HD23 ' A' ' 5' ' ' LEU . 10.3 m -79.25 -6.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.266 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.077 ' HD2' HD23 ' A' ' 3' ' ' LEU . 17.8 mtt-85 -149.18 164.13 35.63 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.738 ' CG2' ' HG3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -167.93 128.77 1.39 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.58 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p -169.6 59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.754 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.78 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.894 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.744 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.84 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.851 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.652 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.84 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.771 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.894 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.847 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.801 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.73 HG21 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' N ' HG21 ' A' ' 38' ' ' THR . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.771 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.727 ' HG3' ' OE2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.701 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.727 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 1.127 HD23 ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.127 ' HG3' HD23 ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.738 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.582 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.565 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.979 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.872 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.537 ' C ' ' H ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.935 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.739 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.872 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.979 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB3' HG21 ' A' ' 72' ' ' ILE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' N ' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.948 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.015 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.935 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.918 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.918 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.015 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.811 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.838 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.997 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.013 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.81 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.838 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.865 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.788 0.327 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.712 HG13 ' H ' ' A' ' 3' ' ' LEU . 4.0 t -100.61 176.76 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.712 ' H ' HG13 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -66.1 -177.68 0.53 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.854 0.835 . . . . 0.0 112.92 -177.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 24.8 t70 -83.13 -95.42 0.06 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.307 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.899 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.93 -75.95 0.2 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.737 0.779 . . . . 0.0 109.068 176.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.899 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -154.06 -48.06 0.09 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.277 -179.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.719 ' H ' HD22 ' A' ' 5' ' ' LEU . 27.5 m -104.47 -0.04 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.815 ' CG ' HD12 ' A' ' 5' ' ' LEU . 48.9 mtt85 -81.08 166.23 20.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.688 -0.632 . . . . 0.0 112.025 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 86.4 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.974 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m 62.84 -171.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.749 HD22 ' HG2' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.798 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 1.024 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.798 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.795 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.889 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.809 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.849 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.621 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 1.02 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.024 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 26' ' ' ILE . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.776 HG21 ' H ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.776 ' H ' HG21 ' A' ' 38' ' ' THR . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.871 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.653 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.749 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.489 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 50' ' ' LEU . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.974 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.664 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.664 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.802 ' NE2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.871 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.94 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.802 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.889 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.877 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.096 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.931 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.94 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.818 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.873 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.873 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.744 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.423 ' HB3' HG22 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.735 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.089 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.096 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.882 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.008 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.951 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.715 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -62.15 169.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD13 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -63.1 163.91 9.31 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.95 0.881 . . . . 0.0 113.17 -177.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.62 ' OD1' HD11 ' A' ' 11' ' ' LEU . 37.8 t0 -76.6 -89.05 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.009 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.7 tp -85.57 -65.43 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.5 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.236 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.35 -0.6 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -79.13 176.27 9.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.647 HG22 ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -127.16 90.92 3.22 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.39 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.738 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 68.6 -168.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.44 -178.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.62 HD11 ' OD1' ' A' ' 4' ' ' ASP . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.996 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.869 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.941 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.615 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.941 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.783 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.738 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.805 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.019 HD12 HG23 ' A' ' 36' ' ' VAL . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.856 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.941 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.941 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG23 HD12 ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.903 HG23 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.409 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.886 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.996 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.647 ' OE1' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.43 ' N ' HE21 ' A' ' 55' ' ' GLN . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.822 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.817 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.988 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.844 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 1.03 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.608 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.918 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.911 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.03 HG21 ' HB2' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.988 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.935 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.995 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.752 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.756 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.039 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.742 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.918 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.039 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 90' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 54' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.3 m 44.94 -174.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -79.26 -179.32 6.68 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.543 0.687 . . . . 0.0 112.57 -178.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 21.2 t70 -81.16 -77.24 0.21 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.821 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.052 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -86.99 -54.01 4.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.214 1.007 . . . . 0.0 108.81 176.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.73 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.25 -48.92 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.373 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.052 ' H ' HD13 ' A' ' 5' ' ' LEU . 19.7 m -115.7 0.49 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.713 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.71 ' HG3' HD12 ' A' ' 5' ' ' LEU . 25.0 mtt180 -83.41 -169.48 2.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -130.97 -168.88 2.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.095 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.14 177.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.564 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.606 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.711 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.813 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.76 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.588 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.867 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.777 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.798 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.785 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.798 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.777 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.8 ' CZ ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 HG23 HD11 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 39' ' ' ALA . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.626 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.813 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' OE2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.621 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.755 ' HB3' HG21 ' A' ' 9' ' ' THR . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.732 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.788 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.959 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.834 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.898 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.827 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.959 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.688 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.023 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.023 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.828 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.805 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.847 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.847 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.856 ' CD ' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.653 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.805 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.43 -179.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.013 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -68.99 160.16 31.45 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.38 -115.02 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.135 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.863 HD13 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -94.22 -144.33 0.24 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.728 ' H ' HD22 ' A' ' 5' ' ' LEU . 1.7 m-20 -80.86 -17.05 51.98 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.306 0.642 . . . . 0.0 111.632 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.863 ' CG2' HD13 ' A' ' 5' ' ' LEU . 34.7 m -107.95 61.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.747 0.785 . . . . 0.0 109.461 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.013 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 14.2 mtt180 -69.99 -169.72 0.29 Allowed 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.673 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER 34.94 39.0 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.643 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 55.08 176.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.017 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.727 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.75 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.828 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.727 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.823 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.75 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.867 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.684 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.714 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.859 HD13 HG13 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.636 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD1' ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.962 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.714 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.735 HG23 ' N ' ' A' ' 39' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.735 ' N ' HG23 ' A' ' 38' ' ' THR . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.847 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.657 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.634 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.702 HD11 ' HD2' ' A' ' 51' ' ' PRO . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.702 ' HD2' HD11 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.72 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.867 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' ' OD1' ' A' ' 30' ' ' ASP . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.999 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.882 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.901 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.038 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.038 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.769 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.901 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.882 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.829 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.903 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.999 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.715 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.684 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.903 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.894 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.67 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.648 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 30.8 m -58.27 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -71.89 171.41 11.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.742 ' HB2' ' O ' ' A' ' 9' ' ' THR . 35.8 t70 -72.52 -77.37 0.1 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.037 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.39 -59.64 2.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.89 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -160.03 -47.63 0.05 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.816 178.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.037 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -114.72 -1.3 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.958 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.812 ' HG3' HD11 ' A' ' 5' ' ' LEU . 54.9 mtt180 -82.58 154.02 25.2 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.742 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -73.85 -169.75 0.78 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -65.75 -171.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.479 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.996 HD21 ' HG2' ' A' ' 47' ' ' GLU . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.78 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.609 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' HD13 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.791 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.931 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.473 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.931 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.886 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.929 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG21 HD12 ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.686 HG21 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG21 ' A' ' 38' ' ' THR . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.845 ' N ' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.609 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.2 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.638 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.996 ' HG2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.648 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.651 ' CB ' ' HA ' ' A' ' 9' ' ' THR . 14.7 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.788 ' HG ' ' H ' ' A' ' 57' ' ' GLY . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.859 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.994 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.879 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.934 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.994 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 72' ' ' ILE . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.795 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.999 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.874 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.934 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.043 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.043 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.724 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.663 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.719 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.857 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.671 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.889 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.751 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.999 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.671 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.669 ' H ' ' C ' ' A' ' 87' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.749 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.15 136.29 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.33 168.74 16.74 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -81.41 -71.32 0.48 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.542 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.076 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -73.84 -78.3 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.922 178.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.914 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -156.31 -65.88 0.11 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.166 -2.288 . . . . 0.0 109.388 -178.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.757 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 9.2 m -128.27 -6.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.076 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 75.8 mtt180 -81.21 165.35 21.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.109 0.564 . . . . 0.0 112.312 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p -72.62 158.73 35.1 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.928 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m -77.73 -85.08 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.93 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD11 ' OG ' ' A' ' 52' ' ' SER . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.844 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.945 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.078 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.621 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.078 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.866 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.752 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.856 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.018 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.856 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.714 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.945 HD13 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.905 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG21 HD13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 27' ' ' CYS . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.874 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.844 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.427 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.733 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.733 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 1.029 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.869 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.003 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.868 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 1.029 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' CB ' HG23 ' A' ' 72' ' ' ILE . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.958 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.776 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.733 HG23 ' CB ' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 1.003 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.817 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.096 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.096 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.767 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.75 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.078 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.776 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.078 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.852 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 90' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.775 0.321 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.25 -169.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.954 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.24 158.55 34.75 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.769 0.795 . . . . 0.0 112.873 -178.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 5' ' ' LEU . 33.0 t70 -73.92 -129.45 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.227 -1.352 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.743 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 96.2 mt -90.33 -137.38 0.13 Allowed 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.0 -8.5 59.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.458 0.647 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -94.61 27.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 125.068 1.347 . . . . 0.0 110.535 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.954 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 82.0 mtt180 -54.72 -178.63 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 51.17 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.43 -171.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.301 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.884 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 1.08 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.884 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.832 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.736 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.87 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.662 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 36' ' ' VAL . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.826 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.08 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.95 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 26' ' ' ILE . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.662 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.732 ' HG1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.826 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.707 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.683 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.489 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.722 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.889 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.894 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.722 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.951 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' CB ' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.973 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.072 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.029 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.894 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.951 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.973 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.799 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.631 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.052 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.718 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.027 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.889 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.072 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.894 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.052 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.027 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.876 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 8' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.712 0.292 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.616 HG11 ' O ' ' A' ' 9' ' ' THR . 27.4 m -96.09 132.33 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.065 HD22 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.92 161.76 16.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.714 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 14.5 t70 -86.22 -29.18 23.37 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.648 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.957 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -71.94 -104.11 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.697 -178.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.762 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.19 -14.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.957 ' H ' HD13 ' A' ' 5' ' ' LEU . 17.2 m -82.53 -7.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.455 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.065 ' HD2' HD22 ' A' ' 3' ' ' LEU . 89.6 mtt180 -149.43 125.16 10.45 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.535 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.616 ' O ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.33 156.5 16.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.712 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 t -56.2 -93.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.463 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.843 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.848 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 1.012 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.531 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.629 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 1.012 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.797 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.875 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.822 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.884 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.861 HD11 HG21 ' A' ' 36' ' ' VAL . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.716 ' SG ' ' HB3' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.797 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.945 HD21 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.861 HG21 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.93 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.613 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.877 ' N ' HD11 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.843 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.843 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.75 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 46' ' ' GLU . 5.3 p30 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD21 ' N ' ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.81 ' HG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.81 ' HD3' ' HG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.492 ' HA ' HG22 ' A' ' 2' ' ' VAL . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.875 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.814 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.016 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.847 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.933 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.012 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.025 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.907 HG21 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 1.016 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.933 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.053 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.053 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.749 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.814 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.743 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.138 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.56 ' C ' ' HG ' ' A' ' 92' ' ' SER . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.702 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.025 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.138 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.56 ' HG ' ' C ' ' A' ' 84' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' H3 ' ' H ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.47 -170.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.899 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.017 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -65.58 157.01 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -178.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.91 ' HB3' HG21 ' A' ' 7' ' ' VAL . 27.8 t0 -63.75 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.99 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.799 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -87.14 -107.66 0.06 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 121.633 -0.667 . . . . 0.0 111.061 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.799 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -84.45 -14.87 48.02 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.911 178.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.91 HG21 ' HB3' ' A' ' 4' ' ' ASP . 16.4 m -81.12 29.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.293 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 1.017 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 51.9 mtt85 -68.59 137.0 53.92 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.599 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 43.63 72.94 0.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.999 0.904 . . . . 0.0 111.579 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.743 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m -78.98 -79.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.243 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.795 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.763 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.858 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.734 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.784 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.765 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.878 ' HB2' HG21 ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.035 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 1.03 HD13 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.759 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.832 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD12 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.03 HG22 HD13 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.93 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.93 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.759 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.817 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.817 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.795 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.547 ' C ' HD21 ' A' ' 50' ' ' LEU . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.685 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.765 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.79 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 1.039 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.568 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.874 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.907 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.986 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.776 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.026 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 1.039 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.907 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 1.042 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.042 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.785 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 1.026 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.666 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 1.139 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.776 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.986 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 1.139 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.77 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.63 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 3' ' ' LEU . 2.6 t -62.44 163.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.422 . . . . 0.0 111.411 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.688 ' H ' ' CD1' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -63.28 -154.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.622 1.201 . . . . 0.0 113.988 -177.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.14 -8.8 1.01 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.24 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.706 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 5.1 tp -55.57 -160.36 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.012 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -69.61 -20.66 63.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 3' ' ' LEU . 2.8 m -84.91 32.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.6 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 5' ' ' LEU . 34.3 mtt180 -64.96 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.451 0.7 . . . . 0.0 112.322 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 1.2 m 74.44 86.41 0.1 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.693 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m -78.75 -138.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.586 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.7 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.731 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.632 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.731 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.573 ' CB ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.703 ' CB ' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.973 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' CB ' ' A' ' 35' ' ' PHE . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.973 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.781 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.775 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.775 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' ' OD1' ' A' ' 48' ' ' ASN . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' NE2' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.444 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.783 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 70' ' ' ALA . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.884 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.848 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.6 HG21 ' CB ' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.872 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.84 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.84 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.641 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.848 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.884 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.641 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.634 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 90' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.766 0.317 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.99 129.09 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.952 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.25 153.66 40.53 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.35 -122.53 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.801 HD13 ' H ' ' A' ' 7' ' ' VAL . 1.5 pp -96.1 -135.75 0.23 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.894 0.315 . . . . 0.0 111.239 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.58 -10.47 59.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.155 0.502 . . . . 0.0 111.405 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.801 ' H ' HD13 ' A' ' 5' ' ' LEU . 27.8 m -96.74 46.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.053 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.61 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 70.0 mtt180 -67.76 154.1 42.26 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.699 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.468 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 96.2 m 60.2 37.55 20.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.735 0.779 . . . . 0.0 109.574 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 9' ' ' THR . 54.4 m 24.11 -150.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.042 -1.436 . . . . 0.0 113.36 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.583 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.962 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.574 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.767 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.767 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.727 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.983 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.983 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 26' ' ' ILE . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.506 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 9' ' ' THR . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.626 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.734 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.671 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.982 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.68 ' HB2' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.556 ' CB ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.84 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.68 HG22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.982 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.928 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.928 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.57 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.753 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.639 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.753 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.711 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.643 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.84 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 85' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 52' ' ' SER . 3.2 t -74.72 172.81 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.005 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.641 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -70.99 178.27 3.28 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.798 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.582 ' N ' ' HB3' ' A' ' 52' ' ' SER . 4.2 t0 -75.79 -46.19 32.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.125 -177.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.725 HD22 ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.13 -71.55 0.59 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 109.741 176.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' H ' ' CG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -152.69 -65.36 0.16 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.811 -1.995 . . . . 0.0 109.046 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.575 ' HA ' HD23 ' A' ' 3' ' ' LEU . 31.4 m -116.7 -1.38 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.725 ' HB2' HD22 ' A' ' 5' ' ' LEU . 49.2 mtt85 -119.78 131.59 55.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.222 0.465 . . . . 0.0 112.194 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.619 ' HA ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -58.8 141.23 53.69 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.999 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 m 61.95 132.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 178.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 5' ' ' LEU . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.744 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.728 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.561 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' C ' ' N ' ' A' ' 26' ' ' ILE . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.695 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 1.01 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 1.01 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.812 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 3.2 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 55' ' ' GLN . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.828 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 3' ' ' LEU . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 9' ' ' THR . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.573 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.73 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 61' ' ' CYS . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.92 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.735 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.824 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.853 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.92 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.817 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.561 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.757 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.853 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.963 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.637 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.842 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.842 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.745 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.675 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.963 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 111.359 0.133 . . . . 2.83 111.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.57 110.488 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.16 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 20' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.9 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.986 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.94 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.93 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.89 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.4 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.91 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 2.91 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.21 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 1.58 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.25 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.28 113.922 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 0.96 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 36' ' ' VAL . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 0.93 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.77 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.894 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.18 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.579 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.07 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.22 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.58 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 0.96 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.723 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 0.98 110.986 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 0.89 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 26' ' ' ILE . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 0.91 110.317 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.95 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.503 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.52 110.905 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.65 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 0.65 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.1 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 2.53 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.51 110.346 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.32 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.07 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.3 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.34 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.25 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.32 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 3.75 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 3.98 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.95 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.661 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.05 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.616 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.68 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 2.83 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 4.64 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.838 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 4.66 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 1.96 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.98 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.29 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.08 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.63 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.02 113.634 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 2.77 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.31 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.894 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 0.67 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.594 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.23 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.27 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.938 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.15 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.512 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 0.64 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.555 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.59 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.84 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.35 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.3 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.17 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.13 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.83 110.798 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.13 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.07 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.938 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.928 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.16 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.86 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 92' ' ' SER . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.43 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.11 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 4.81 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.117 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.074 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.653 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.074 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.899 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.772 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.874 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.697 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.874 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.927 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.675 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.991 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.517 HG22 ' CG1' ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.927 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.793 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.722 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 42' ' ' LEU . 1.3 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.747 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.747 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 1.117 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.657 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.751 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.055 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.45 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.921 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.584 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.984 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.055 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.003 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.003 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.66 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.036 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.792 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.984 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.036 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.749 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.014 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.869 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.869 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.641 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.997 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.014 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.663 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.947 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.612 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.581 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.947 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.671 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.634 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.72 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.904 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.046 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.942 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.046 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.922 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.881 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.098 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.098 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.678 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.663 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.631 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.914 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.873 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.914 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.841 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.009 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.038 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.829 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.814 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.962 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.887 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.994 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.658 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.762 HD11 ' NH1' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 1.009 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.841 ' OE1' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.557 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.626 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.626 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.814 ' HG2' ' NE ' ' A' ' 20' ' ' ARG . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.914 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.04 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.914 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.1 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.069 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.101 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.1 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.04 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.998 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.071 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.071 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.767 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.6 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.801 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.67 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.101 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.0 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.701 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.708 0.289 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.892 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.828 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.723 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 1.028 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.028 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.78 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.627 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.978 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.008 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.799 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.743 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.008 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.758 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.743 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.638 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.904 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.036 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.036 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.73 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.86 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.907 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.86 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.782 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.018 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.991 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG22 ' CD1' ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.904 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.1 mp0 -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CD ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.521 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.032 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.057 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.057 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.032 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.963 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.016 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.713 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.858 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.717 ' C ' HD13 ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.792 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.766 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.057 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.712 ' HD1' ' H ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.998 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.793 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.793 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.781 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.942 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.874 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.998 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.792 ' HE1' ' HG3' ' A' ' 20' ' ' ARG . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.785 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.785 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.958 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.958 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.781 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 52' ' ' SER . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.753 ' HG2' HH12 ' A' ' 20' ' ' ARG . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.586 ' H ' HE21 ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.728 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.95 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.888 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.076 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.633 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.035 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.034 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.076 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.976 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.04 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.04 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.75 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.722 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.839 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.765 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.035 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.94 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.652 0.263 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.126 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.883 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.724 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.126 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.655 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.789 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.789 ' HD3' ' C ' ' A' ' 58' ' ' GLN . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.984 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.752 ' O ' ' N ' ' A' ' 68' ' ' ALA . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.849 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.695 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.904 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.876 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.904 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.874 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.874 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.796 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.871 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.674 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.871 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG13 HG13 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.739 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.577 ' OE1' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.733 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.696 ' CD2' ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.696 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.605 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.608 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.008 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.867 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.965 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.759 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.867 ' HD2' ' CB ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.008 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.842 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.676 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.996 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.039 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.982 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.8 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.834 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.03 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.039 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.847 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.918 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD22 ' CG ' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.881 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.881 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.829 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.937 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 1.068 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.068 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.66 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.899 ' HB3' HD22 ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 49' ' ' TYR . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 1.008 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.671 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.671 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.795 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.3 mm-40 -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.892 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.951 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.691 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.937 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.874 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.031 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.008 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.951 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.91 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.925 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.746 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.019 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.701 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.052 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.031 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.911 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.019 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.955 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.052 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.784 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.886 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 1.013 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.969 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.961 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.784 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.823 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.725 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.823 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.807 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.983 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.836 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.983 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.709 HG22 ' CG1' ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.807 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 1.013 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.886 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.838 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.835 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.033 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.88 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.087 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.964 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.927 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.087 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.033 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.961 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.039 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.039 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.845 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.676 ' C ' HD13 ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.774 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.044 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.808 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.964 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.044 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.813 0.34 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.88 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.011 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.815 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.797 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.815 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.88 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.749 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.006 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.806 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.849 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.935 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' HB3' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.006 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.085 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.085 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.693 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.553 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.885 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.885 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.537 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 120.656 0.265 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.804 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.804 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.905 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.762 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.79 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.835 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.779 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.681 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.0 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.666 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.738 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.895 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.895 ' HB3' ' H ' ' A' ' 38' ' ' THR . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.817 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 49' ' ' TYR . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.831 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.735 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.831 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.905 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.993 HD13 ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.094 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.094 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.726 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.729 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.993 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.84 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.994 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.051 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.736 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.73 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.894 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.994 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.692 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 52' ' ' SER . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.017 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HD2' HD11 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.676 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.836 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.953 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.781 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.836 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.017 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.957 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 4.0 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.567 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.863 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 52' ' ' SER . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 56' ' ' SER . 14.7 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.887 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 1.034 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.873 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.946 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.034 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.742 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.781 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.696 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.946 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.095 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.095 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.71 ' SG ' HD11 ' A' ' 26' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.873 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.689 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.934 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.689 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.676 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.539 0.209 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.896 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.959 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.077 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.077 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.864 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.864 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.009 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.888 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.009 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.577 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.751 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.896 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.623 ' C ' HD12 ' A' ' 50' ' ' LEU . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD12 ' C ' ' A' ' 49' ' ' TYR . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.727 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.727 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 1.097 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.0 mm-40 -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.887 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.052 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.097 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.938 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.858 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.914 ' HB ' ' HB3' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.052 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.938 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.111 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.111 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.818 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.799 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.741 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.858 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.1 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.92 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.158 0.504 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.063 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.957 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.063 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.957 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.854 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.792 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.885 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.81 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.885 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.79 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.57 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.951 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.676 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.79 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.714 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.063 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.747 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.909 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.866 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.747 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.955 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.952 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.996 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.054 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.895 ' CB ' ' HB3' ' A' ' 63' ' ' SER . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.007 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.007 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.619 ' CA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.083 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.034 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.909 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.996 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.906 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.083 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.034 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.946 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 11' ' ' LEU . 1.9 t . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.584 0.23 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 1.037 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.568 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.662 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 1.037 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.893 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.842 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.842 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.827 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.001 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.666 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.866 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.898 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.866 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.776 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 49' ' ' TYR . 2.2 p-10 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.795 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.893 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.058 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.901 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.117 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.064 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.016 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.117 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.964 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.125 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.125 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.76 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.829 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.748 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.106 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.771 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.064 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.106 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.985 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.739 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.853 HD13 ' OG ' ' A' ' 52' ' ' SER . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.777 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.777 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 1.047 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.744 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.812 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.819 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.8 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.853 ' OG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.624 ' HB3' ' O ' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.796 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 1.014 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.593 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.914 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.965 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.844 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.039 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.014 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.962 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.051 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HB3' ' HG3' ' A' ' 24' ' ' PRO . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.695 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 1.039 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.665 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.13 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.844 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.965 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 1.13 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.797 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.546 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.717 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.916 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.717 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.784 ' HB2' HG21 ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.784 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.72 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.837 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.782 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' HD22 ' A' ' 50' ' ' LEU . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.459 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.797 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.928 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.877 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.561 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.876 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.904 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.928 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.644 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.876 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.675 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.63 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.726 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.787 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.966 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.966 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.782 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.542 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.729 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.688 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.01 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.88 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.888 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.001 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 1.01 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 1.002 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.704 ' C ' HD13 ' A' ' 72' ' ' ILE . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.822 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.764 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.888 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.776 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.709 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.753 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 76' ' ' PRO . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.033 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.665 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 15.8 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.776 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLN . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 3.1 pt20 -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.753 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.93 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.93 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.997 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.715 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.897 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.917 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.997 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.887 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.897 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 1.001 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 63' ' ' SER . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.885 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.001 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.753 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.427 0.158 . . . . 7.77 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 42.77 -157.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.564 -0.902 . . . . 6.71 108.564 -178.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -87.63 25.09 1.54 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.83 -1.174 . . . . 3.93 107.83 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 43.4 t0 100.02 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 126.216 2.912 . . . . 6.04 103.767 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -160.35 -28.22 0.06 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 110.552 -3.022 . . . . 6.17 110.204 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.757 ' N ' HD22 ' A' ' 5' ' ' LEU . 14.0 t70 168.04 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.355 0.805 0 N-CA-C 113.809 1.04 . . . . 7.52 113.809 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.532 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 5.9 m -152.53 8.55 0.05 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.438 0 N-CA-C 117.691 2.478 . . . . 6.1 117.691 -175.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.664 HH11 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -115.46 157.77 23.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.152 1.342 . . . . 7.97 112.538 -175.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.602 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 81.3 p -112.27 84.57 1.99 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.136 -0.484 . . . . 3.21 112.29 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t 45.03 -144.0 0.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.937 -0.574 . . . . 2.83 111.359 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.57 110.488 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.16 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 20' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.9 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.986 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.94 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.93 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.89 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.4 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.91 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 2.91 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.21 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 1.58 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.25 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.28 113.922 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 0.96 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 36' ' ' VAL . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 0.93 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.77 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.894 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.18 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.579 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.07 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.22 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.58 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 0.96 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.723 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 0.98 110.986 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 0.89 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 26' ' ' ILE . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 0.91 110.317 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.95 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.503 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.52 110.905 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.65 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 0.65 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.1 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 2.53 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.51 110.346 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.32 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.07 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.3 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.34 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.25 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.32 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 3.75 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 3.98 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.95 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.05 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.616 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.68 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 2.83 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 4.64 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.838 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 4.66 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 1.96 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.98 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.29 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.08 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.63 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.02 113.634 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 2.77 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.31 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.894 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 0.67 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.594 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.23 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.27 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.938 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.15 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.512 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 0.64 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.555 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.59 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.84 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.35 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.3 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.17 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.13 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.83 110.798 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.13 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.07 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.938 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.928 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.16 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.86 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 92' ' ' SER . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.43 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.11 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 4.81 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.731 0.301 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.699 HG12 ' C ' ' A' ' 53' ' ' PRO . 18.4 m -64.9 124.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.042 ' HG ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -90.98 150.42 21.47 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.054 0.93 . . . . 0.0 112.449 179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 27.1 t70 -112.21 -33.44 6.22 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.687 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.42 -150.97 0.09 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.749 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -85.56 -12.9 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.926 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.042 HG12 ' HG ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -81.43 8.9 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 122.362 1.077 . . . . 0.0 108.546 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.823 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 75.6 mtt180 -64.6 155.42 33.26 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.066 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.1 75.38 0.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.117 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER -46.86 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.909 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.074 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.653 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.074 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.899 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.772 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.874 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.697 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.874 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.927 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.675 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.991 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.517 HG22 ' CG1' ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.927 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.722 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 42' ' ' LEU . 1.3 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.747 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.747 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.117 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.657 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.751 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.055 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.921 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.584 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.984 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.055 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.003 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.003 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.66 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.036 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.792 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.984 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.036 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.776 0.322 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 1' ' ' ALA . 9.3 m -158.47 -168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.701 HD13 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.23 165.8 24.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 7.1 t70 -80.12 -76.7 0.21 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.174 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD11 ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -72.96 -79.12 0.08 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.642 177.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.977 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.06 -60.1 0.11 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.59 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.575 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 12.9 m -120.05 -6.09 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.086 ' H ' HD11 ' A' ' 5' ' ' LEU . 50.7 mtt85 -90.99 -169.15 2.26 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.318 0.58 . . . . 0.0 111.951 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.747 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -89.71 -173.84 4.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.773 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 2.5 t -60.02 -93.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.362 -0.211 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.749 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.014 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.869 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.869 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.747 ' HE ' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.997 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.014 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.663 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.947 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.612 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.581 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.947 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.76 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.671 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.701 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.634 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.72 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.904 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.046 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.942 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.046 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.922 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.881 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.098 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.098 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.678 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.663 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.631 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.914 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.873 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.914 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.759 0.314 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 3' ' ' LEU . 6.3 t -81.34 165.56 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -73.64 175.02 7.52 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.041 0.924 . . . . 0.0 113.12 -178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.902 ' HB2' ' CA ' ' A' ' 55' ' ' GLN . 33.9 t70 -72.11 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.108 -1.406 . . . . 0.0 107.784 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.89 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.78 -82.48 0.14 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.816 0.817 . . . . 0.0 111.158 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.889 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -158.41 -28.9 0.08 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.914 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.89 HG22 HD21 ' A' ' 5' ' ' LEU . 33.4 m -108.82 -1.89 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.846 ' CD ' ' HA ' ' A' ' 54' ' ' CYS . 55.0 mtt85 -79.33 153.85 29.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.84 89.1 0.28 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m -76.01 -168.87 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.841 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.009 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.038 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.829 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.814 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.962 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.887 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.994 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.658 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.762 HD11 ' NH1' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 1.009 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.841 ' OE1' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.557 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.626 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.846 ' HA ' ' CD ' ' A' ' 8' ' ' ARG . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.902 ' CA ' ' HB2' ' A' ' 4' ' ' ASP . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.914 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.04 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.914 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.1 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.069 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.101 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.1 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.04 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.998 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.071 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.071 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.767 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.6 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.801 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.67 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.101 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.0 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.701 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.774 0.321 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 3' ' ' LEU . 3.0 t 65.81 164.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.756 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -68.99 167.42 15.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.332 0.587 . . . . 0.0 112.523 -178.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 15.0 t0 -81.21 -74.76 0.31 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.045 HD11 ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -75.69 -80.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.178 178.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.044 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -158.62 -58.51 0.07 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.197 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.606 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 17.1 m -120.33 -3.98 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.045 ' H ' HD11 ' A' ' 5' ' ' LEU . 57.7 mtt-85 -82.25 173.18 12.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.218 0.532 . . . . 0.0 112.236 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.58 -169.86 2.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m -147.16 -46.96 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.375 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.892 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.828 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.723 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 1.028 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.028 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.78 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.627 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.745 ' HA ' HD13 ' A' ' 3' ' ' LEU . 1.8 tt0 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.978 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.008 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.799 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.743 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.008 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.758 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.743 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.69 0.281 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.1 t -58.87 169.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.847 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.14 153.02 41.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 35.1 t70 -67.17 -127.61 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.799 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.015 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.0 pp -91.97 -137.49 0.16 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.714 ' N ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -72.41 -15.73 61.84 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.353 0.597 . . . . 0.0 109.608 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.015 ' H ' HD12 ' A' ' 5' ' ' LEU . 27.6 m -86.81 46.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.895 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.847 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 33.9 mtt180 -61.96 139.47 58.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.3 m 66.74 96.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.638 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m -42.54 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.904 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.036 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.036 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.73 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.86 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.907 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.86 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.782 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.018 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.991 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG22 ' CD1' ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.904 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.1 mp0 -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CD ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.521 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.032 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.057 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.057 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.032 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.963 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.016 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.713 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.858 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.717 ' C ' HD13 ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.792 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.766 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.057 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.712 ' H ' ' HD1' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.85 ' O ' ' HB3' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.42 0.153 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 17.6 m -56.66 162.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.66 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.963 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -70.77 152.48 43.74 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.067 0.936 . . . . 0.0 112.104 -177.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.78 -72.58 0.59 Allowed 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.344 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -91.75 -158.51 0.58 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.855 ' HA ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -93.27 -16.75 24.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 5' ' ' LEU . 17.2 m -84.19 -2.6 7.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.947 0.403 . . . . 0.0 111.718 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.821 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 32.7 mtt180 -119.88 -23.19 6.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.939 1.352 . . . . 0.0 113.159 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 6' ' ' ASP . 8.3 p -27.51 162.41 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.286 -2.688 . . . . 0.0 115.65 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.998 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m -44.9 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.739 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.793 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.793 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.781 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.942 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.874 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.998 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.792 ' HE1' ' HG3' ' A' ' 20' ' ' ARG . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.785 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.785 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.958 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.958 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.781 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.963 ' H ' ' HB2' ' A' ' 3' ' ' LEU . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.586 ' H ' HE21 ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.728 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.95 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.888 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.076 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.633 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.035 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.034 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.076 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.976 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.04 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.04 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.75 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.722 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.839 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.765 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.035 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.94 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H3 ' HD13 ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.809 0.338 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 m -70.72 144.89 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 112.239 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.02 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -68.51 -147.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.335 1.064 . . . . 0.0 113.844 -177.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 55' ' ' GLN . 15.0 t0 -157.12 -12.46 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.547 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.036 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -18.13 -77.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.794 -1.548 . . . . 0.0 113.97 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.967 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.5 -28.12 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.19 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.036 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -97.71 -2.92 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.868 ' HG3' HG23 ' A' ' 7' ' ' VAL . 84.4 mtt180 -149.47 -164.94 2.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -157.29 -173.53 4.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.038 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t -65.73 -173.33 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.672 HD13 ' H3 ' ' A' ' 1' ' ' ALA . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.126 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.883 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.724 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.126 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.655 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.789 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.789 ' HD3' ' C ' ' A' ' 58' ' ' GLN . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.984 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.752 ' O ' ' N ' ' A' ' 68' ' ' ALA . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.849 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.695 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.904 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.876 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.904 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.322 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 m -69.32 149.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 111.225 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.92 HD23 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -56.37 -177.59 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.731 ' HA ' ' N ' ' A' ' 55' ' ' GLN . 13.3 t70 -144.81 -25.28 0.5 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 111.646 -2.524 . . . . 0.0 109.62 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.077 HD21 HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -67.1 -135.84 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.014 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.922 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -97.73 -18.77 18.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.077 HG13 HD21 ' A' ' 5' ' ' LEU . 10.3 m -79.25 -6.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.266 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.92 ' HD2' HD23 ' A' ' 3' ' ' LEU . 17.8 mtt-85 -149.18 164.13 35.63 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.02 HG23 ' HG3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -167.93 128.77 1.39 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.58 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p -169.6 59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.874 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.874 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.796 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.871 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.674 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.871 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG13 HG13 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.577 ' OE1' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.733 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.696 ' CD2' ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.696 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.02 ' HG3' HG23 ' A' ' 9' ' ' THR . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.605 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.608 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.008 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.867 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.965 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.759 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.867 ' HD2' ' CB ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.008 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.842 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.676 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.996 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.039 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.982 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.8 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.834 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.03 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.039 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.847 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.918 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.788 0.327 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t -100.61 176.76 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.795 ' H ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -66.1 -177.68 0.53 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.854 0.835 . . . . 0.0 112.92 -177.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 24.8 t70 -83.13 -95.42 0.06 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.307 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.066 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.93 -75.95 0.2 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.737 0.779 . . . . 0.0 109.068 176.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.066 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -154.06 -48.06 0.09 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.277 -179.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 5' ' ' LEU . 27.5 m -104.47 -0.04 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 48.9 mtt85 -81.08 166.23 20.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.688 -0.632 . . . . 0.0 112.025 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 86.4 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m 62.84 -171.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD22 ' CG ' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.881 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.881 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.829 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.937 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 1.068 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.068 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.66 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.899 ' HB3' HD22 ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 49' ' ' TYR . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 1.008 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.671 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.671 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.795 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.3 mm-40 -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.892 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.951 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.691 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.937 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.874 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.031 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.008 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.951 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.91 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.925 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.746 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.019 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.701 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.052 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.031 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.911 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.019 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.955 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.052 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -62.15 169.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -63.1 163.91 9.31 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.95 0.881 . . . . 0.0 113.17 -177.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.6 -89.05 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.009 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.7 tp -85.57 -65.43 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.5 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.236 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.35 -0.6 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -79.13 176.27 9.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.784 HG23 ' NE2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -127.16 90.92 3.22 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.39 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.784 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 68.6 -168.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.44 -178.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.886 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 1.013 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.969 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.961 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.784 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.823 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.725 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.823 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.807 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.983 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.836 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.983 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.709 HG22 ' CG1' ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.807 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 1.013 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.886 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.784 ' NE2' HG23 ' A' ' 9' ' ' THR . 3.6 tt0 -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.838 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.835 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.033 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.88 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.087 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.964 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.927 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.087 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.033 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.961 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.039 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.039 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.845 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' C ' HD13 ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.774 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.044 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.808 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.964 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.044 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 54' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 1' ' ' ALA . 34.3 m 44.94 -174.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.277 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -79.26 -179.32 6.68 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.543 0.687 . . . . 0.0 112.57 -178.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.743 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 21.2 t70 -81.16 -77.24 0.21 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.821 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -86.99 -54.01 4.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.214 1.007 . . . . 0.0 108.81 176.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.047 ' HB2' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.25 -48.92 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.373 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.625 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 19.7 m -115.7 0.49 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.713 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.839 ' CG ' HD12 ' A' ' 5' ' ' LEU . 25.0 mtt180 -83.41 -169.48 2.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.847 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -130.97 -168.88 2.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.095 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.14 177.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.564 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.88 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.011 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.815 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.797 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.815 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.88 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.749 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.006 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.806 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.849 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.935 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' HB3' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.006 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.085 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.085 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.693 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.553 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.885 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.885 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.537 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.43 -179.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.034 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -68.99 160.16 31.45 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.38 -115.02 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.135 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -94.22 -144.33 0.24 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' H ' HD22 ' A' ' 5' ' ' LEU . 1.7 m-20 -80.86 -17.05 51.98 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.306 0.642 . . . . 0.0 111.632 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 5' ' ' LEU . 34.7 m -107.95 61.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.747 0.785 . . . . 0.0 109.461 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.034 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 14.2 mtt180 -69.99 -169.72 0.29 Allowed 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.673 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 34.94 39.0 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.643 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 55.08 176.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.017 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.804 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.804 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.905 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.762 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.79 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.835 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.779 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.681 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.0 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.666 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.738 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.895 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.895 ' HB3' ' H ' ' A' ' 38' ' ' THR . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.817 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 49' ' ' TYR . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.831 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.735 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.831 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.905 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.993 HD13 ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.094 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.094 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.726 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.729 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.993 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.84 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.994 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.051 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.73 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.894 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.994 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.692 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 30.8 m -58.27 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -71.89 171.41 11.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.773 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 35.8 t70 -72.52 -77.37 0.1 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.063 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.39 -59.64 2.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.063 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -160.03 -47.63 0.05 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.816 178.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.655 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -114.72 -1.3 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.958 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.866 ' CG ' HD12 ' A' ' 5' ' ' LEU . 54.9 mtt180 -82.58 154.02 25.2 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -73.85 -169.75 0.78 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -65.75 -171.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.479 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 52' ' ' SER . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.017 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HD2' HD11 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.836 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.953 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.781 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.836 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.017 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.957 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 4.0 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.863 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.688 ' CB ' ' HA ' ' A' ' 9' ' ' THR . 34.8 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.887 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 1.034 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.873 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.946 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.034 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.742 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.781 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.696 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.946 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.095 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.095 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.71 ' SG ' HD11 ' A' ' 26' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.873 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.689 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.934 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.689 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.676 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.15 136.29 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.33 168.74 16.74 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -81.41 -71.32 0.48 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.542 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -73.84 -78.3 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.922 178.275 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.99 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -156.31 -65.88 0.11 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.166 -2.288 . . . . 0.0 109.388 -178.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.76 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 9.2 m -128.27 -6.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.084 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 75.8 mtt180 -81.21 165.35 21.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.109 0.564 . . . . 0.0 112.312 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HH12 ' A' ' 20' ' ' ARG . 81.1 p -72.62 158.73 35.1 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m -77.73 -85.08 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.93 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.896 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.959 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.077 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.077 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.864 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.864 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.009 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.888 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.009 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.577 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.896 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.623 ' C ' HD12 ' A' ' 50' ' ' LEU . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD12 ' C ' ' A' ' 49' ' ' TYR . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.727 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.727 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 1.097 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.0 mm-40 -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.887 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.052 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.097 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.938 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.858 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.914 ' HB ' ' HB3' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.052 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.938 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.111 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.111 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.818 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.799 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.741 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.858 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.1 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.92 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.775 0.321 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.25 -169.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.951 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.24 158.55 34.75 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.769 0.795 . . . . 0.0 112.873 -178.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 5' ' ' LEU . 33.0 t70 -73.92 -129.45 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.227 -1.352 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.758 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 96.2 mt -90.33 -137.38 0.13 Allowed 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.0 -8.5 59.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.458 0.647 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -94.61 27.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 125.068 1.347 . . . . 0.0 110.535 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.951 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 82.0 mtt180 -54.72 -178.63 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 51.17 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.43 -171.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.301 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.063 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.957 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.063 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.957 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.854 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.792 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.885 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.81 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.885 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.79 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.951 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.676 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.79 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.714 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.063 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.747 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.909 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.866 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.747 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.955 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.952 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.996 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.054 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.895 ' CB ' ' HB3' ' A' ' 63' ' ' SER . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.007 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.007 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.619 ' CA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.083 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.034 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.909 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.996 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.906 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.083 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.034 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.946 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.767 ' HB1' ' NH1' ' A' ' 8' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.712 0.292 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 9' ' ' THR . 27.4 m -96.09 132.33 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.97 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.92 161.76 16.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.755 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 14.5 t70 -86.22 -29.18 23.37 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.648 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -71.94 -104.11 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.697 -178.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.047 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.19 -14.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.021 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 5' ' ' LEU . 17.2 m -82.53 -7.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.455 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.97 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 89.6 mtt180 -149.43 125.16 10.45 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.535 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.789 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.33 156.5 16.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.712 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 11' ' ' LEU . 1.9 t -56.2 -93.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.463 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 1.037 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.568 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.662 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 1.037 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.893 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.842 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.842 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.827 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.001 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.866 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.898 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.866 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.776 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.55 ' ND2' ' CE1' ' A' ' 49' ' ' TYR . 2.2 p-10 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.626 ' N ' HD22 ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.795 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.893 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.058 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.901 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.117 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.064 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.016 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.117 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.964 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.125 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.125 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.76 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.829 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.748 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.106 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.771 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.064 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.106 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.985 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -170.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.899 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.038 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -65.58 157.01 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -178.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.856 ' HB3' HG23 ' A' ' 7' ' ' VAL . 27.8 t0 -63.75 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.99 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.044 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -87.14 -107.66 0.06 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 121.633 -0.667 . . . . 0.0 111.061 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.044 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -84.45 -14.87 48.02 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.911 178.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.856 HG23 ' HB3' ' A' ' 4' ' ' ASP . 16.4 m -81.12 29.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.293 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.038 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 51.9 mtt85 -68.59 137.0 53.92 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.744 HG22 ' NH2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 43.63 72.94 0.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.999 0.904 . . . . 0.0 111.579 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.739 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m -78.98 -79.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.243 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.853 HD13 ' OG ' ' A' ' 52' ' ' SER . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.777 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.777 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 1.047 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.744 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.812 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.819 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.8 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.853 ' OG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.796 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 1.014 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.593 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.914 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.965 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.844 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.039 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.014 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.962 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.051 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HB3' ' HG3' ' A' ' 24' ' ' PRO . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.695 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 1.039 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.665 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.13 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.844 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.965 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 1.13 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.797 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.546 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 3' ' ' LEU . 2.6 t -62.44 163.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.422 . . . . 0.0 111.411 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.092 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -63.28 -154.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.622 1.201 . . . . 0.0 113.988 -177.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.14 -8.8 1.01 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.24 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.7 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 5.1 tp -55.57 -160.36 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.012 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -69.61 -20.66 63.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.692 HG23 HD13 ' A' ' 3' ' ' LEU . 2.8 m -84.91 32.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.6 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 5' ' ' LEU . 34.3 mtt180 -64.96 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.451 0.7 . . . . 0.0 112.322 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 9' ' ' THR . 1.2 m 74.44 86.41 0.1 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.693 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m -78.75 -138.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.586 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.717 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.916 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.717 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.784 ' HB2' HG21 ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.784 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.72 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.837 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.782 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' HD22 ' A' ' 50' ' ' LEU . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' CG ' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.797 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.928 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.877 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.561 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.876 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.904 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.928 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.572 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.644 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.876 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.675 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.766 0.317 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.99 129.09 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.952 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.25 153.66 40.53 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.35 -122.53 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.87 ' CD1' HG22 ' A' ' 7' ' ' VAL . 1.5 pp -96.1 -135.75 0.23 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.894 0.315 . . . . 0.0 111.239 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.562 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.6 m-20 -79.58 -10.47 59.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.155 0.502 . . . . 0.0 111.405 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.87 HG22 ' CD1' ' A' ' 5' ' ' LEU . 27.8 m -96.74 46.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.053 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.618 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 70.0 mtt180 -67.76 154.1 42.26 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.699 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 9' ' ' THR . 96.2 m 60.2 37.55 20.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.735 0.779 . . . . 0.0 109.574 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 9' ' ' THR . 54.4 m 24.11 -150.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.042 -1.436 . . . . 0.0 113.36 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.63 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.726 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.787 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.966 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.966 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.782 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.542 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.729 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 9' ' ' THR . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.688 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.01 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.88 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.888 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.001 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 1.01 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 1.002 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.704 ' C ' HD13 ' A' ' 72' ' ' ILE . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.822 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.764 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.888 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.848 ' O ' ' HA ' ' A' ' 52' ' ' SER . 3.2 t -74.72 172.81 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.005 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -70.99 178.27 3.28 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.798 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 52' ' ' SER . 4.2 t0 -75.79 -46.19 32.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.125 -177.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.13 -71.55 0.59 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 109.741 176.988 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.434 ' H ' ' CG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -152.69 -65.36 0.16 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.811 -1.995 . . . . 0.0 109.046 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.638 ' HA ' HD23 ' A' ' 3' ' ' LEU . 31.4 m -116.7 -1.38 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.822 ' HB2' HD21 ' A' ' 5' ' ' LEU . 49.2 mtt85 -119.78 131.59 55.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.222 0.465 . . . . 0.0 112.194 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.826 ' HA ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -58.8 141.23 53.69 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.999 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 4' ' ' ASP . 5.6 m 61.95 132.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.776 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.709 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.753 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 76' ' ' PRO . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.033 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.665 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 15.8 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.776 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' HD3' ' HA ' ' A' ' 3' ' ' LEU . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' THR . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 3.1 pt20 -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.753 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.93 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.93 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.997 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.715 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.897 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.917 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.997 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.887 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.897 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 1.001 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 63' ' ' SER . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.885 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.001 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.753 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 111.359 0.133 . . . . 2.8300000000000001 111.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.5699999999999998 110.488 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.1599999999999999 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 20' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.986 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68000000000000005 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.93999999999999995 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.93000000000000005 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.89000000000000001 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.3999999999999999 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.91000000000000003 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 2.9100000000000001 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.21 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 1.5800000000000001 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.25 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.28 113.922 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 0.95999999999999996 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 36' ' ' VAL . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 0.93000000000000005 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.77000000000000002 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.894 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.1799999999999999 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.579 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.0700000000000001 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.2200000000000002 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.5800000000000001 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 0.95999999999999996 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.723 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 0.97999999999999998 110.986 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 0.89000000000000001 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 26' ' ' ILE . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 0.91000000000000003 110.317 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.94999999999999996 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.503 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.52 110.905 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.6499999999999999 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 0.65000000000000002 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.1000000000000001 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 2.5299999999999998 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.5099999999999998 110.346 178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.3199999999999998 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.2999999999999998 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.3399999999999999 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.25 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.3199999999999998 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 3.75 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 3.98 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.9500000000000002 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.661 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.0499999999999998 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.616 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.6800000000000002 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 2.8300000000000001 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 4.6399999999999997 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.838 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 4.6600000000000001 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 1.96 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.97999999999999998 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.29 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.0800000000000001 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.6299999999999999 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.02 113.634 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 2.77 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.3100000000000001 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.894 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 0.67000000000000004 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.594 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.23 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.27 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.938 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.512 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 0.64000000000000001 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.555 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.58999999999999997 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.83999999999999997 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.3500000000000001 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.3 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.1699999999999999 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.1299999999999999 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.82999999999999996 110.798 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.491 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.1299999999999999 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.0700000000000001 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.938 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.928 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.1599999999999999 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.8600000000000001 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 92' ' ' SER . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.4299999999999999 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.1099999999999999 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 4.8099999999999996 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.117 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.074 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.653 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.074 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.899 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.772 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.874 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.697 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.874 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.927 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.675 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.991 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.517 HG22 ' CG1' ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.927 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.722 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.59 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.5 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.747 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.747 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 1.117 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.657 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.751 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.055 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.45 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.921 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.584 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.984 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.055 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.003 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.003 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.66 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.036 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.792 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.984 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.036 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.749 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.014 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.869 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.869 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.641 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.997 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.014 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.663 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.947 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.612 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.581 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.947 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.585 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.671 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.634 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.72 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.904 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.046 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.942 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.046 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.922 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.881 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.098 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.098 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.678 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.663 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.631 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.914 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.873 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.914 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.841 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.009 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.038 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.614 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.829 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.814 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.962 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.887 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.038 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.994 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.658 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.762 HD11 ' NH1' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 1.009 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.841 ' OE1' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.557 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.626 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.626 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.814 ' HG2' ' NE ' ' A' ' 20' ' ' ARG . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.914 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.04 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.914 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.1 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.069 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.101 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.1 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.04 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.998 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.071 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.071 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.767 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.6 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.801 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.67 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.101 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.0 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.701 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.708 0.289 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.892 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.828 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.723 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 1.028 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.028 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.78 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.627 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.978 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.008 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.552 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.799 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.743 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.008 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.758 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.743 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.638 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.904 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.036 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.036 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.73 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.86 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.907 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.86 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.782 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.018 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.991 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG22 ' CD1' ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.904 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CD ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.521 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.032 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.057 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.057 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.032 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.963 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.016 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.713 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.858 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.717 ' C ' HD13 ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.792 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.766 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.057 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.712 ' HD1' ' H ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.998 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.793 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.793 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.781 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.942 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.874 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.998 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.792 ' HE1' ' HG3' ' A' ' 20' ' ' ARG . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.785 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.785 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.958 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.791 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.958 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.781 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 52' ' ' SER . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.753 ' HG2' HH12 ' A' ' 20' ' ' ARG . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.586 ' H ' HE21 ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.728 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.95 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.888 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.076 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.633 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.035 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.034 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.076 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.976 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.04 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.04 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.75 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.722 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.839 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.765 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.035 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.94 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.652 0.263 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.126 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.883 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.724 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.126 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.655 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.789 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.789 ' HD3' ' C ' ' A' ' 58' ' ' GLN . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.984 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.752 ' O ' ' N ' ' A' ' 68' ' ' ALA . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.849 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.695 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.904 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.876 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.904 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.874 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.874 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.796 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.871 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.674 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.871 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG13 HG13 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.797 ' HB2' HE22 ' A' ' 45' ' ' GLN . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.797 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.733 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.696 ' CD2' ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.696 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.605 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.608 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.008 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.867 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.965 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.759 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.867 ' HD2' ' CB ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.008 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.842 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.676 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.996 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.039 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.982 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.8 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.834 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.03 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.039 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.847 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.918 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD22 ' CG ' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.881 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.881 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.829 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.937 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 1.068 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.068 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.66 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.899 ' HB3' HD22 ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 49' ' ' TYR . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 1.008 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.671 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.671 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.841 ' NE2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.892 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.951 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.841 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.937 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.874 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.031 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.008 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.951 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.91 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.925 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.746 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.019 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.701 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.052 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.031 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.911 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.019 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.955 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.052 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.784 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.886 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 1.013 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.969 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.961 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.784 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.823 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.725 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.823 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.807 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.983 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.836 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.983 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.709 HG22 ' CG1' ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.807 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 1.013 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.886 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.469 HE21 ' N ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.469 ' N ' HE21 ' A' ' 55' ' ' GLN . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.838 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.835 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.033 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.88 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.087 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.964 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.927 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.087 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.033 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.961 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.039 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.039 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.845 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.676 ' C ' HD13 ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.774 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.044 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.808 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.964 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.044 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.813 0.34 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.88 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.011 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.815 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.797 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.815 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.88 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.749 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.006 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.806 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.849 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.935 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' HB3' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.006 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.085 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.085 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.693 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.553 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.885 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.885 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.537 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 CA-C-O 120.656 0.265 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.804 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.804 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.905 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.762 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.79 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.835 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.779 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.681 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.0 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.666 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.738 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.895 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.895 ' HB3' ' H ' ' A' ' 38' ' ' THR . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.817 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 49' ' ' TYR . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.831 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.735 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.831 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.905 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.993 HD13 ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.094 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.094 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.726 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.729 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.993 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.84 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.994 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.051 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.736 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.73 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.894 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.994 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.692 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 52' ' ' SER . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.017 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HD2' HD11 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.676 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.836 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.953 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.781 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.836 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.017 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.957 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.2 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.567 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.77 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.863 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 52' ' ' SER . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 56' ' ' SER . 14.7 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.887 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 1.034 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.873 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.946 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.034 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.742 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.781 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.696 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.946 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.095 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.095 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.71 ' SG ' HD11 ' A' ' 26' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.873 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.689 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.934 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.689 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.676 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.539 0.209 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.896 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.959 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.077 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.077 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.864 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.864 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.009 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.888 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.009 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.577 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.896 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.623 ' C ' HD12 ' A' ' 50' ' ' LEU . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD12 ' C ' ' A' ' 49' ' ' TYR . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.727 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.727 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 1.097 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.887 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.052 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.097 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.938 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.858 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.914 ' HB ' ' HB3' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.052 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.938 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.111 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.111 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.818 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.799 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.741 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.858 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.1 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.92 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.158 0.504 . . . . 0.0 112.301 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.063 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.957 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.063 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.957 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.854 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.792 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.885 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.81 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.885 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.79 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.57 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.951 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.676 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.79 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.714 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.063 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.747 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.909 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.866 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.747 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.955 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.952 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.996 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.054 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.895 ' CB ' ' HB3' ' A' ' 63' ' ' SER . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.007 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.007 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.619 ' CA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.083 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.034 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.909 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.996 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.906 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.083 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.034 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.946 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 11' ' ' LEU . 1.9 t . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.584 0.23 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 1.037 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.568 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.662 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 1.037 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.893 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.842 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.842 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.827 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.001 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.666 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.866 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.898 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.866 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.776 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 46' ' ' GLU . 5.3 p30 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.795 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.893 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.412 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.058 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.901 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.117 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.064 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.016 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.117 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.964 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.125 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.125 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.76 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.829 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.748 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.106 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.771 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.064 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.106 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.985 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.739 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.853 HD13 ' OG ' ' A' ' 52' ' ' SER . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.777 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.777 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 1.047 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.744 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.812 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.819 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.8 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.853 ' OG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.624 ' HB3' ' O ' ' A' ' 54' ' ' CYS . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.796 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 1.014 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.593 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.914 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.965 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.844 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.039 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.014 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.962 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.051 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HB3' ' HG3' ' A' ' 24' ' ' PRO . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.695 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 1.039 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.665 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.13 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.844 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.965 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 1.13 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.797 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.546 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.717 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.916 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.717 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.784 ' HB2' HG21 ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.784 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.72 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.837 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.873 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.782 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' HD22 ' A' ' 50' ' ' LEU . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.459 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.797 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.928 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.877 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.561 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.876 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.904 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.928 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.644 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.876 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.675 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.545 0.775 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.63 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.726 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.787 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.966 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.966 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.782 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.542 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.729 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.688 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.01 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.88 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.888 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.001 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 1.01 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 1.002 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.704 ' C ' HD13 ' A' ' 72' ' ' ILE . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.822 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.764 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.888 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.776 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.709 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.753 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 76' ' ' PRO . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.033 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.665 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 3.2 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.776 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HG2' ' NE2' ' A' ' 55' ' ' GLN . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 55' ' ' GLN . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.753 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.93 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.93 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.997 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.715 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.897 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.917 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.997 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.887 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.897 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 1.001 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 63' ' ' SER . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.885 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.001 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.753 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.427 0.158 . . . . 7.7699999999999996 111.427 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 42.77 -157.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.564 -0.902 . . . . 6.71 108.564 -178.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -87.63 25.09 1.54 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.83 -1.174 . . . . 3.9300000000000002 107.83 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 43.4 t0 100.02 -50.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 126.216 2.912 . . . . 6.04 103.767 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -160.35 -28.22 0.06 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 110.552 -3.022 . . . . 6.1699999999999999 110.204 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.757 ' N ' HD22 ' A' ' 5' ' ' LEU . 14.0 t70 168.04 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.355 0.805 0 N-CA-C 113.809 1.04 . . . . 7.5199999999999996 113.809 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.532 ' HA ' ' HG ' ' A' ' 3' ' ' LEU . 5.9 m -152.53 8.55 0.05 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.438 0 N-CA-C 117.691 2.478 . . . . 6.0999999999999996 117.691 -175.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.664 HH11 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -115.46 157.77 23.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.152 1.342 . . . . 7.9699999999999998 112.538 -175.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.602 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 81.3 p -112.27 84.57 1.99 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.136 -0.484 . . . . 3.21 112.29 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 54' ' ' CYS . 1.3 t 45.03 -144.0 0.18 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.937 -0.574 . . . . 2.8300000000000001 111.359 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD23 ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -101.8 126.66 33.29 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-O 121.004 0.431 . . . . 2.5699999999999998 110.488 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 81.2 Cg_exo -49.17 168.39 0.12 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.654 2.236 . . . . 1.1599999999999999 112.834 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.565 ' HB2' ' CA ' ' A' ' 20' ' ' ARG . 14.2 t -145.97 169.0 19.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.762 0.315 . . . . 0.90000000000000002 111.362 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.986 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 76.85 -148.66 35.24 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 111.133 -0.787 . . . . 0.68000000000000005 111.133 176.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.34 90.62 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.592 2.194 . . . . 0.93999999999999995 112.084 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.13 -75.41 1.2 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.93000000000000005 112.049 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -169.2 37.98 0.2 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.323 -0.941 . . . . 0.89000000000000001 112.283 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -31.18 70.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.155 0.502 . . . . 1.3999999999999999 112.18 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -131.59 -140.0 4.48 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 120.72 -0.752 . . . . 0.91000000000000003 113.779 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.661 ' NH2' ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -172.52 -179.36 2.18 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.203 -0.295 . . . . 2.9100000000000001 110.203 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -104.38 137.91 41.57 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.195 0.521 . . . . 1.21 111.053 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 28' ' ' CYS . 2.8 m-85 -105.06 -14.78 15.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 120.462 -0.495 . . . . 1.5800000000000001 111.619 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.38 -92.29 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 119.417 -1.373 . . . . 1.25 114.684 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 88.6 Cg_endo -90.68 100.53 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.129 2.553 . . . . 1.28 113.922 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 40.68 28.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.224 -0.444 . . . . 0.95999999999999996 111.567 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 36' ' ' VAL . 10.3 tt -108.81 164.53 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.857 0.361 . . . . 0.93000000000000005 110.965 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.2 157.98 35.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.77000000000000002 110.836 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.894 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.82 131.24 10.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.323 -0.399 . . . . 1.1799999999999999 111.503 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.579 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -134.59 154.83 21.64 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.838 -0.696 . . . . 1.0700000000000001 112.578 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -81.02 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 N-CA-C 110.441 -0.207 . . . . 2.2200000000000002 110.441 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -1.57 30.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.113 0.482 . . . . 1.5800000000000001 110.654 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.986 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -88.97 -36.02 16.09 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.96 -0.564 . . . . 0.95999999999999996 111.431 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.13 -145.73 17.86 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.525 -1.03 . . . . 1.04 110.525 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.723 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.08 131.47 37.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.496 0.648 . . . . 0.97999999999999998 110.986 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 1.8 m-85 -125.9 144.23 50.76 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.473 -0.785 . . . . 0.89000000000000001 110.942 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 26' ' ' ILE . 3.0 t -130.17 101.38 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.043 -0.526 . . . . 0.91000000000000003 110.317 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.22 23.63 77.65 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.734 -0.746 . . . . 0.94999999999999996 111.801 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.503 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 1.3 m -103.01 168.35 9.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.78 0.324 . . . . 1.52 110.905 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.3 -40.79 49.52 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.189 -0.46 . . . . 1.2 110.788 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.98 9.59 9.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.335 -0.393 . . . . 1.6499999999999999 110.676 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.01 -1.58 6.51 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.358 0.599 . . . . 0.65000000000000002 110.419 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.57 -7.58 15.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.917 0.71 . . . . 1.1000000000000001 112.917 177.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -56.78 -22.5 36.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.824 0.305 . . . . 2.5299999999999998 111.824 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.6 m -59.28 -10.86 3.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.487 -0.485 . . . . 1.26 111.308 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -69.97 -29.46 66.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.346 -0.242 . . . . 2.5099999999999998 110.346 178.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 2.6 pt-20 -73.26 -21.54 60.59 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 120.533 -0.467 . . . . 3.3199999999999998 110.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -9.4 58.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 109.743 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -77.11 -22.95 51.93 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.494 -0.775 . . . . 3.2999999999999998 111.15 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -77.05 -67.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 5.3399999999999999 111.75 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -103.98 112.23 65.44 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 113.023 0.749 . . . . 4.25 113.023 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.23 88.9 0.11 Allowed 'Trans proline' 0 CA--C 1.507 -0.861 0 N-CA-C 106.641 -2.1 . . . . 3.3199999999999998 106.641 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' LEU . 11.0 m -115.27 133.99 22.63 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 113.062 0.764 . . . . 3.75 113.062 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 73.4 Cg_endo -74.3 -176.24 2.61 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.441 2.094 . . . . 3.98 107.663 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.585 ' O ' ' O ' ' A' ' 55' ' ' GLN . 3.2 p 162.28 118.64 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.6 0.636 . . . . 2.9500000000000002 111.884 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 27.25 -153.0 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.754 0.659 . . . . 4.0499999999999998 110.092 178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.616 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -173.52 -162.41 0.15 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 120.407 1.458 . . . . 3.6800000000000002 111.497 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . . . -32.02 148.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.134 -0.555 . . . . 2.8300000000000001 112.874 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 59' ' ' LYS . 1.9 mm-40 -113.0 92.17 3.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.83 0.348 . . . . 4.6399999999999997 110.324 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.838 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 24.25 93.17 0.04 OUTLIER Pre-proline 0 C--O 1.213 -0.85 0 CA-C-O 124.595 2.14 . . . . 4.6600000000000001 112.265 -175.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 73.1 Cg_exo -49.34 151.97 6.16 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.375 2.05 . . . . 1.96 112.867 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.31 165.25 24.62 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 124.631 1.207 . . . . 0.97999999999999998 108.842 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.14 20.55 32.63 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 120.661 -0.78 . . . . 1.29 113.254 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.469 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 26.5 t -103.46 17.94 22.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.288 -0.537 . . . . 1.0800000000000001 111.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.36 12.54 24.91 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.83 -0.983 . . . . 1.6299999999999999 115.44 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 163.11 -146.42 11.7 Favored Glycine 0 CA--C 1.494 -1.223 0 C-N-CA 119.547 -1.311 . . . . 1.02 113.634 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 26.5 mmt-85 -109.51 160.65 16.05 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.43 -0.952 . . . . 2.77 108.43 -172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.0 t -62.78 69.09 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 113.856 1.058 . . . . 1.3100000000000001 113.856 172.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.894 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -49.48 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.021 -0.99 . . . . 0.67000000000000004 112.64 -174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.594 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -132.48 150.3 52.18 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 114.016 1.117 . . . . 1.23 114.016 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . 25.17 42.5 0.0 OUTLIER 'General case' 0 C--N 1.368 1.374 0 O-C-N 124.377 1.048 . . . . 1.27 111.986 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.938 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 81.15 63.72 1.85 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 113.583 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.512 ' HB ' ' H ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -133.25 103.2 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.782 0 N-CA-C 109.678 -0.49 . . . . 0.64000000000000001 109.678 178.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.555 ' HB2' ' CB ' ' A' ' 82' ' ' ASP . 5.5 t -72.14 88.82 1.13 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.556 -0.905 . . . . 0.58999999999999997 108.556 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 t -123.21 154.83 38.22 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.865 1.061 . . . . 0.83999999999999997 113.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.638 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -135.08 -151.84 0.01 OUTLIER Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 106.696 -1.594 . . . . 1.3500000000000001 106.696 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 75' ' ' SER . 97.9 Cg_endo -83.19 -17.78 6.46 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.127 1.438 . . . . 1.3 111.582 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.05 -53.38 10.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.878 -0.601 . . . . 2.1699999999999999 111.227 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.71 163.96 36.0 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.266 -0.969 . . . . 1.1299999999999999 113.009 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 34.3 m -112.69 148.46 34.65 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-O 121.486 0.66 . . . . 0.82999999999999996 110.798 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.39 130.1 6.69 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 115.288 -0.869 . . . . 1.53 111.571 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.491 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 pt-20 -52.77 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.818 -0.438 . . . . 2.23 109.818 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 29.0 p-10 -84.44 114.73 56.73 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-O 120.845 0.355 . . . . 2.29 111.94 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.502 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 43.0 Cg_exo -56.88 -2.89 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.059 1.839 . . . . 1.1299999999999999 112.837 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -92.49 17.72 9.61 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 122.096 -0.377 . . . . 1.0700000000000001 111.765 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.938 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -145.39 -47.2 0.22 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.341 1.608 . . . . 1.25 115.341 -178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' ' CD ' ' A' ' 87' ' ' PRO . 6.7 t0 -174.79 -28.42 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 119.106 3.002 . . . . 1.54 119.106 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.928 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -93.27 -81.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.507 -0.855 0 CA-C-N 122.326 1.867 . . . . 1.1599999999999999 112.728 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.88 8.22 1.29 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.012 0.91 . . . . 1.8600000000000001 110.168 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 92' ' ' SER . . . -68.15 165.41 18.29 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 114.618 -1.174 . . . . 1.4299999999999999 111.616 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.75 -84.89 0.2 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-O 122.816 1.293 . . . . 2.1099999999999999 109.866 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.04 30.35 7.33 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 114.074 -1.421 . . . . 4.8099999999999996 110.58 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.699 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 10.8 t . . . . . 0 C--N 1.297 -1.714 0 CA-C-O 118.173 -0.917 . . . . 3.48 111.24 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.731 0.301 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.699 HG12 ' C ' ' A' ' 53' ' ' PRO . 18.4 m -64.9 124.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.042 ' HG ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -90.98 150.42 21.47 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.054 0.93 . . . . 0.0 112.449 179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 27.1 t70 -112.21 -33.44 6.22 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.687 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.42 -150.97 0.09 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.749 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -85.56 -12.9 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.926 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.042 HG12 ' HG ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -81.43 8.9 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-O 122.362 1.077 . . . . 0.0 108.546 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.823 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 75.6 mtt180 -64.6 155.42 33.26 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.066 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.1 75.38 0.32 Allowed 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.117 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 0.7 OUTLIER -46.86 171.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.909 179.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.4 mp -69.06 104.69 0.79 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 43.6 Cg_exo -46.88 168.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.442 2.095 . . . . 0.0 114.959 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 14.5 t -150.69 -159.39 1.03 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.429 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.02 -141.81 28.71 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.688 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.074 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 19.7 Cg_endo -86.29 80.14 1.78 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 123.912 3.075 . . . . 0.0 112.421 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.32 -62.15 0.56 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.343 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.653 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.62 35.64 0.07 OUTLIER Glycine 0 N--CA 1.441 -0.998 0 CA-C-O 122.333 0.963 . . . . 0.0 111.453 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.074 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mptt -68.02 -24.03 65.06 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.074 -1.563 . . . . 0.0 110.539 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.899 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.18 -148.8 4.94 Favored Glycine 0 N--CA 1.421 -2.335 0 CA-C-N 113.226 -1.807 . . . . 0.0 111.157 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.772 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.28 179.03 7.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.225 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -111.9 134.23 53.59 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.874 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -101.05 -1.39 34.32 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -175.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.05 -77.99 0.25 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 118.521 -1.8 . . . . 0.0 116.959 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.697 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 65.4 Cg_endo -95.91 87.05 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.988 1.792 . . . . 0.0 113.394 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.13 17.05 1.32 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 110.108 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.874 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.13 159.02 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.927 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -157.94 145.73 18.55 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 113.368 -1.742 . . . . 0.0 109.776 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.675 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -142.48 124.15 15.01 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -112.21 161.98 12.55 Favored Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.551 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.42 -81.02 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -4.25 18.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.194 0.997 . . . . 0.0 108.707 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -93.26 -16.9 24.26 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.204 -175.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 70.83 -160.96 53.97 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.997 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -113.05 140.37 47.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 117.651 0.725 . . . . 0.0 112.559 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.991 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.9 m-85 -131.6 153.92 49.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.854 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.517 HG22 ' CG1' ' A' ' 26' ' ' ILE . 3.0 t -142.03 124.12 13.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 110.052 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.31 6.57 6.0 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.742 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 12.0 p -76.42 -179.44 5.17 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.882 0.372 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -72.48 -43.03 64.25 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.66 9.41 2.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.451 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.927 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.26 -3.5 6.85 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.86 -12.96 28.36 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.722 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -49.04 -17.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -12.96 62.02 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.098 0.475 . . . . 0.0 110.511 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.59 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.5 mt-30 -63.59 -16.11 59.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.698 0.761 . . . . 0.0 109.389 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -81.46 -24.87 36.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.176 -1.375 . . . . 0.0 108.241 177.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.51 -0.44 37.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.685 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.2 -6.97 59.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -123.3 -33.18 3.31 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.777 0.322 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.58 139.65 22.32 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.747 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 65.4 Cg_exo -48.43 -179.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.898 2.399 . . . . 0.0 113.035 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -107.96 66.33 0.27 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.992 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.747 ' HD3' ' C ' ' A' ' 51' ' ' PRO . 64.4 Cg_endo -95.7 105.88 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.138 2.559 . . . . 0.0 112.165 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.117 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 14.8 p 173.22 126.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.657 ' HG2' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER 43.9 -162.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.131 178.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 17.2 t 179.45 104.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' NE2' ' A' ' 55' ' ' GLN . . . 59.74 124.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.859 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.751 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -121.99 137.48 54.78 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -12.35 83.12 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.078 0 CA-C-O 122.707 1.241 . . . . 0.0 113.253 -174.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.756 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 44.6 Cg_exo -55.41 168.02 1.67 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.497 3.465 . . . . 0.0 116.985 -176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.1 p -161.48 163.26 30.48 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.028 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.35 25.0 11.42 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.976 -1.466 . . . . 0.0 115.528 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.055 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -104.93 35.44 2.79 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.68 6.3 59.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.737 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.32 -147.51 15.4 Favored Glycine 0 CA--C 1.5 -0.849 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.921 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.2 mmt-85 -92.83 -175.34 3.88 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.014 -0.593 . . . . 0.0 112.495 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.43 52.76 1.68 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.219 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.925 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -22.51 -65.19 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.584 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -165.46 142.21 5.56 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.307 0.958 . . . . 0.0 110.2 -176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.984 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 25.58 44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.384 1.053 . . . . 0.0 110.19 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 79.24 89.25 0.46 Allowed Glycine 0 N--CA 1.41 -3.095 0 CA-C-O 122.566 1.092 . . . . 0.0 110.393 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.4 mm -156.63 103.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.055 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.9 t -86.28 98.63 11.06 Favored 'General case' 0 N--CA 1.396 -3.136 0 N-CA-C 103.128 -2.915 . . . . 0.0 103.128 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.925 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -137.68 145.29 42.43 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 113.927 -1.488 . . . . 0.0 114.773 -171.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.003 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.5 m -126.56 -140.05 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.51 -2.132 . . . . 0.0 107.834 175.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.003 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.5 Cg_endo -92.22 -28.48 0.15 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 121.85 1.696 . . . . 0.0 108.836 175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.78 -52.75 64.12 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.575 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.08 157.32 28.67 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.671 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.9 m -117.05 144.44 44.63 Favored 'General case' 0 CA--C 1.476 -1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 110.157 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.66 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.12 138.95 17.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.646 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.804 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -55.11 115.26 2.13 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.791 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 34.0 p30 -99.42 106.12 37.41 Favored Pre-proline 0 N--CA 1.423 -1.804 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.327 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.036 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.1 Cg_exo -58.34 -16.47 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.612 2.875 . . . . 0.0 108.74 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.76 -18.92 65.62 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.766 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.792 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.99 -33.28 4.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.711 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.4 t70 166.58 -21.92 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.415 1 N-CA-C 121.92 4.044 . . . . 0.0 121.92 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.984 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -97.83 -67.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.474 -2.485 0 CA-C-N 122.037 1.763 . . . . 0.0 112.943 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.036 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.9 tt0 -80.59 2.75 24.35 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.706 -2.043 . . . . 0.0 106.914 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.879 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.65 -179.51 1.42 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 109.574 -3.466 . . . . 0.0 119.128 -173.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.46 -156.42 0.56 Allowed 'General case' 0 N--CA 1.431 -1.401 1 CA-C-N 106.936 -4.665 . . . . 0.0 107.513 175.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -79.0 55.47 1.79 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.249 1.074 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.115 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.776 0.322 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 1' ' ' ALA . 9.3 m -158.47 -168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.701 HD13 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.23 165.8 24.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 7.1 t70 -80.12 -76.7 0.21 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.174 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD11 ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -72.96 -79.12 0.08 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.642 177.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.977 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.06 -60.1 0.11 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.59 -179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.575 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 12.9 m -120.05 -6.09 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.086 ' H ' HD11 ' A' ' 5' ' ' LEU . 50.7 mtt85 -90.99 -169.15 2.26 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.318 0.58 . . . . 0.0 111.951 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.747 ' HB ' ' HE ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -89.71 -173.84 4.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.773 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 2.5 t -60.02 -93.3 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.362 -0.211 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -121.75 118.24 29.59 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.749 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.9 Cg_exo -47.67 170.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.601 2.201 . . . . 0.0 114.881 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.873 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 22.6 t -147.54 -162.74 1.61 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.225 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.014 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.89 -143.98 13.22 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.312 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.869 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 Cg_endo -84.14 83.35 1.73 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.744 2.963 . . . . 0.0 113.189 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.67 -63.79 0.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.772 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.28 38.59 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 122.051 0.806 . . . . 0.0 111.165 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.869 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -69.79 -22.45 63.32 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 113.46 -1.37 . . . . 0.0 110.336 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -149.8 -151.99 5.65 Favored Glycine 0 N--CA 1.424 -2.151 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.431 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.747 ' HE ' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -162.75 176.74 9.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.615 -0.793 . . . . 0.0 109.57 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -106.13 130.96 53.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -96.67 -1.89 45.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.88 -76.01 0.26 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.405 -1.855 . . . . 0.0 117.135 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.997 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 92.8 Cg_endo -93.78 81.95 0.18 Allowed 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.388 2.059 . . . . 0.0 113.076 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.2 t 52.72 21.65 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -101.78 160.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -157.32 147.07 20.46 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.633 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.95 127.62 18.08 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.69 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.09 171.79 14.35 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.475 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.75 -80.46 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.54 -2.0 23.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.014 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -89.93 -23.01 21.69 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.123 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.48 -161.48 52.78 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.541 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.663 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -117.89 138.07 52.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.434 0.617 . . . . 0.0 112.042 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.947 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -131.64 161.79 31.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.847 177.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.612 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.7 t -138.58 92.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 121.478 0.656 . . . . 0.0 109.979 176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 85.26 -2.43 88.15 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.265 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.581 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 16.7 p -65.28 175.89 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.899 0.349 . . . . 0.0 110.227 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -59.43 -46.5 88.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 110.521 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -76.58 8.13 3.86 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.947 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -123.03 -3.58 8.57 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.64 -13.65 34.2 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.984 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.22 -17.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -1.11 2.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.585 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.25 -10.75 45.13 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -80.86 -17.96 48.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.829 176.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 3.6 tt0 -68.81 0.49 4.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.64 -4.06 2.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.959 0.409 . . . . 0.0 110.382 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 21.4 p90 -160.76 112.59 1.9 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.52 104.39 23.76 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.659 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 89.5 Cg_exo -52.74 -168.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.092 2.528 . . . . 0.0 112.653 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.671 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -92.56 -48.92 0.3 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.416 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 63.4 Cg_endo -92.9 88.04 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.877 2.385 . . . . 0.0 112.723 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.0 t -117.76 163.7 16.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.701 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -134.44 160.43 38.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 111.711 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HH22 ' A' ' 20' ' ' ARG . 42.6 t 170.66 170.19 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.16 99.56 0.21 Allowed Glycine 0 CA--C 1.509 -0.314 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.61 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.634 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -123.68 161.19 25.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.73 86.79 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 122.543 1.163 . . . . 0.0 112.524 -173.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.72 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.9 Cg_exo -55.48 166.2 2.76 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.058 3.839 . . . . 0.0 117.173 -177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.63 159.8 33.54 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.849 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.38 25.89 8.69 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.249 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.904 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -106.53 37.01 2.42 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.56 4.08 59.46 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 115.006 -0.997 . . . . 0.0 114.841 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 158.99 -144.5 10.35 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.922 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.1 mmt-85 -94.09 -175.85 3.82 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.943 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 68' ' ' ALA . 48.7 t -77.9 50.23 0.85 Allowed 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.053 0.454 . . . . 0.0 110.225 176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.046 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.8 -64.99 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -159.92 144.52 14.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.368 0.986 . . . . 0.0 111.84 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.982 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 18.23 65.29 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.883 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.942 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.67 82.57 0.06 OUTLIER Glycine 0 N--CA 1.412 -2.932 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.317 -176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.046 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -155.82 103.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.922 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -86.65 101.04 12.89 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.881 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 4.1 t -139.05 148.36 43.27 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.098 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -129.14 -137.41 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 112.414 -2.176 . . . . 0.0 107.973 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.098 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.2 Cg_endo -90.19 -29.69 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.32 1.347 . . . . 0.0 109.193 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.678 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -58.43 -52.47 65.49 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 113.451 -1.704 . . . . 0.0 110.322 -177.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.31 155.25 18.61 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.92 174.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.8 m -110.21 138.16 46.96 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-O 121.582 0.706 . . . . 0.0 109.867 176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.663 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -147.92 135.61 20.89 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.489 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.631 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.89 114.67 1.36 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 36.5 p30 -100.68 102.8 20.64 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.914 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 68.4 Cg_exo -55.59 -17.71 18.09 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.603 2.869 . . . . 0.0 108.776 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.25 -16.36 63.95 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.305 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.873 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -121.46 -29.2 4.48 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.785 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 10.9 t70 165.77 -22.82 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.133 0 N-CA-C 121.744 3.979 . . . . 0.0 121.744 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.5 Cg_endo -102.28 -68.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.939 0 CA-C-N 122.318 1.864 . . . . 0.0 113.996 -172.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.914 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 21.0 tt0 -78.75 4.07 14.84 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.844 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.83 175.95 2.23 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 120.057 3.355 . . . . 0.0 120.057 -173.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.71 -157.23 0.59 Allowed 'General case' 0 N--CA 1.426 -1.664 1 CA-C-N 107.305 -4.498 . . . . 0.0 106.246 174.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -76.6 55.19 1.01 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.503 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 6.4 t . . . . . 0 C--O 1.249 1.068 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.238 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.759 0.314 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.592 ' H ' ' NE2' ' A' ' 58' ' ' GLN . 6.3 t -81.34 165.56 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -73.64 175.02 7.52 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.041 0.924 . . . . 0.0 113.12 -178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.902 ' HB2' ' CA ' ' A' ' 55' ' ' GLN . 33.9 t70 -72.11 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.108 -1.406 . . . . 0.0 107.784 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.89 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -82.78 -82.48 0.14 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.816 0.817 . . . . 0.0 111.158 178.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.889 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -158.41 -28.9 0.08 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.914 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.89 HG22 HD21 ' A' ' 5' ' ' LEU . 33.4 m -108.82 -1.89 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.846 ' CD ' ' HA ' ' A' ' 54' ' ' CYS . 55.0 mtt85 -79.33 153.85 29.51 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.84 89.1 0.28 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.791 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.566 ' SG ' ' HB3' ' A' ' 55' ' ' GLN . 7.4 m -76.01 -168.87 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.696 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.841 HD22 ' OE1' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -105.78 147.46 34.77 Favored Pre-proline 0 N--CA 1.467 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 12.5 Cg_exo -62.41 -178.72 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.482 2.121 . . . . 0.0 113.528 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.009 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 15.5 t -148.3 -162.28 1.52 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.322 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.038 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.56 -146.7 15.9 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.618 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.829 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.66 85.4 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.85 3.033 . . . . 0.0 112.834 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.39 -65.96 0.41 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.455 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.614 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -179.53 35.08 0.07 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 CA-C-O 122.136 0.853 . . . . 0.0 111.496 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.829 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.19 -26.18 66.5 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.242 -1.479 . . . . 0.0 110.791 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -140.25 -152.22 5.77 Favored Glycine 0 N--CA 1.418 -2.532 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.284 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.814 ' NE ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.3 -178.15 5.33 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.001 -1.099 . . . . 0.0 110.443 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -106.4 127.15 53.06 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.8 m-85 -95.7 -4.23 44.56 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.41 -75.63 0.29 Allowed Glycine 0 CA--C 1.518 0.274 0 N-CA-C 117.317 1.687 . . . . 0.0 117.317 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.962 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 63.0 Cg_endo -96.28 87.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.868 1.712 . . . . 0.0 113.566 -175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.33 16.97 0.95 Allowed 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.186 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.887 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -100.62 158.16 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.434 1.111 . . . . 0.0 113.922 -176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -155.24 144.24 20.81 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.548 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.28 129.96 19.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.841 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -115.19 169.34 12.84 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -72.62 -81.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.178 0.989 . . . . 0.0 108.365 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -0.83 14.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.932 0.872 . . . . 0.0 108.706 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.038 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -91.33 -23.94 19.96 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.876 -1.511 . . . . 0.0 114.327 -174.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.56 -163.39 52.73 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.255 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -111.88 137.64 49.57 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.994 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.92 123.4 27.35 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.462 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -109.0 117.26 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.453 0.645 . . . . 0.0 110.156 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.15 12.79 17.76 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.334 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.658 HG22 ' H ' ' A' ' 39' ' ' ALA . 19.2 m -85.87 177.56 7.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.732 0.301 . . . . 0.0 110.875 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.658 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.57 -51.8 68.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.887 0.375 . . . . 0.0 111.033 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -68.12 9.25 0.33 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.611 179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.805 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.52 -2.12 6.16 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.762 HD11 ' NH1' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -62.63 -11.7 18.59 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.362 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 1.009 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 2.0 mpp_? -48.73 -17.68 0.2 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.5 m -67.98 -9.89 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -63.7 -18.2 63.76 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 121.964 0.888 . . . . 0.0 108.886 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.841 ' OE1' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -81.34 -20.93 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.73 177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.8 mt-10 -76.58 -1.01 25.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.943 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.6 -4.89 42.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.185 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -132.67 7.28 4.1 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.363 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -143.33 79.41 14.09 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.073 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -53.28 -163.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.072 2.515 . . . . 0.0 113.44 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.557 ' OG ' ' HD2' ' A' ' 53' ' ' PRO . 5.2 t 75.93 155.54 0.15 Allowed Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.712 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.626 ' HG2' ' H ' ' A' ' 54' ' ' CYS . 72.2 Cg_endo -90.09 -72.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.527 2.818 . . . . 0.0 112.215 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.846 ' HA ' ' CD ' ' A' ' 8' ' ' ARG . 31.6 p 58.61 155.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.068 0.947 . . . . 0.0 112.319 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.902 ' CA ' ' HB2' ' A' ' 4' ' ' ASP . 25.4 tp60 45.06 -95.91 0.02 OUTLIER 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.156 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.627 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 79.1 p 46.64 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.2 138.17 0.01 OUTLIER Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.466 0.547 . . . . 0.0 114.466 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.914 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -115.06 176.1 5.21 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.833 0.853 . . . . 0.0 111.097 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -10.11 94.07 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-O 123.34 1.543 . . . . 0.0 112.985 -174.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 87.0 Cg_exo -51.16 165.32 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.925 1 C-N-CA 126.006 4.47 . . . . 0.0 117.733 -176.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.9 p -158.61 162.41 37.31 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.313 -1.767 . . . . 0.0 113.047 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.15 23.52 14.46 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 113.978 -1.465 . . . . 0.0 115.173 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.04 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.9 t -104.49 36.9 2.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.58 0.705 . . . . 0.0 109.365 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.57 7.61 60.2 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.625 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.73 -147.05 14.92 Favored Glycine 0 CA--C 1.497 -1.075 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.914 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 8.3 mmt-85 -92.11 -177.57 4.72 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.91 -0.645 . . . . 0.0 112.298 -173.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.7 t -77.92 50.14 0.84 Allowed 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.1 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -23.31 -66.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -161.95 145.28 12.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.761 -0.587 . . . . 0.0 111.003 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.069 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 17.92 63.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.028 0.83 . . . . 0.0 111.301 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.101 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 64.18 81.17 0.12 Allowed Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.1 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.28 99.23 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.523 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.04 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.06 98.58 10.5 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.998 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 3.9 t -134.98 143.03 46.62 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.071 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 66.1 m -123.99 -140.02 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 112.695 -2.048 . . . . 0.0 107.298 176.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.071 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_endo -91.06 -28.64 0.18 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 CA-C-N 121.621 1.615 . . . . 0.0 108.851 175.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.77 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -56.79 -50.22 72.98 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.564 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.44 153.85 11.92 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.029 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.767 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -104.47 143.43 33.03 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.511 0.672 . . . . 0.0 110.06 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.6 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -149.93 137.85 20.23 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.374 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.801 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 7.6 pt-20 -52.33 112.44 0.81 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.849 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.6 p30 -98.34 103.64 19.2 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.674 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.0 Cg_exo -57.29 -13.7 13.58 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.545 2.83 . . . . 0.0 109.179 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -70.12 -18.38 63.23 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 112.526 -2.125 . . . . 0.0 109.42 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.67 ' HB2' ' OD1' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -124.17 -26.28 4.02 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 -178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.701 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 12.4 t0 171.56 -27.24 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.044 1 N-CA-C 122.372 4.212 . . . . 0.0 122.372 -177.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.101 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.9 Cg_endo -106.21 -69.87 0.0 OUTLIER 'Trans proline' 0 CA--C 1.483 -2.054 0 C-N-CA 122.015 1.81 . . . . 0.0 114.401 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 11.4 tt0 -77.34 4.11 11.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 123.644 1.688 . . . . 0.0 107.029 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.0 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -63.86 170.19 3.63 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 120.722 3.601 . . . . 0.0 120.722 -172.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.66 -150.59 0.39 Allowed 'General case' 0 N--CA 1.422 -1.872 1 CA-C-N 106.572 -4.831 . . . . 0.0 106.144 174.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -74.83 56.96 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.701 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 39.3 p . . . . . 0 C--O 1.247 0.97 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.883 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.774 0.321 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 3' ' ' LEU . 3.0 t 65.81 164.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.756 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -68.99 167.42 15.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.332 0.587 . . . . 0.0 112.523 -178.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.538 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 15.0 t0 -81.21 -74.76 0.31 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.045 HD11 ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -75.69 -80.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.178 178.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.044 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -158.62 -58.51 0.07 Allowed 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.197 -179.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.606 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 17.1 m -120.33 -3.98 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.045 ' H ' HD11 ' A' ' 5' ' ' LEU . 57.7 mtt-85 -82.25 173.18 12.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.218 0.532 . . . . 0.0 112.236 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.58 -169.86 2.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 79.8 m -147.16 -46.96 0.17 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.375 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.5 90.16 47.42 Favored Pre-proline 0 C--O 1.239 0.527 0 CA-C-O 121.046 0.45 . . . . 0.0 110.892 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 Cg_endo -80.75 176.29 9.18 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.677 2.252 . . . . 0.0 112.752 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.6 t -142.48 -163.97 1.72 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.692 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.764 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.21 -141.46 43.69 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.24 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 35.8 Cg_endo -84.72 97.74 0.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.862 3.042 . . . . 0.0 113.24 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.78 -70.54 1.84 Allowed Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.249 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.892 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -173.44 29.62 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-O 121.613 0.563 . . . . 0.0 112.33 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mptt -64.98 -60.56 2.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.368 -0.916 . . . . 0.0 110.0 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.828 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -81.13 -158.51 20.39 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.142 -1.028 . . . . 0.0 115.242 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.7 OUTLIER -153.71 160.54 42.36 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 112.913 -1.644 . . . . 0.0 113.097 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.78 128.23 46.91 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.394 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.725 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.2 m-85 -106.89 15.76 25.07 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.36 -78.09 0.35 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 117.725 1.85 . . . . 0.0 117.725 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 51.5 Cg_endo -100.84 102.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.352 2.034 . . . . 0.0 114.747 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.01 23.41 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.723 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.1 tt -112.88 155.32 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-O 122.225 1.012 . . . . 0.0 113.203 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -158.24 138.11 12.18 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.457 -1.702 . . . . 0.0 108.945 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 34.1 m -144.11 114.28 7.41 Favored 'General case' 0 N--CA 1.414 -2.25 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.554 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 1.028 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.16 160.77 25.05 Favored Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.027 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -72.69 0.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.5 0.0 24.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.896 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.028 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -107.49 -4.49 18.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.96 -1.473 . . . . 0.0 114.376 -174.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 84.74 -154.79 29.83 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.472 -0.87 . . . . 0.0 114.572 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.78 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.84 109.55 7.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.285 0.234 . . . . 0.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.627 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.1 m-85 -108.09 154.36 21.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.944 0.402 . . . . 0.0 111.879 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG13 HG13 ' A' ' 26' ' ' ILE . 2.9 t -141.52 109.42 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.424 0.631 . . . . 0.0 109.763 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 67.15 24.25 73.27 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.797 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.591 ' O ' ' N ' ' A' ' 41' ' ' ALA . 11.9 m -107.0 160.9 15.19 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.606 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -41.66 -53.82 3.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.531 0.682 . . . . 0.0 109.519 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.18 10.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.226 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . -137.39 5.68 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.89 -11.58 60.72 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.339 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.727 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -57.92 -12.62 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.0 m -76.62 -17.48 59.15 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.805 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.51 -29.37 70.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.727 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 14.8 mt-10 -63.83 -31.4 72.57 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 112.868 -1.969 . . . . 0.0 109.215 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.67 -4.04 57.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.587 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -100.92 -7.88 23.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.639 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.58 -19.68 17.45 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 0.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' SER . 6.7 tp -143.94 92.1 6.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.464 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 52' ' ' SER . 53.5 Cg_exo -45.77 84.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.15 2.567 . . . . 0.0 113.305 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.7 t 172.68 113.85 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 66.6 Cg_endo -95.12 -61.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.992 2.461 . . . . 0.0 112.633 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.636 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 38.9 t 79.61 147.84 0.09 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.09 0.556 . . . . 0.0 110.025 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.745 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 64.3 10.87 5.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.439 . . . . 0.0 110.507 -177.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.2 p -63.44 159.32 18.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 120.76 0.314 . . . . 0.0 110.393 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.44 97.89 0.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.741 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 54.8 mt-30 -57.65 130.04 44.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.671 0.272 . . . . 0.0 110.387 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -94.3 43.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 86.6 Cg_exo -42.95 137.65 4.32 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.059 1.839 . . . . 0.0 114.589 -176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -152.38 146.34 25.26 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.011 0.91 . . . . 0.0 113.103 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.94 0.44 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 113.301 -1.772 . . . . 0.0 115.939 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.757 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 16.5 t -93.06 38.06 1.03 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.963 1.382 . . . . 0.0 109.596 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.36 53.76 40.77 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 114.488 -1.233 . . . . 0.0 114.928 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.5 26.46 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.159 -0.544 . . . . 0.0 113.352 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 mmt180 -105.58 154.93 19.73 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.741 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 27.1 t -72.43 57.86 0.39 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.071 0.462 . . . . 0.0 112.028 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -39.4 -98.81 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.419 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -68.85 -159.87 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.978 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -63.96 104.46 0.71 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.187 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.008 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 59.24 29.32 65.64 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 118.857 -1.639 . . . . 0.0 112.852 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -109.12 138.02 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.0 t -121.52 104.53 9.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.735 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 16.7 t -134.47 161.25 35.56 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.235 -1.802 . . . . 0.0 111.59 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.923 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -113.78 -137.23 0.0 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.923 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 91.2 Cg_endo -92.39 -28.49 0.14 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 120.667 1.274 . . . . 0.0 109.767 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.552 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -70.89 -59.3 2.87 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 113.372 -1.74 . . . . 0.0 113.232 -173.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.14 153.46 24.75 Favored Glycine 0 C--N 1.346 1.088 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.035 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 3.2 m -115.34 138.27 51.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -140.62 121.63 14.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.04 -178.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -46.87 117.69 1.77 Allowed 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.799 ' CG ' ' HB2' ' A' ' 73' ' ' CYS . 18.5 p-10 -96.18 109.37 46.83 Favored Pre-proline 0 N--CA 1.435 -1.22 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.01 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.743 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 67.0 Cg_exo -54.55 -21.88 26.01 Favored 'Trans proline' 0 CA--C 1.5 -1.184 0 C-N-CA 123.809 3.006 . . . . 0.0 108.729 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.48 73.1 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.13 -1.85 . . . . 0.0 108.806 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.008 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -98.53 -35.28 10.29 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.758 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 11.8 t0 166.32 -21.99 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.054 1 N-CA-C 121.901 4.037 . . . . 0.0 121.901 -176.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.8 Cg_endo -102.35 -68.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 CA-C-N 122.692 1.997 . . . . 0.0 113.138 -172.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.743 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.1 tt0 -71.29 -4.47 26.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.16 -175.17 0.2 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 120.27 3.433 . . . . 0.0 120.27 -173.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.23 -158.24 0.66 Allowed 'General case' 0 N--CA 1.437 -1.114 2 CA-C-N 107.158 -4.565 . . . . 0.0 106.828 175.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.53 1.88 0.32 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 119.6 1.091 . . . . 0.0 111.126 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 28.8 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.791 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.69 0.281 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.1 t -58.87 169.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.847 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.14 153.02 41.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . 35.1 t70 -67.17 -127.61 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.799 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.015 HD12 ' H ' ' A' ' 7' ' ' VAL . 3.0 pp -91.97 -137.49 0.16 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.714 ' N ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -72.41 -15.73 61.84 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.353 0.597 . . . . 0.0 109.608 178.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.015 ' H ' HD12 ' A' ' 5' ' ' LEU . 27.6 m -86.81 46.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.895 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.847 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 33.9 mtt180 -61.96 139.47 58.4 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.3 m 66.74 96.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.638 ' HB2' ' NH1' ' A' ' 20' ' ' ARG . 13.7 m -42.54 175.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD22 ' CD ' ' A' ' 46' ' ' GLU . 1.4 tp -67.37 133.46 93.13 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.695 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.6 Cg_exo -65.97 -174.77 0.42 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.465 2.11 . . . . 0.0 113.265 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.904 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 9.2 t -148.81 -162.43 1.56 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.803 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.018 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.93 -141.63 28.69 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.348 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.036 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.4 Cg_endo -87.52 80.71 1.29 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.072 3.181 . . . . 0.0 113.284 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.94 -62.52 0.51 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.049 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.73 35.67 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.795 0 CA-C-O 122.204 0.891 . . . . 0.0 111.526 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.036 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.09 -23.08 64.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.343 -1.429 . . . . 0.0 110.681 179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -147.59 -149.14 4.9 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.143 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.73 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.62 -179.86 7.2 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.353 -0.923 . . . . 0.0 109.744 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -113.27 132.39 55.55 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.86 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -99.59 1.06 43.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.65 -75.46 0.34 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 118.494 -1.812 . . . . 0.0 117.149 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.907 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 89.3 Cg_endo -93.73 83.59 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.856 1.704 . . . . 0.0 113.604 -176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 54.46 17.71 1.69 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.86 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -100.09 160.05 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.782 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -158.17 146.46 18.74 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.357 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.66 124.06 13.1 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.109 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.809 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -112.81 166.92 12.2 Favored Glycine 0 N--CA 1.427 -1.929 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.447 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 32' ' ' LEU . 28.5 t70 -72.31 -80.95 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -0.11 12.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.026 0.917 . . . . 0.0 108.677 175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.018 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -93.94 -22.2 18.74 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.936 -1.484 . . . . 0.0 114.204 -175.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.45 -159.73 51.59 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.838 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -118.64 138.1 52.83 Favored 'General case' 0 C--N 1.32 -0.702 0 O-C-N 122.183 -0.598 . . . . 0.0 112.414 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.991 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.7 121.02 22.48 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.047 177.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG22 ' CD1' ' A' ' 26' ' ' ILE . 9.0 t -106.71 118.94 55.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.01 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.45 23.47 60.39 Favored Glycine 0 C--N 1.319 -0.37 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.818 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.4 m -98.66 175.92 5.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.79 0.328 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.14 -55.05 38.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 121.187 0.518 . . . . 0.0 110.888 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 9.03 0.27 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.375 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.991 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -127.93 -1.74 5.91 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.31 -12.58 43.3 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.576 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.904 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 1.3 mpp_? -48.73 -20.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -20.02 60.57 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.429 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -67.09 -20.95 65.88 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.798 0.809 . . . . 0.0 109.2 177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CD ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -75.17 -23.73 57.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.628 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.52 -0.88 27.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.481 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.22 4.84 32.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.477 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.74 -37.16 6.48 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.84 0.352 . . . . 0.0 110.653 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.2 100.69 4.88 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -42.69 112.22 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.826 2.351 . . . . 0.0 112.977 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.471 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -141.71 52.36 2.67 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.572 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 52' ' ' SER . 90.8 Cg_endo -86.26 72.59 3.75 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.394 2.062 . . . . 0.0 111.557 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 4' ' ' ASP . 11.8 p -77.44 -151.68 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.524 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -31.95 154.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.909 0.884 . . . . 0.0 113.274 -179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.521 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 37.5 t -179.19 158.35 0.89 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.163 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.42 104.52 2.66 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.468 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.745 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -124.11 146.29 48.72 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -15.98 85.47 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 122.546 1.165 . . . . 0.0 112.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 45.0 Cg_exo -52.82 166.27 0.93 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 124.982 3.788 . . . . 0.0 117.06 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.8 p -158.41 162.48 37.6 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.292 -1.776 . . . . 0.0 112.57 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.46 22.78 11.71 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 114.108 -1.405 . . . . 0.0 115.416 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.032 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -104.37 37.12 2.18 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.588 0.709 . . . . 0.0 109.134 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.96 7.99 63.77 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.008 -0.997 . . . . 0.0 114.584 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 160.52 -149.16 18.21 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 8.6 mmt180 -93.75 -175.61 3.8 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.001 -0.599 . . . . 0.0 112.162 -173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -77.03 48.79 0.62 Allowed 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.077 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.057 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -19.98 -67.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -158.8 144.34 16.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.227 0.467 . . . . 0.0 111.21 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.057 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 16.44 67.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.058 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.013 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.46 81.04 0.08 OUTLIER Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 119.565 -1.302 . . . . 0.0 109.862 -176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.057 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -156.09 101.43 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.404 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.032 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.6 t -85.85 99.53 11.44 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.963 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.8 t -138.87 147.36 42.3 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -172.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.016 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.0 m -126.59 -137.82 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.586 176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.016 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 16.5 Cg_endo -91.91 -27.27 0.2 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 CA-C-N 121.764 1.666 . . . . 0.0 108.849 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.713 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -59.07 -53.59 56.61 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-N 113.639 -1.619 . . . . 0.0 109.539 -177.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.27 155.15 19.72 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.149 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.858 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.0 m -109.8 141.28 42.67 Favored 'General case' 0 CA--C 1.481 -1.707 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.868 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.717 ' C ' HD13 ' A' ' 72' ' ' ILE . 1.8 pt-20 -148.62 137.25 21.37 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.23 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -52.69 112.64 0.87 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.471 -179.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.792 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.3 p30 -99.05 101.17 11.63 Favored Pre-proline 0 N--CA 1.432 -1.36 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.049 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 53.9 Cg_exo -56.89 -14.41 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 0.0 109.067 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.26 -18.2 65.11 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.085 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.766 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -119.35 -31.79 4.54 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.6 t70 167.79 -24.0 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.2 1 N-CA-C 121.897 4.036 . . . . 0.0 121.897 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.057 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.2 Cg_endo -100.78 -67.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.481 -2.139 0 C-N-CA 122.056 1.838 . . . . 0.0 113.301 -172.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.049 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.6 tt0 -77.11 0.49 21.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.917 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -70.4 -176.13 1.16 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -173.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.99 -158.07 0.65 Allowed 'General case' 0 N--CA 1.425 -1.714 1 CA-C-N 107.387 -4.46 . . . . 0.0 107.099 174.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.712 ' H ' ' HD1' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -78.68 57.3 2.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' OG ' ' CA ' ' A' ' 85' ' ' CYS . 9.8 t . . . . . 0 C--O 1.249 1.063 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.079 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.85 ' O ' ' HB3' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.42 0.153 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' CB ' ' A' ' 53' ' ' PRO . 17.6 m -56.66 162.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.66 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.963 ' HB2' ' H ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -70.77 152.48 43.74 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-O 122.067 0.936 . . . . 0.0 112.104 -177.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.78 -72.58 0.59 Allowed 'General case' 0 N--CA 1.412 -2.335 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.344 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -91.75 -158.51 0.58 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.855 ' HA ' HG23 ' A' ' 9' ' ' THR . 1.1 m-20 -93.27 -16.75 24.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -177.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.924 HG22 HD11 ' A' ' 5' ' ' LEU . 17.2 m -84.19 -2.6 7.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.947 0.403 . . . . 0.0 111.718 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.821 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 32.7 mtt180 -119.88 -23.19 6.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.939 1.352 . . . . 0.0 113.159 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.855 HG23 ' HA ' ' A' ' 6' ' ' ASP . 8.3 p -27.51 162.41 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 111.286 -2.688 . . . . 0.0 115.65 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.998 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . 3.9 m -44.9 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.739 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.793 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.7 tp -89.18 146.98 37.37 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.793 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 37.6 Cg_exo -52.19 169.04 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.026 1.817 . . . . 0.0 114.583 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.781 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.0 t -147.82 -158.76 0.95 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.534 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.942 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 55.63 -149.36 24.61 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.572 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.874 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 24.5 Cg_endo -83.52 73.68 5.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.634 2.889 . . . . 0.0 112.595 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.13 -65.8 0.26 Allowed Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.237 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.0 34.36 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 122.048 0.804 . . . . 0.0 111.529 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.66 -22.89 65.28 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.56 -1.32 . . . . 0.0 110.87 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.63 -149.37 5.08 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.192 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.998 ' HD3' ' HB2' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -167.4 -178.18 3.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.185 -1.008 . . . . 0.0 110.102 -179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -102.76 132.1 49.15 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.792 ' HE1' ' HG3' ' A' ' 20' ' ' ARG . 2.5 m-85 -102.86 -2.48 27.81 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.73 -83.89 0.15 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 118.728 -1.701 . . . . 0.0 116.844 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.785 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 44.9 Cg_endo -98.94 91.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.437 2.092 . . . . 0.0 113.52 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.65 16.93 1.51 Allowed 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.785 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -99.77 160.43 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -154.23 145.67 23.09 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 113.581 -1.645 . . . . 0.0 110.128 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.2 t -142.13 116.33 9.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.773 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.819 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.47 167.23 15.47 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.336 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -72.54 -81.0 0.06 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 5.75 4.02 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.875 0.845 . . . . 0.0 108.852 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.958 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.969 -174.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 83.09 -155.44 32.96 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.465 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.791 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -128.85 109.56 11.37 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.958 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.96 161.16 14.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.408 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 HG22 HD11 ' A' ' 26' ' ' ILE . 3.8 t -141.02 112.99 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.005 177.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.22 2.34 5.18 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.721 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.585 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -75.14 176.09 7.63 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.815 0.307 . . . . 0.0 110.529 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.96 -53.07 62.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 110.568 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 9.9 0.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.563 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -132.82 1.19 3.6 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.55 -12.99 37.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.379 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.781 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -50.35 -15.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.2 m -69.47 -11.82 61.14 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.912 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -18.72 64.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 35.7 mt-10 -78.46 -17.62 56.06 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.578 178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 47' ' ' GLU . 1.2 tp10 -77.26 -4.25 43.92 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.527 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -90.12 6.74 41.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.286 -0.259 . . . . 0.0 111.578 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.639 ' HB3' HD12 ' A' ' 50' ' ' LEU . 26.8 m-85 -106.94 -70.01 0.81 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD12 ' HB3' ' A' ' 49' ' ' TYR . 1.3 mp -124.89 89.19 52.93 Favored Pre-proline 0 N--CA 1.464 0.245 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.97 168.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.846 2.364 . . . . 0.0 112.523 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -179.24 168.85 0.79 Allowed Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.85 ' HB3' ' O ' ' A' ' 1' ' ' ALA . 33.8 Cg_endo -66.28 164.6 27.49 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.417 2.078 . . . . 0.0 111.517 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 40.59 1.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.963 ' H ' ' HB2' ' A' ' 3' ' ' LEU . 0.0 OUTLIER 53.5 -155.7 0.21 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.474 0.579 . . . . 0.0 111.99 177.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.586 ' H ' HE21 ' A' ' 55' ' ' GLN . 0.2 OUTLIER -139.77 -169.59 2.75 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.8 145.68 17.89 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.935 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.728 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -102.57 173.51 6.31 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -14.16 88.2 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 122.493 1.14 . . . . 0.0 112.338 -173.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 22.2 Cg_exo -58.73 167.18 5.55 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.395 3.396 . . . . 0.0 116.646 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.45 161.11 37.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 113.21 -1.814 . . . . 0.0 112.595 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.06 23.74 10.46 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.866 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.95 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.4 t -105.48 37.0 2.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.451 0.643 . . . . 0.0 109.56 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.72 7.69 61.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.184 -0.916 . . . . 0.0 115.092 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.67 -147.63 15.94 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.888 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -93.64 -174.5 3.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.765 -0.718 . . . . 0.0 111.585 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.1 t -76.69 49.04 0.6 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.094 0.473 . . . . 0.0 110.458 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.076 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.55 -63.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.633 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.74 145.97 9.48 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.698 0.681 . . . . 0.0 111.271 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.035 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.53 66.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 123.63 0.581 . . . . 0.0 110.641 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.034 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.42 79.93 0.11 Allowed Glycine 0 N--CA 1.421 -2.362 0 C-N-CA 119.302 -1.428 . . . . 0.0 109.661 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.076 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -154.04 103.84 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 20.1 t -87.02 98.84 11.49 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.976 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 1.7 t -139.1 146.45 40.72 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.04 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 53.3 m -123.19 -138.58 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 113.032 -1.895 . . . . 0.0 107.897 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.04 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 18.8 Cg_endo -92.54 -27.57 0.17 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 121.6 1.607 . . . . 0.0 108.947 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.75 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -61.22 -49.05 78.7 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.169 -178.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 158.53 25.96 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.184 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.7 m -115.47 142.59 46.51 Favored 'General case' 0 CA--C 1.484 -1.562 0 CA-C-O 121.504 0.669 . . . . 0.0 110.408 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.722 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.9 138.01 20.38 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.26 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 6.7 pt-20 -52.25 115.83 1.93 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.839 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 35.7 p30 -101.84 102.54 23.74 Favored Pre-proline 0 N--CA 1.434 -1.247 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.003 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 75.2 Cg_exo -55.36 -17.34 15.79 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.649 2.899 . . . . 0.0 109.206 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.67 -16.84 64.5 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.423 -2.171 . . . . 0.0 108.846 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.765 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -122.11 -29.72 4.17 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 15.4 t0 169.14 -26.51 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.035 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -102.52 -68.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.967 0 C-N-CA 122.244 1.963 . . . . 0.0 113.887 -171.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.003 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -77.65 4.56 11.14 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.94 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -66.48 174.83 2.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 120.128 3.381 . . . . 0.0 120.128 -172.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.87 -155.28 0.49 Allowed 'General case' 0 N--CA 1.428 -1.567 1 CA-C-N 107.085 -4.598 . . . . 0.0 106.594 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.97 53.54 0.95 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.576 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 7.4 t . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.874 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.672 ' H3 ' HD13 ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.809 0.338 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 9' ' ' THR . 2.2 m -70.72 144.89 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.372 0.606 . . . . 0.0 112.239 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.02 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -68.51 -147.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.335 1.064 . . . . 0.0 113.844 -177.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.572 ' CG ' ' HA ' ' A' ' 55' ' ' GLN . 15.0 t0 -157.12 -12.46 0.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.547 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.036 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -18.13 -77.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.794 -1.548 . . . . 0.0 113.97 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.967 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.5 -28.12 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.19 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.036 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -97.71 -2.92 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.868 ' HG3' HG23 ' A' ' 7' ' ' VAL . 84.4 mtt180 -149.47 -164.94 2.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -157.29 -173.53 4.47 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.038 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . 5.0 t -65.73 -173.33 0.16 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.672 HD13 ' H3 ' ' A' ' 1' ' ' ALA . 2.6 tp -72.68 113.75 24.06 Favored Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.765 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.8 Cg_exo -53.12 172.84 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.003 1.802 . . . . 0.0 114.391 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.652 ' N ' ' O ' ' A' ' 19' ' ' GLY . 20.6 t -148.73 -164.63 2.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.118 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.126 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 50.42 -150.71 5.44 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.983 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 32' ' ' LEU . 32.2 Cg_endo -84.11 96.34 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.377 2.718 . . . . 0.0 112.348 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.49 -75.03 0.49 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -178.9 35.19 0.08 OUTLIER Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 122.02 0.789 . . . . 0.0 111.885 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.56 -29.57 69.68 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.658 -1.271 . . . . 0.0 110.655 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -134.56 -158.67 8.53 Favored Glycine 0 N--CA 1.42 -2.369 0 CA-C-N 114.097 -1.411 . . . . 0.0 112.799 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -159.68 179.31 8.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 113.883 -1.158 . . . . 0.0 109.985 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.752 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.9 m -70.71 177.02 3.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.901 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.883 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -154.08 -45.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -172.91 -107.35 0.2 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 119.053 -1.546 . . . . 0.0 116.524 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 69.0 Cg_endo -92.36 97.35 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.025 2.483 . . . . 0.0 112.666 -177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 57.16 17.9 3.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.2 tt -107.76 153.9 9.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 CA-C-O 122.833 1.301 . . . . 0.0 113.268 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.83 157.28 36.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.66 150.15 38.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.724 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -131.8 176.47 19.21 Favored Glycine 0 N--CA 1.424 -2.148 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.542 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -81.81 0.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.846 0.823 . . . . 0.0 109.204 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -12.0 60.28 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.126 HD11 ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -71.39 -54.87 9.28 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.977 -1.92 . . . . 0.0 112.963 -177.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 97.35 -171.12 26.39 Favored Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.939 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.815 ' HB2' HG21 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -102.73 129.26 49.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -130.36 122.93 28.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.157 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.587 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -99.46 107.01 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.242 0.544 . . . . 0.0 110.416 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.97 13.06 51.48 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.055 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.1 m -74.16 -169.46 0.79 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 38' ' ' THR . . . -72.49 -49.25 34.42 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -75.42 -6.49 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.222 -0.298 . . . . 0.0 111.796 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -96.1 -9.89 29.65 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -68.8 -13.38 62.37 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -49.73 -22.61 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -9.35 28.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.123 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -66.99 -16.13 64.16 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -82.48 -16.69 47.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.466 176.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG2' ' HE1' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -73.65 1.38 10.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.715 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.41 -13.83 53.34 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.8 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.655 ' CZ ' HD22 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -60.51 -143.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.928 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' N ' ' CG ' ' A' ' 49' ' ' TYR . 1.2 mp -101.1 154.61 37.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.775 0.322 . . . . 0.0 111.479 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -45.1 169.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.413 2.742 . . . . 0.0 113.149 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 53' ' ' PRO . 94.8 p -179.17 175.93 0.43 Allowed Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 77.3 Cg_endo -93.06 140.54 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.937 2.425 . . . . 0.0 111.907 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -120.96 88.02 2.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 54' ' ' CYS . 0.0 OUTLIER 40.02 -176.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 t -156.67 179.08 9.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.905 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.84 103.41 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.789 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -114.19 165.81 12.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 -176.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 2.9 tmtt? -90.93 53.89 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 112.256 -2.247 . . . . 0.0 113.194 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.789 ' HD3' ' C ' ' A' ' 58' ' ' GLN . 35.8 Cg_exo -53.49 137.4 65.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 N-CA-C 118.201 2.347 . . . . 0.0 118.201 -175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.01 152.46 30.55 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.16 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.09 34.69 0.64 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 115.556 0.983 . . . . 0.0 115.556 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.984 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.3 t -111.15 41.72 1.79 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.103 0.477 . . . . 0.0 110.067 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.85 18.07 75.91 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.199 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.468 ' O ' ' SG ' ' A' ' 73' ' ' CYS . . . 159.83 -148.29 16.65 Favored Glycine 0 CA--C 1.496 -1.107 0 C-N-CA 119.951 -1.118 . . . . 0.0 115.43 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.752 ' O ' ' N ' ' A' ' 68' ' ' ALA . 6.9 mmt180 -117.93 146.48 43.94 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.062 -0.569 . . . . 0.0 110.624 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.881 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 24.2 t -37.81 57.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 66' ' ' ARG . . . -30.17 -35.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.8 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -162.1 -174.42 4.1 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.987 1.267 . . . . 0.0 112.857 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 69' ' ' ALA . . . -9.38 -43.74 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 123.314 1.531 . . . . 0.0 111.376 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 69' ' ' ALA . . . 179.17 79.32 0.06 OUTLIER Glycine 0 N--CA 1.413 -2.888 0 CA-C-N 111.057 -2.792 . . . . 0.0 109.021 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 34' ' ' CYS . 1.6 mm -150.87 108.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 112.907 -1.647 . . . . 0.0 107.317 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.5 t -91.77 105.4 17.69 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.913 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -147.15 157.74 43.71 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -171.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.849 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 16.1 m -132.02 -139.47 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 112.202 -2.272 . . . . 0.0 108.007 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.849 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 78.2 Cg_endo -92.39 -38.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 108.253 -1.48 . . . . 0.0 108.253 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -54.11 -36.53 63.33 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.151 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.87 154.94 12.5 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.363 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 7.7 m -124.47 145.09 49.72 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.695 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -155.03 143.38 20.39 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.64 -1.163 . . . . 0.0 112.062 179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -55.44 118.8 4.77 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 29.0 p30 -102.93 101.16 19.45 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.686 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.904 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 82.2 Cg_exo -53.13 -16.93 7.28 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.812 3.008 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.93 -23.65 66.66 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 113.052 -1.885 . . . . 0.0 108.786 175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.876 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -108.03 -36.05 6.44 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 -178.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.876 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.9 t70 160.55 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.716 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 4.8 Cg_endo -98.13 -68.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.487 0 CA-C-N 122.407 1.895 . . . . 0.0 111.761 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.528 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.7 tp10 -80.96 13.77 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 175.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.904 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -56.17 155.95 6.12 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 120.115 3.376 . . . . 0.0 120.115 -171.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.552 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -97.01 -154.6 0.45 Allowed 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 108.711 -3.859 . . . . 0.0 104.864 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 45.88 0.12 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.046 1.748 . . . . 0.0 107.771 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.1 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.322 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 m -69.32 149.55 10.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.736 0.779 . . . . 0.0 111.225 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.92 HD23 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -56.37 -177.59 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.731 ' HA ' ' N ' ' A' ' 55' ' ' GLN . 13.3 t70 -144.81 -25.28 0.5 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 111.646 -2.524 . . . . 0.0 109.62 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.077 HD21 HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -67.1 -135.84 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.014 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.922 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -97.73 -18.77 18.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.077 HG13 HD21 ' A' ' 5' ' ' LEU . 10.3 m -79.25 -6.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.266 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.92 ' HD2' HD23 ' A' ' 3' ' ' LEU . 17.8 mtt-85 -149.18 164.13 35.63 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.02 HG23 ' HG3' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -167.93 128.77 1.39 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.58 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 p -169.6 59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.5 mp -122.12 87.88 47.91 Favored Pre-proline 0 N--CA 1.465 0.28 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.05 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.874 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.9 Cg_endo -81.5 165.19 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.822 2.348 . . . . 0.0 115.167 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 7.9 t -132.4 -164.75 1.5 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.623 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.02 -148.28 32.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.001 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 16.8 Cg_endo -85.85 103.11 0.71 Allowed 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.75 2.967 . . . . 0.0 112.981 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.21 -71.77 1.39 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.291 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.874 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.96 34.27 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -64.44 -61.55 2.15 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.019 -1.091 . . . . 0.0 108.724 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -91.47 -152.33 28.15 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.721 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.796 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.09 -178.71 5.27 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.48 -1.36 . . . . 0.0 109.287 179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.72 136.59 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.871 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.4 m-85 -107.66 4.37 25.73 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.72 0.48 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 118.465 2.146 . . . . 0.0 118.465 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 42.5 Cg_endo -100.11 95.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.876 1.838 . . . . 0.0 114.893 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.674 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.1 t 53.02 9.87 0.14 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.773 0.321 . . . . 0.0 110.774 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.871 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -100.58 154.39 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 122.681 1.229 . . . . 0.0 114.244 -175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -157.43 145.62 19.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.155 -2.293 . . . . 0.0 108.181 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 5.0 t -143.59 116.64 8.89 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.261 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -104.51 165.13 14.73 Favored Glycine 0 N--CA 1.428 -1.844 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.025 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 32' ' ' LEU . 12.9 t0 -72.46 -81.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 10.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.801 0.81 . . . . 0.0 108.856 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -107.68 -17.29 14.13 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.865 -174.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.44 -155.39 32.38 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.688 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -127.5 109.24 11.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.684 0.278 . . . . 0.0 111.137 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 5.9 m-85 -97.87 148.79 23.07 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.632 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG13 HG13 ' A' ' 26' ' ' ILE . 2.5 t -143.15 116.01 3.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.276 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 62.3 44.42 97.69 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.882 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 39' ' ' ALA . 89.1 m -133.51 170.26 15.77 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.181 0.192 . . . . 0.0 110.858 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -53.03 -46.9 68.66 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.628 0.728 . . . . 0.0 110.33 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.02 11.97 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.18 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . . . -137.2 2.32 2.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.797 ' HB2' HE22 ' A' ' 45' ' ' GLN . 0.0 OUTLIER -64.39 -14.84 58.77 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.084 178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.745 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.82 -15.87 0.34 Allowed 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.3 m -74.81 -14.57 60.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.797 HE22 ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.82 -14.95 61.02 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.672 1.225 . . . . 0.0 108.149 176.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.733 ' OE2' ' HG3' ' A' ' 43' ' ' ARG . 34.4 mt-10 -72.23 -38.48 68.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.289 -2.232 . . . . 0.0 107.452 176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -86.32 27.41 0.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.113 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.38 -6.21 3.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.409 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.74 -35.92 0.64 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.288 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.696 ' CD2' ' HG3' ' A' ' 53' ' ' PRO . 2.1 tp -108.85 110.02 61.08 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.572 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 31.3 Cg_exo -42.14 143.82 1.22 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.841 2.361 . . . . 0.0 112.797 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.8 m -42.99 96.57 0.12 Allowed Pre-proline 0 N--CA 1.465 0.306 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.696 ' HG3' ' CD2' ' A' ' 50' ' ' LEU . 68.7 Cg_endo -96.66 39.42 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.323 2.682 . . . . 0.0 111.234 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 3' ' ' LEU . 45.3 t 152.34 157.15 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.903 0.881 . . . . 0.0 109.286 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.02 ' HG3' HG23 ' A' ' 9' ' ' THR . 3.6 tp60 -67.52 168.79 10.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.605 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 26.3 t -110.11 -65.0 1.19 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.874 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.27 108.79 1.04 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.713 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.608 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 mm-40 -111.11 93.45 4.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.254 0.55 . . . . 0.0 110.428 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.008 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -92.04 37.23 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.867 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 81.5 Cg_exo -46.51 135.66 16.13 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.16 1.907 . . . . 0.0 116.204 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.81 146.84 26.0 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 122.062 0.934 . . . . 0.0 113.501 -178.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -48.0 3.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.162 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.965 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.1 t -85.2 40.73 0.84 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.027 1.413 . . . . 0.0 108.351 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 54.96 52.12 48.86 Favored Glycine 0 CA--C 1.495 -1.16 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.191 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.759 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 154.8 -147.68 17.09 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.152 -0.524 . . . . 0.0 112.135 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.867 ' HD2' ' CB ' ' A' ' 60' ' ' PRO . 8.1 mmt-85 -126.44 158.19 36.65 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.008 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 12.5 t -58.53 170.39 0.76 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.53 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.842 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -156.57 -94.83 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.676 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -78.06 -158.01 0.12 Allowed 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.022 1.729 . . . . 0.0 114.049 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.996 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.32 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.386 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.039 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 59.92 39.54 95.67 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 118.472 -1.823 . . . . 0.0 114.361 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -111.3 147.9 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.965 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 8.8 t -127.62 101.57 6.46 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.798 ' N ' ' O ' ' A' ' 66' ' ' ARG . 40.3 t -115.87 153.86 30.76 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 111.37 -2.65 . . . . 0.0 111.842 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.982 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 48.8 m -112.57 -137.72 0.0 OUTLIER Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.4 Cg_endo -93.34 -31.47 0.07 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.219 1.471 . . . . 0.0 109.087 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.8 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.4 t0 -67.85 -60.68 2.33 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.945 -172.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.59 154.9 25.96 Favored Glycine 0 C--N 1.351 1.373 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.715 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 74' ' ' CYS . 1.3 m -115.56 142.69 46.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.07 130.49 16.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -48.37 123.62 6.8 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -176.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.834 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 18.1 p-10 -99.77 117.65 63.2 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.147 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.847 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 85.5 Cg_exo -53.22 -17.79 9.13 Favored 'Trans proline' 0 CA--C 1.501 -1.162 0 C-N-CA 123.232 2.621 . . . . 0.0 110.421 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -66.95 -33.68 76.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 111.343 -2.662 . . . . 0.0 108.961 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.03 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -100.72 -34.91 9.66 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 21.7 t70 170.54 -27.04 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.528 0 N-CA-C 121.619 3.933 . . . . 0.0 121.619 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.039 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.9 Cg_endo -105.87 -64.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.403 0 C-N-CA 123.931 3.087 . . . . 0.0 110.907 -173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.832 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 3.2 tp10 -65.43 -7.18 12.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.847 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -53.86 -106.68 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 113.701 -1.591 . . . . 0.0 109.094 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -63.35 -147.63 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.398 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -81.89 29.08 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.918 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 26.4 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.391 -176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.788 0.327 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t -100.61 176.76 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.795 ' H ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -66.1 -177.68 0.53 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.854 0.835 . . . . 0.0 112.92 -177.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 24.8 t70 -83.13 -95.42 0.06 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.307 177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.066 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -77.93 -75.95 0.2 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.737 0.779 . . . . 0.0 109.068 176.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.066 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -154.06 -48.06 0.09 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.277 -179.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 5' ' ' LEU . 27.5 m -104.47 -0.04 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 4' ' ' ASP . 48.9 mtt85 -81.08 166.23 20.91 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 121.688 -0.632 . . . . 0.0 112.025 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 86.4 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 54' ' ' CYS . 10.1 m 62.84 -171.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD22 ' CG ' ' A' ' 46' ' ' GLU . 2.2 tp -79.21 132.94 61.51 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.154 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.881 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.9 Cg_exo -73.26 177.22 8.14 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.16 1.906 . . . . 0.0 113.574 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 6.7 t -141.26 -163.97 1.66 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.407 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.886 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.38 -149.62 39.07 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.115 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -84.0 92.98 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.509 2.806 . . . . 0.0 112.856 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.81 -74.24 0.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.335 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.881 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.74 32.65 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.02 0 CA-C-O 121.708 0.616 . . . . 0.0 112.068 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.65 -61.3 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.327 -0.937 . . . . 0.0 108.927 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.829 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -88.25 -151.11 22.04 Favored Glycine 0 N--CA 1.426 -2.002 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.026 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.751 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.93 -178.97 4.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.601 -1.3 . . . . 0.0 109.586 178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -102.59 135.06 44.91 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.937 ' HE2' ' HA ' ' A' ' 68' ' ' ALA . 1.6 m-85 -104.3 9.04 36.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.724 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.35 -70.1 0.42 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 118.062 1.985 . . . . 0.0 118.062 175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 62.8 Cg_endo -97.37 92.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 119.849 1.825 . . . . 0.0 114.582 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.7 19.03 0.22 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.341 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.868 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.2 tt -106.68 158.22 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -153.53 144.69 22.96 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.913 179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 2.8 t -145.1 114.15 6.95 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.543 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 1.068 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -99.46 154.84 19.78 Favored Glycine 0 N--CA 1.422 -2.242 0 C-N-CA 119.87 -1.157 . . . . 0.0 111.071 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.35 -73.05 0.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 118.024 0.912 . . . . 0.0 108.677 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.03 1.17 13.69 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.068 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.3 -6.54 18.3 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.024 -1.444 . . . . 0.0 114.272 -174.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.87 -154.25 37.35 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.556 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.732 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.72 111.08 9.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.783 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.3 m-85 -103.67 147.14 27.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.7 t -137.27 116.17 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.623 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.15 37.3 94.28 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.857 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 39' ' ' ALA . 29.8 m -123.63 173.41 8.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.229 0.211 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -54.59 -51.31 65.72 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.347 0.594 . . . . 0.0 110.129 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -63.99 11.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.993 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -137.15 3.39 2.63 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.71 -13.43 54.48 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.351 177.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.4 -15.74 0.28 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 m -74.29 -9.63 58.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.838 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -16.73 59.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.136 0.969 . . . . 0.0 108.858 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.66 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -76.27 -36.03 58.62 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.439 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.3 23.83 1.24 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.54 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -148.42 10.75 0.87 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.355 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.899 ' HB3' HD22 ' A' ' 50' ' ' LEU . 1.7 m-85 -142.06 -64.67 0.42 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.259 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 49' ' ' TYR . 2.3 mm? -106.08 98.34 18.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -43.97 128.29 7.16 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.881 2.387 . . . . 0.0 112.903 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m -131.18 136.36 28.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 59.2 Cg_endo -93.12 136.61 1.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.915 2.41 . . . . 0.0 111.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 1.008 ' HB2' ' HA ' ' A' ' 10' ' ' CYS . 26.0 p -163.48 169.69 18.45 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.671 ' HG3' ' H ' ' A' ' 56' ' ' SER . 3.6 tp60 -57.9 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.57 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.671 ' H ' ' HG3' ' A' ' 55' ' ' GLN . 0.8 OUTLIER -61.26 -169.75 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.111 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.59 -130.11 6.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.841 ' NE2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -127.69 88.97 2.86 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -39.47 120.17 1.32 Allowed Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 72.2 Cg_exo -45.47 167.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.897 3.065 . . . . 0.0 112.848 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.545 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -151.01 149.55 29.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.761 0.791 . . . . 0.0 112.13 -178.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -42.2 -6.68 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-N 113.69 -1.596 . . . . 0.0 115.087 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.892 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 2.0 t -92.37 35.56 1.01 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 118.584 1.192 . . . . 0.0 109.903 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.04 58.95 7.28 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.234 -1.348 . . . . 0.0 114.258 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.08 -165.26 36.43 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.951 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.5 mmt85 -98.88 159.78 14.72 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.173 0.486 . . . . 0.0 111.431 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.841 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 9.0 t -72.41 50.09 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.384 0.612 . . . . 0.0 110.211 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.937 ' HA ' ' HE2' ' A' ' 22' ' ' PHE . . . -42.22 -97.48 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.492 -176.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.775 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -67.27 -159.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.544 1.937 . . . . 0.0 115.53 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.874 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -56.49 80.85 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 113.473 -1.694 . . . . 0.0 107.489 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.031 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 66.08 32.85 83.68 Favored Glycine 0 N--CA 1.419 -2.48 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.506 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.008 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -94.01 151.67 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.365 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.951 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.7 t -120.77 101.04 7.46 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.91 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 8.2 t -127.86 142.29 51.32 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.181 -172.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.925 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 42.8 m -108.81 -138.19 0.0 OUTLIER Pre-proline 0 N--CA 1.436 -1.156 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.925 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 51.1 Cg_endo -94.1 -29.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.517 0 CA-C-N 121.137 1.442 . . . . 0.0 109.258 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.746 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -67.0 -54.16 24.36 Favored 'General case' 0 CA--C 1.479 -1.769 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.078 -173.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.57 151.41 18.89 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.935 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' HG21 ' A' ' 72' ' ' ILE . 1.8 m -111.37 141.31 45.08 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 117.541 0.67 . . . . 0.0 111.728 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.481 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -142.84 132.79 24.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.392 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.019 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -49.35 89.29 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.365 0.602 . . . . 0.0 111.552 -178.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.701 ' C ' ' H ' ' A' ' 84' ' ' ALA . 48.5 m-20 -88.89 121.15 69.99 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.052 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.6 Cg_exo -60.75 4.84 0.17 Allowed 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 123.187 2.591 . . . . 0.0 108.902 175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.892 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -77.96 -33.18 51.66 Favored 'General case' 0 N--CA 1.409 -2.519 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.561 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.031 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -120.65 -21.52 6.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.911 ' CB ' ' HA3' ' A' ' 71' ' ' GLY . 17.6 t0 159.73 -16.6 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.845 0 N-CA-C 121.308 3.818 . . . . 0.0 121.308 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.019 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.6 Cg_endo -95.06 -66.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.349 0 CA-C-N 122.693 1.998 . . . . 0.0 111.652 -174.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.955 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.4 tt0 -77.28 -4.85 47.04 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.052 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.83 126.68 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 119.97 3.322 . . . . 0.0 119.97 -175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.36 -148.12 0.34 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 108.644 -3.889 . . . . 0.0 104.469 170.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -71.98 50.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.734 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 7.3 p . . . . . 0 C--O 1.248 1.0 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.961 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.84 0.352 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 m -62.15 169.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -63.1 163.91 9.31 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.95 0.881 . . . . 0.0 113.17 -177.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.6 -89.05 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.009 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.7 tp -85.57 -65.43 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.5 -48.78 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.236 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.35 -0.6 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -79.13 176.27 9.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.634 HG23 ' OE1' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -127.16 90.92 3.22 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.39 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.784 ' CB ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 68.6 -168.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.44 -178.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.886 HD23 ' OE2' ' A' ' 46' ' ' GLU . 7.5 mp -100.17 124.43 43.27 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.794 0.331 . . . . 0.0 111.095 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 72.7 Cg_exo -43.64 165.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.514 2.142 . . . . 0.0 114.676 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 1.013 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.2 t -149.4 -160.57 1.19 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.882 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.969 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.08 -146.32 14.71 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.664 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.961 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 18.7 Cg_endo -85.19 81.9 1.77 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.731 2.954 . . . . 0.0 112.65 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 104.83 -63.62 0.33 Allowed Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 112.319 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 179.08 37.04 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 122.141 0.856 . . . . 0.0 111.309 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.961 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -68.69 -23.75 64.42 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.626 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.78 -152.01 5.57 Favored Glycine 0 N--CA 1.42 -2.432 0 CA-C-N 113.523 -1.671 . . . . 0.0 111.222 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.784 ' HD3' ' CB ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -165.34 -178.84 5.21 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.34 -0.93 . . . . 0.0 109.778 -178.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -105.03 130.18 53.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.823 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -100.04 -5.32 28.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.066 0.848 . . . . 0.0 113.183 -177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.65 -80.06 0.19 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 118.669 -1.729 . . . . 0.0 116.766 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.725 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 44.4 Cg_endo -98.96 90.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.336 2.024 . . . . 0.0 113.603 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 55.24 15.44 1.32 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.192 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.823 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.0 tt -99.48 158.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-O 122.261 1.029 . . . . 0.0 113.529 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.807 ' HB2' ' CB ' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -154.5 146.14 23.26 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.644 -179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -142.31 125.65 16.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.615 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.835 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.91 165.04 12.01 Favored Glycine 0 N--CA 1.42 -2.368 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.9 -81.01 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.77 -2.19 16.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.064 0.935 . . . . 0.0 108.83 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.983 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -91.9 -20.87 20.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.28 -174.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.18 -162.46 49.8 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.917 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.836 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -119.75 109.98 16.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.983 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -101.91 147.3 26.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.946 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.709 HG22 ' CG1' ' A' ' 26' ' ' ILE . 7.0 t -132.81 118.65 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 109.773 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.54 18.61 38.14 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.087 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.65 HG22 ' H ' ' A' ' 39' ' ' ALA . 17.5 m -96.07 177.65 5.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.725 0.297 . . . . 0.0 111.016 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -50.77 72.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.307 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.26 8.13 0.49 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.551 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.807 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -127.77 -1.41 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -61.07 -9.91 5.26 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.38 178.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 1.013 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.3 -19.45 0.3 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.024 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 2.1 m -69.87 -16.26 63.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.511 . . . . 0.0 110.454 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.22 -19.93 64.97 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.744 0.783 . . . . 0.0 108.998 177.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.886 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -78.47 -17.9 55.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.947 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.4 mm-40 -77.27 5.0 9.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.105 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -86.66 -6.28 58.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.97 -75.02 0.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.98 117.63 11.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.982 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -44.87 136.29 9.86 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.82 2.346 . . . . 0.0 113.054 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.52 152.08 77.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.768 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -89.58 172.37 4.01 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.625 2.216 . . . . 0.0 112.115 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 9.4 t -122.34 150.86 41.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.634 ' OE1' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -56.15 -78.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.469 ' N ' HE21 ' A' ' 55' ' ' GLN . 3.8 t -172.98 173.01 3.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.057 0.456 . . . . 0.0 111.91 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.77 156.18 51.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.804 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.838 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 1.4 mt-30 -114.77 135.93 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.1 tttt -14.37 85.49 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 122.874 1.321 . . . . 0.0 112.663 -174.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.835 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 52.0 Cg_exo -53.58 166.4 1.29 Allowed 'Trans proline' 0 C--N 1.363 1.331 0 C-N-CA 125.149 3.899 . . . . 0.0 117.247 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.0 p -160.25 162.08 33.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.156 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.99 25.8 9.44 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 113.947 -1.479 . . . . 0.0 114.853 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.033 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -106.65 36.37 2.65 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.29 5.98 59.01 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.055 -0.975 . . . . 0.0 114.834 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.28 -146.39 13.56 Favored Glycine 0 CA--C 1.498 -1.009 0 N-CA-C 115.126 0.81 . . . . 0.0 115.126 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.88 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 13.1 mmt85 -93.47 -175.57 3.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.161 -0.519 . . . . 0.0 111.326 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.4 t -78.24 51.44 1.01 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.212 0.53 . . . . 0.0 109.645 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.087 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -21.13 -66.06 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 72' ' ' ILE . . . -159.03 142.86 15.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.158 0.436 . . . . 0.0 110.44 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.964 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.36 69.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.331 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.927 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 60.19 79.94 0.1 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.087 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -155.87 101.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 178.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.033 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 13.1 t -85.62 98.85 10.89 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.961 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 3.3 t -137.15 147.58 46.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -172.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.039 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 68.3 m -128.12 -137.94 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.985 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.039 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 14.9 Cg_endo -91.74 -28.15 0.18 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.545 1.588 . . . . 0.0 108.675 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -59.35 -52.3 66.24 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.847 -177.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.57 156.13 20.21 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.923 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.845 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 4.1 m -108.84 142.09 39.93 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.562 0.696 . . . . 0.0 109.781 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.676 ' C ' HD13 ' A' ' 72' ' ' ILE . 2.5 pt-20 -148.79 134.41 18.73 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.03 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.774 ' O ' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -51.15 112.94 0.81 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.863 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 32.7 p30 -98.29 99.65 7.6 Favored Pre-proline 0 N--CA 1.432 -1.342 0 CA-C-O 121.43 0.633 . . . . 0.0 111.543 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.044 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 71.1 Cg_exo -55.06 -14.23 8.05 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.064 3.176 . . . . 0.0 109.555 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -68.31 -19.72 64.7 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.388 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.808 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -113.7 -34.83 5.38 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.74 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.7 t70 165.06 -22.48 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 121.791 3.997 . . . . 0.0 121.791 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.964 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.5 Cg_endo -99.53 -67.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.277 0 C-N-CA 122.021 1.814 . . . . 0.0 113.734 -171.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.044 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 7.5 tt0 -79.74 3.83 18.17 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.996 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -60.64 168.96 1.98 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 -172.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.04 -154.07 0.45 Allowed 'General case' 0 N--CA 1.425 -1.705 1 CA-C-N 107.017 -4.629 . . . . 0.0 106.479 176.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -74.94 49.41 0.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.618 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.8 t . . . . . 0 C--O 1.252 1.225 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 54' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 1' ' ' ALA . 34.3 m 44.94 -174.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.277 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -79.26 -179.32 6.68 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.543 0.687 . . . . 0.0 112.57 -178.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.743 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 21.2 t70 -81.16 -77.24 0.21 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.821 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' HB2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -86.99 -54.01 4.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.214 1.007 . . . . 0.0 108.81 176.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.047 ' HB2' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -166.25 -48.92 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.373 178.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.625 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 19.7 m -115.7 0.49 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.713 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.839 ' CG ' HD12 ' A' ' 5' ' ' LEU . 25.0 mtt180 -83.41 -169.48 2.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.847 HG22 ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -130.97 -168.88 2.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.095 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.14 177.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.564 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 3.9 tp -71.19 145.74 91.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.07 0.462 . . . . 0.0 111.475 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 52.6 Cg_exo -48.97 164.84 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.787 2.325 . . . . 0.0 114.522 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.88 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 19.8 t -147.86 -158.51 0.92 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.181 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.011 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 48.84 -144.89 7.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.533 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.879 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 29.5 Cg_endo -83.25 84.93 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.889 3.06 . . . . 0.0 112.825 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.33 -65.88 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -177.82 36.83 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 122.005 0.78 . . . . 0.0 111.495 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.879 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -70.08 -22.67 63.02 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.662 -1.269 . . . . 0.0 110.209 179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -143.67 -156.09 6.67 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.112 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -162.98 -179.15 6.53 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.58 -0.81 . . . . 0.0 110.121 -178.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -104.95 125.7 51.23 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.815 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -91.98 -3.12 56.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.29 -71.28 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 118.786 -1.673 . . . . 0.0 117.183 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.797 ' CG ' ' HB3' ' A' ' 76' ' ' PRO . 85.5 Cg_endo -93.04 83.25 0.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.398 2.065 . . . . 0.0 113.712 -176.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER 50.04 22.53 0.92 Allowed 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.815 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -106.14 159.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -153.03 144.8 23.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.721 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.6 OUTLIER -143.36 135.9 27.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.856 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -122.47 172.1 15.63 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.144 178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.49 -78.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.506 0.653 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -1.68 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -90.87 -23.58 20.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.869 -1.514 . . . . 0.0 113.37 -176.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.9 -161.06 52.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.5 139.52 49.48 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -131.12 162.31 30.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.406 177.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.601 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -141.22 101.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.827 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 72.72 -7.36 9.26 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.854 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.1 m -64.74 167.26 7.65 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.942 0.497 . . . . 0.0 110.256 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -46.55 -53.01 12.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.312 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.33 7.34 0.61 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.388 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -124.97 0.06 7.92 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.92 -13.15 56.14 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 178.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.88 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.94 -18.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -67.45 -5.53 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.141 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.47 -15.91 59.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.646 0.736 . . . . 0.0 109.085 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.69 -26.32 34.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.287 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -82.25 -1.33 48.98 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.437 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.03 -2.19 57.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.397 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -96.1 -62.15 1.33 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.569 0.223 . . . . 0.0 111.269 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -136.13 120.09 12.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.085 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.08 115.77 1.01 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.936 2.424 . . . . 0.0 112.76 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.6 t -122.69 133.38 24.41 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' CYS . 79.9 Cg_endo -88.95 -177.78 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.799 2.333 . . . . 0.0 112.189 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 12.5 p 174.6 -166.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.427 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.9 tt0 -69.87 -81.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 p 58.49 109.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 111.424 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.31 97.47 2.39 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.824 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.749 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 2.3 mm-40 -124.45 166.49 15.92 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' GLN . 28.3 tttt -16.54 85.19 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 CA-C-O 122.494 1.14 . . . . 0.0 111.874 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.1 Cg_exo -53.41 168.06 0.73 Allowed 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 125.186 3.924 . . . . 0.0 117.517 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.6 p -159.32 159.11 33.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.589 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.42 26.29 9.36 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.565 -1.198 . . . . 0.0 114.948 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.6 t -107.21 36.79 2.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.97 3.26 59.17 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 115.02 -0.991 . . . . 0.0 114.679 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 159.68 -144.63 10.33 Favored Glycine 0 CA--C 1.499 -0.918 0 N-CA-C 115.871 1.108 . . . . 0.0 115.871 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.006 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 9.7 mmt85 -93.19 -175.55 3.88 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.048 -0.576 . . . . 0.0 112.227 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.8 t -80.02 46.13 0.78 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.806 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -24.15 -59.67 0.05 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.898 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -161.83 138.18 8.02 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.859 1.663 . . . . 0.0 112.735 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.849 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . 37.93 -3.3 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.133 0.896 . . . . 0.0 112.447 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.935 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 126.4 76.42 0.24 Allowed Glycine 0 N--CA 1.4 -3.706 0 N-CA-C 106.974 -2.451 . . . . 0.0 106.974 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' HB3' ' A' ' 68' ' ' ALA . 2.1 mm -150.9 108.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.006 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.6 t -87.03 96.6 10.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.714 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 4.3 t -137.05 146.57 45.37 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -172.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.085 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 35.9 m -128.68 -138.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.72 175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.085 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_endo -89.7 -32.5 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.367 1.378 . . . . 0.0 109.166 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.693 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -55.03 -51.4 66.42 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.204 -177.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.76 153.64 13.68 Favored Glycine 0 CA--C 1.502 -0.757 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.91 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 5.9 m -109.53 139.53 44.41 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-O 121.654 0.74 . . . . 0.0 110.085 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.553 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -150.98 138.37 19.47 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.816 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.701 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -57.24 120.4 8.06 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.843 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 20.1 p-10 -116.09 112.59 42.06 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.885 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 74.2 Cg_exo -54.07 -23.46 28.82 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.973 3.115 . . . . 0.0 109.628 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.58 -20.57 66.38 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.331 -1.759 . . . . 0.0 108.761 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 20.2 t -102.51 -44.47 5.34 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.37 -177.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 23.1 t70 160.4 -20.21 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 120.426 3.491 . . . . 0.0 120.426 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.7 Cg_endo -100.2 -65.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.485 -1.937 0 C-N-CA 122.531 2.154 . . . . 0.0 113.328 -173.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 10.5 tt0 -76.01 3.73 9.76 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.885 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -69.24 174.86 4.3 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 121.399 3.851 . . . . 0.0 121.399 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -98.83 -156.13 0.53 Allowed 'General case' 0 N--CA 1.425 -1.685 1 CA-C-N 106.767 -4.742 . . . . 0.0 106.317 173.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.89 55.3 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.537 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 3.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.028 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.025 0.44 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.43 -179.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.034 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -68.99 160.16 31.45 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -78.38 -115.02 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.135 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -94.22 -144.33 0.24 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' H ' HD22 ' A' ' 5' ' ' LEU . 1.7 m-20 -80.86 -17.05 51.98 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.306 0.642 . . . . 0.0 111.632 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.056 HG22 HD21 ' A' ' 5' ' ' LEU . 34.7 m -107.95 61.98 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 121.747 0.785 . . . . 0.0 109.461 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.034 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 14.2 mtt180 -69.99 -169.72 0.29 Allowed 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.673 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 34.94 39.0 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.643 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 55.08 176.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.017 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 47' ' ' GLU . 4.8 mp -86.12 153.34 56.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.278 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.804 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 12.2 Cg_exo -58.97 168.06 4.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.841 1.694 . . . . 0.0 113.034 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.817 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 0.9 OUTLIER -129.22 -163.93 1.35 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.226 -178.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.63 -144.35 26.19 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.481 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 12.8 Cg_endo -87.75 106.27 0.58 Allowed 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.944 3.096 . . . . 0.0 113.206 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.86 -68.96 2.74 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.594 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.804 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.34 31.6 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 121.532 0.518 . . . . 0.0 112.343 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.58 -54.72 31.55 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.636 -0.782 . . . . 0.0 109.803 -177.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -96.21 -150.41 26.89 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.361 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.789 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -162.11 175.52 11.64 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.284 -1.458 . . . . 0.0 108.167 178.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.6 145.36 27.64 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.613 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.905 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 4.8 m-85 -119.52 -4.65 10.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.558 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.35 -85.02 0.14 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.762 ' HG3' ' HB2' ' A' ' 76' ' ' PRO . 10.5 Cg_endo -109.01 104.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.391 2.727 . . . . 0.0 114.058 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.79 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 1.4 t 54.8 12.63 0.61 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.559 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.835 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -102.32 148.22 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 122.655 1.217 . . . . 0.0 113.536 -176.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.779 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 10.9 m -148.93 136.53 20.42 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 111.695 -2.502 . . . . 0.0 107.533 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.681 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 1.6 m -136.17 102.88 5.14 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.878 -0.514 . . . . 0.0 111.031 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 1.0 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.03 159.02 22.63 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.738 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -68.76 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -0.5 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.024 0.916 . . . . 0.0 109.043 175.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.0 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -101.24 -6.41 24.24 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 113.822 -1.536 . . . . 0.0 114.141 -174.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 29' ' ' GLY . . . 77.26 -154.88 43.23 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.54 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -135.48 103.57 5.52 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-85 -95.85 152.65 18.3 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.213 0.53 . . . . 0.0 111.721 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.666 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.7 t -143.06 104.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.271 177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.738 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 67.19 55.66 15.16 Favored Glycine 0 C--N 1.316 -0.56 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.952 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.895 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 93.7 m -141.87 173.22 11.72 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.955 0.502 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.06 -47.76 61.71 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 121.646 0.736 . . . . 0.0 109.961 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -70.96 13.75 0.18 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.303 177.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.895 ' HB3' ' H ' ' A' ' 38' ' ' THR . . . -131.44 -7.78 3.72 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.718 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -66.0 -12.82 57.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.148 0.499 . . . . 0.0 110.618 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.817 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.0 -13.12 0.27 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.03 -19.15 60.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.464 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -73.25 -30.72 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -66.33 -27.33 67.81 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.921 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mt-10 -78.19 25.94 0.22 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.436 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -97.02 -21.22 17.53 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.725 0.298 . . . . 0.0 111.026 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.815 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -89.77 13.09 15.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.033 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.815 HD22 ' O ' ' A' ' 49' ' ' TYR . 2.5 mm? -140.63 156.29 69.22 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 50' ' ' LEU . 14.8 Cg_exo -36.93 130.69 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.136 2.557 . . . . 0.0 113.589 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.584 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -51.59 -47.39 89.77 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.412 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 52' ' ' SER . 37.0 Cg_endo -66.94 170.54 12.71 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.112 1.875 . . . . 0.0 113.144 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 175.65 123.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.957 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 56' ' ' SER . 10.6 pt20 41.96 -130.94 0.52 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.303 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 7.6 p -174.83 -156.48 0.06 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.29 130.15 47.19 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.591 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.831 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 3.9 mm-40 -88.67 121.68 31.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.284 0.564 . . . . 0.0 112.422 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -19.91 89.11 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 50.6 Cg_exo -46.78 158.8 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.927 2.418 . . . . 0.0 111.52 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.5 OUTLIER -150.97 149.91 30.16 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.804 0.811 . . . . 0.0 112.37 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -37.31 -13.47 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 CA-C-N 113.421 -1.718 . . . . 0.0 115.879 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 7.0 t -83.56 38.09 0.61 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 118.441 1.121 . . . . 0.0 108.923 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 62' ' ' GLY . . . 42.36 68.37 0.74 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.718 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.735 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 158.28 -152.83 24.01 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.831 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 6.2 mmt-85 -125.19 160.75 28.44 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.909 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 13.8 t -64.64 169.79 4.65 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.715 177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.905 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . . . -153.39 -87.57 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -67.3 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.79 1.636 . . . . 0.0 115.193 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.46 -44.55 2.93 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.39 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . -166.55 55.09 0.24 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.703 -1.589 . . . . 0.0 110.64 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.993 HD13 ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -108.98 150.22 11.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 113.433 -1.383 . . . . 0.0 109.232 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.834 ' HB2' ' HB3' ' A' ' 82' ' ' ASP . 16.3 t -127.49 103.07 7.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.5 OUTLIER -144.55 170.13 16.64 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.796 -172.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.094 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 58.6 m -118.12 -136.43 0.0 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.094 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 21.6 Cg_endo -94.03 -25.44 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.44 0 CA-C-N 121.149 1.446 . . . . 0.0 109.438 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.726 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 t0 -68.87 -59.11 3.3 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.611 -173.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.69 156.73 27.74 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.01 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -120.96 145.2 47.98 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.729 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -142.01 127.0 18.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.516 -2.129 . . . . 0.0 110.149 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.993 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -54.38 129.34 35.26 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -174.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.84 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 25.4 p-10 -105.43 105.37 52.11 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.814 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.994 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 85.3 Cg_exo -52.88 -16.43 5.98 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.384 2.722 . . . . 0.0 109.36 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -65.37 -35.61 81.48 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 112.984 -1.917 . . . . 0.0 107.67 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.051 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -93.0 -35.42 13.28 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.736 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 6.5 t70 167.61 -25.85 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 1 N-CA-C 122.15 4.13 . . . . 0.0 122.15 -177.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.73 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 3.8 Cg_endo -104.06 -70.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.243 0 C-N-CA 122.55 2.167 . . . . 0.0 114.104 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.894 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tp10 -68.12 -0.74 4.87 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.994 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.17 -174.9 0.13 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 119.865 3.283 . . . . 0.0 119.865 -174.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -101.53 -152.9 0.44 Allowed 'General case' 0 N--CA 1.432 -1.354 2 CA-C-N 106.99 -4.641 . . . . 0.0 106.112 176.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.41 1.02 0.58 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 119.908 1.231 . . . . 0.0 110.057 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.692 ' OXT' ' HA ' ' A' ' 86' ' ' ASP . 47.4 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.503 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.796 0.331 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 30.8 m -58.27 -179.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.083 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -71.89 171.41 11.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.773 ' HB3' ' HB2' ' A' ' 8' ' ' ARG . 35.8 t70 -72.52 -77.37 0.1 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.063 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.39 -59.64 2.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.063 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -160.03 -47.63 0.05 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.816 178.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.655 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -114.72 -1.3 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.958 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.866 ' CG ' HD12 ' A' ' 5' ' ' LEU . 54.9 mtt180 -82.58 154.02 25.2 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.76 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -73.85 -169.75 0.78 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -65.75 -171.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.479 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 52' ' ' SER . 10.4 mp -70.07 119.76 73.76 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.6 Cg_exo -68.89 178.58 3.91 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.828 1.685 . . . . 0.0 114.669 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 11.1 t -141.75 -162.2 1.35 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.83 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.017 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.19 -153.21 4.75 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.015 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HD2' HD11 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -81.6 95.36 0.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.948 2.432 . . . . 0.0 112.959 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 98.96 -72.54 0.54 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.073 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.676 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -178.27 38.7 0.08 OUTLIER Glycine 0 CA--C 1.498 -0.969 0 CA-C-O 122.09 0.828 . . . . 0.0 111.337 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.54 -27.96 68.16 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.361 -1.419 . . . . 0.0 110.519 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.836 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -133.0 -153.36 7.18 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 114.125 -1.398 . . . . 0.0 112.819 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.953 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -159.68 176.62 11.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.815 -1.193 . . . . 0.0 109.799 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.759 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 1.6 m -71.22 177.12 4.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.781 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.0 m-85 -156.7 -43.31 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.568 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.46 -108.11 0.21 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 119.495 -1.336 . . . . 0.0 116.287 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 76' ' ' PRO . 54.8 Cg_endo -95.15 103.01 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.626 2.884 . . . . 0.0 112.394 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.8 t 56.4 14.82 1.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.781 HG23 ' HB2' ' A' ' 22' ' ' PHE . 6.8 tt -113.85 160.72 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-O 122.976 1.37 . . . . 0.0 114.545 -176.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 9.2 p -164.49 -174.63 3.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.537 -2.12 . . . . 0.0 109.78 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -154.59 146.84 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.538 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.836 ' HA2' ' CA ' ' A' ' 19' ' ' GLY . . . -119.74 171.85 14.58 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 119.739 -1.219 . . . . 0.0 110.955 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.12 -81.01 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -2.6 33.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.017 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.6 OUTLIER -86.51 -28.14 23.58 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.893 -1.503 . . . . 0.0 114.227 -175.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.07 -161.22 50.65 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.391 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -111.32 137.53 48.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.957 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -130.6 139.76 50.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.182 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 26' ' ' ILE . 4.1 t -120.64 109.16 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 121.129 0.49 . . . . 0.0 110.623 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 66.34 1.43 10.48 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.229 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.541 HG22 ' H ' ' A' ' 39' ' ' ALA . 4.3 m -69.38 176.82 3.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.094 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.01 -47.43 83.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.482 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.48 -7.75 51.56 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.24 -0.287 . . . . 0.0 111.469 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -101.34 -6.31 24.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.61 -12.67 59.05 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.64 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.98 -21.7 0.72 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -15.61 63.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.323 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.2 mp0 -68.47 -18.68 64.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' OE2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.76 -15.88 55.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.055 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.77 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -81.5 0.79 36.34 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.823 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -90.75 -8.7 49.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.64 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -74.1 -79.03 0.09 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.737 0.304 . . . . 0.0 110.235 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 98.52 12.86 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.778 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -44.05 104.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.063 2.509 . . . . 0.0 113.224 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.863 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -92.23 178.84 1.53 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.128 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 4.0 Cg_endo -86.66 141.13 6.38 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.972 2.448 . . . . 0.0 111.851 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 12.8 t -102.39 107.11 18.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.521 0.328 . . . . 0.0 111.711 -179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.688 ' CB ' ' HA ' ' A' ' 9' ' ' THR . 14.7 tt0 -46.67 -86.93 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.681 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 22.7 t 176.74 -174.61 0.11 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.731 0.301 . . . . 0.0 110.845 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.887 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -169.68 -132.53 1.46 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.295 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 1.034 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 5.0 mm-40 -67.32 168.5 10.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.203 -0.499 . . . . 0.0 111.894 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -89.26 131.42 40.7 Favored Pre-proline 0 N--CA 1.442 -0.87 0 O-C-N 122.11 -0.369 . . . . 0.0 111.549 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 88.0 Cg_exo -44.68 166.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.91 2.407 . . . . 0.0 113.06 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.647 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.9 p -162.28 164.92 27.31 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.72 35.78 4.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 113.845 -1.525 . . . . 0.0 115.898 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.873 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.7 t -117.81 32.99 5.85 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 105.79 1.08 39.61 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 114.71 -1.132 . . . . 0.0 114.539 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.647 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.62 -143.99 10.09 Favored Glycine 0 CA--C 1.501 -0.824 0 N-CA-C 114.4 0.52 . . . . 0.0 114.4 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.946 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.4 mmt-85 -92.67 -176.53 4.29 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.932 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.034 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 48.2 t -80.96 56.98 2.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.305 1.05 . . . . 0.0 109.422 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.742 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -35.61 -62.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -166.81 141.29 4.03 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 121.745 2.066 . . . . 0.0 111.224 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.781 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 28.54 39.56 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 81.14 84.22 0.74 Allowed Glycine 0 N--CA 1.398 -3.861 0 C-N-CA 119.301 -1.428 . . . . 0.0 111.672 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.696 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 2.7 mm -148.86 100.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.946 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.7 t -85.89 94.0 9.07 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 103.238 -2.875 . . . . 0.0 103.238 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.618 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 2.6 t -133.52 143.16 48.58 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -171.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.095 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.2 m -125.07 -137.64 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.263 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.095 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 19.2 Cg_endo -92.25 -32.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.188 0 CA-C-N 121.163 1.451 . . . . 0.0 108.731 176.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.741 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -53.78 -51.05 64.7 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.541 -179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -178.98 156.2 18.06 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.087 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.71 ' SG ' HD11 ' A' ' 26' ' ' ILE . 5.6 m -108.6 144.05 36.83 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.953 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 139.02 16.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.746 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -56.38 112.5 1.27 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.519 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.873 ' OD2' ' HB2' ' A' ' 85' ' ' CYS . 19.5 p-10 -112.07 120.44 41.85 Favored Pre-proline 0 N--CA 1.444 -0.734 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.654 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.689 ' HG3' ' CB ' ' A' ' 88' ' ' GLU . 39.8 Cg_exo -60.51 -21.19 67.42 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 C-N-CA 123.684 2.923 . . . . 0.0 110.027 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.82 -17.89 64.66 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.176 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.934 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 13.7 t -111.8 -42.61 3.77 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.322 -1.763 . . . . 0.0 115.364 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 28.7 t0 163.93 -21.15 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 119.83 3.27 . . . . 0.0 119.83 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 19.4 Cg_endo -103.66 -65.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.594 0 C-N-CA 123.166 2.577 . . . . 0.0 111.764 -174.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.689 ' CB ' ' HG3' ' A' ' 83' ' ' PRO . 4.0 tt0 -68.46 -0.66 5.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.676 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -54.19 -83.98 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.94 -129.26 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -91.21 10.31 27.65 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 87' ' ' PRO . 32.6 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.777 -174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -78.15 136.29 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.33 168.74 16.74 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -81.41 -71.32 0.48 Allowed 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.542 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.084 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -73.84 -78.3 0.1 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.922 178.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.99 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -156.31 -65.88 0.11 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 112.166 -2.288 . . . . 0.0 109.388 -178.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.76 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 9.2 m -128.27 -6.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.084 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 75.8 mtt180 -81.21 165.35 21.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.109 0.564 . . . . 0.0 112.312 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' CG2' HH12 ' A' ' 20' ' ' ARG . 81.1 p -72.62 158.73 35.1 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.928 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 92.1 m -77.73 -85.08 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.93 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.02 91.9 7.01 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 24.2 Cg_exo -54.63 173.24 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.918 1.745 . . . . 0.0 114.329 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.896 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 16.8 t -150.31 -155.39 0.62 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.959 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 54.32 -147.62 22.22 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.581 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.077 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 26.9 Cg_endo -83.44 70.68 6.35 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.462 2.774 . . . . 0.0 112.363 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.23 -64.95 0.27 Allowed Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.203 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.646 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -173.32 33.38 0.11 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-O 122.258 0.921 . . . . 0.0 111.582 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.077 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mptt -68.32 -23.73 64.76 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.181 -1.509 . . . . 0.0 111.683 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -141.2 -150.4 5.39 Favored Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.797 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.799 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.45 -177.94 4.7 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.222 -0.989 . . . . 0.0 110.786 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -107.87 127.79 54.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.864 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -97.21 0.26 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.61 -75.15 0.3 Allowed Glycine 0 CA--C 1.522 0.519 0 C-N-CA 118.482 -1.818 . . . . 0.0 116.974 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 65.2 Cg_endo -95.51 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.237 1.958 . . . . 0.0 113.399 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 52.97 21.81 2.18 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.084 -179.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.864 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.6 tt -101.28 160.72 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.9 OUTLIER -152.37 143.06 22.85 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.793 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -142.43 122.56 13.77 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.94 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.98 163.41 12.6 Favored Glycine 0 N--CA 1.411 -2.969 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.83 -80.94 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 0.57 8.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.817 0.818 . . . . 0.0 109.013 176.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.009 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -95.97 -19.83 19.2 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.716 -174.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.17 -155.85 44.64 Favored Glycine 0 C--N 1.308 -0.986 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.625 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.888 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -125.03 125.63 44.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.009 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -121.04 168.11 11.88 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.893 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.56 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -140.63 103.8 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 CA-C-O 121.645 0.736 . . . . 0.0 109.712 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 66.74 0.13 8.08 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.955 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.577 ' CG2' ' HB3' ' A' ' 35' ' ' PHE . 45.5 p -57.92 -175.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 110.926 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -62.31 -52.42 63.75 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.9 9.12 1.63 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -125.01 -3.29 7.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.47 -12.08 19.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.159 0.504 . . . . 0.0 111.369 178.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.896 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.82 -16.52 0.13 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 1.2 m -70.05 -9.97 57.14 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.559 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -62.87 -18.82 63.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.289 1.043 . . . . 0.0 108.467 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 33.9 mt-10 -79.21 -22.88 44.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 113.259 -1.791 . . . . 0.0 109.287 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -78.02 -2.53 37.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.934 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.08 -2.99 43.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.269 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.623 ' C ' HD12 ' A' ' 50' ' ' LEU . 16.4 m-85 -99.08 -73.26 0.63 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.266 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD12 ' C ' ' A' ' 49' ' ' TYR . 6.8 mp -139.26 100.83 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.455 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -45.76 161.05 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.9 2.4 . . . . 0.0 113.09 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 115.75 0.26 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.128 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -89.36 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.63 2.22 . . . . 0.0 112.252 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.1 p 48.04 -177.69 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.384 0.673 . . . . 0.0 112.005 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.727 ' HG3' ' N ' ' A' ' 56' ' ' SER . 39.2 tp60 64.58 173.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.928 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.727 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 17.7 p -166.76 -168.94 1.22 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.783 0.325 . . . . 0.0 111.696 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.96 -113.83 0.29 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.886 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 1.097 ' HB3' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -78.08 174.63 10.92 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -178.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -88.46 140.49 30.11 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.262 177.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.887 ' HD2' ' HG2' ' A' ' 59' ' ' LYS . 95.2 Cg_exo -48.12 171.72 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.067 3.178 . . . . 0.0 113.604 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 65' ' ' GLY . 6.2 p -165.48 166.73 18.15 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.12 32.74 5.91 Favored Glycine 0 N--CA 1.423 -2.205 0 CA-C-N 113.923 -1.49 . . . . 0.0 116.243 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.052 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 4.0 t -114.82 34.85 4.57 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-O 122.193 0.997 . . . . 0.0 108.765 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.93 2.74 52.13 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 114.233 -1.349 . . . . 0.0 114.784 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 156.9 -146.81 14.4 Favored Glycine 0 C--O 1.21 -1.389 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.422 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 22.5 mmt-85 -90.59 -177.25 4.98 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.908 -174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.097 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 42.0 t -81.71 57.53 3.42 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.069 0.461 . . . . 0.0 110.901 177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.938 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -21.65 -68.62 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -163.07 139.77 7.38 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.583 1.083 . . . . 0.0 109.666 -177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 32.71 34.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 124.479 1.112 . . . . 0.0 110.863 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.858 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 87.17 92.15 0.97 Allowed Glycine 0 N--CA 1.407 -3.236 0 CA-C-O 123.111 1.395 . . . . 0.0 110.45 -174.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.914 ' HB ' ' HB3' ' A' ' 68' ' ' ALA . 1.5 mm -156.48 105.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.034 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.052 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 7.2 t -86.48 98.08 10.84 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.938 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -136.63 144.51 44.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 113.707 -1.588 . . . . 0.0 114.512 -171.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.111 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.3 m -131.79 -139.83 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 112.251 -2.249 . . . . 0.0 108.856 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.111 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 11.6 Cg_endo -91.51 -28.19 0.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 CA-C-N 121.568 1.596 . . . . 0.0 108.447 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.756 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.5 OUTLIER -58.66 -52.97 63.4 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.426 -179.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.31 156.82 24.05 Favored Glycine 0 CA--C 1.502 -0.731 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.491 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.818 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 9.7 m -111.39 145.53 38.74 Favored 'General case' 0 CA--C 1.48 -1.721 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -154.66 136.62 14.6 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.572 -179.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.799 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -56.52 112.24 1.21 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.741 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 33.5 p30 -96.71 106.64 31.56 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.967 -177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -58.26 -16.99 30.64 Favored 'Trans proline' 0 CA--C 1.513 -0.539 0 C-N-CA 123.541 2.827 . . . . 0.0 109.153 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -17.78 64.95 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.855 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.858 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -117.92 -36.61 3.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.727 ' HB2' ' O ' ' A' ' 85' ' ' CYS 0.267 11.4 t0 164.5 -20.11 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.485 0 N-CA-C 121.496 3.887 . . . . 0.0 121.496 -177.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 5.0 Cg_endo -94.48 -67.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.473 -2.53 0 CA-C-N 122.217 1.827 . . . . 0.0 112.678 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.1 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 12.6 tt0 -81.68 1.3 34.82 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.672 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.92 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -65.93 176.75 1.53 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 109.887 -3.324 . . . . 0.0 118.99 -172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.05 -155.12 0.49 Allowed 'General case' 0 N--CA 1.424 -1.756 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.664 176.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.08 51.19 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.4 t . . . . . 0 C--O 1.246 0.912 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.775 0.321 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.25 -169.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.951 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.24 158.55 34.75 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.769 0.795 . . . . 0.0 112.873 -178.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 5' ' ' LEU . 33.0 t70 -73.92 -129.45 0.01 OUTLIER 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.227 -1.352 . . . . 0.0 107.901 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.758 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 96.2 mt -90.33 -137.38 0.13 Allowed 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -82.0 -8.5 59.67 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.458 0.647 . . . . 0.0 111.338 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -94.61 27.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 C-N-CA 125.068 1.347 . . . . 0.0 110.535 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.951 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 82.0 mtt180 -54.72 -178.63 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 51.17 103.45 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.053 0.541 . . . . 0.0 111.952 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.43 -171.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.301 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.063 HD22 ' HB3' ' A' ' 46' ' ' GLU . 1.1 tp -74.04 134.14 78.0 Favored Pre-proline 0 C--O 1.247 0.968 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.957 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 5.5 Cg_exo -75.4 -170.34 0.79 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.824 2.35 . . . . 0.0 112.2 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 4.8 t -144.84 -162.42 1.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.522 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.063 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.69 -149.28 29.45 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.791 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -84.35 86.71 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.571 2.847 . . . . 0.0 112.774 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.26 -70.87 0.21 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.433 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.957 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 179.71 33.72 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.101 0 CA-C-O 122.014 0.786 . . . . 0.0 112.019 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -63.96 -62.16 1.81 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.589 -1.305 . . . . 0.0 108.856 -177.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.854 ' CA ' ' HA2' ' A' ' 29' ' ' GLY . . . -89.06 -148.55 18.32 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.0 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.792 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.29 -179.08 5.37 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.275 -1.462 . . . . 0.0 109.704 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.38 138.9 39.5 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.885 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 m-85 -110.64 2.09 18.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.027 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.01 -81.92 0.24 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.81 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 34.6 Cg_endo -102.09 97.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.183 1.922 . . . . 0.0 114.271 -175.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.676 ' OG ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t 54.42 10.97 0.36 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.885 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 2.4 tt -99.63 157.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-O 122.672 1.225 . . . . 0.0 114.057 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.79 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -156.88 150.42 24.4 Favored 'General case' 0 N--CA 1.413 -2.319 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.137 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 1.7 t -143.94 105.88 4.34 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.073 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.83 162.58 23.18 Favored Glycine 0 N--CA 1.42 -2.386 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.369 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' C ' ' H ' ' A' ' 32' ' ' LEU . 31.0 t70 -71.39 -80.99 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.256 1.028 . . . . 0.0 108.368 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.88 8.47 1.52 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.096 0.951 . . . . 0.0 108.845 175.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.16 -12.58 15.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.979 -174.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.81 -148.83 29.24 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.988 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -137.99 110.32 7.41 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.476 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.951 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -103.35 154.91 18.88 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.385 0.612 . . . . 0.0 111.847 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 76' ' ' PRO . 3.4 t -142.02 108.32 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.903 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.676 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 75.4 28.14 62.28 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 114.68 -1.145 . . . . 0.0 113.183 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -110.83 177.06 4.79 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.879 0.34 . . . . 0.0 110.626 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.05 -46.83 85.66 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.58 13.64 0.05 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.934 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.79 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -138.72 0.38 2.01 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -63.18 -14.88 54.07 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.006 0.432 . . . . 0.0 111.46 178.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.714 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -53.02 -11.34 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 0.8 OUTLIER -66.62 -4.25 8.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.914 0.388 . . . . 0.0 110.684 -179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 49' ' ' TYR . 3.6 mt-30 -65.6 -12.43 53.13 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.536 1.16 . . . . 0.0 108.315 176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.063 ' HB3' HD22 ' A' ' 11' ' ' LEU . 2.4 pp20? -78.77 -25.6 44.42 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.858 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 44' ' ' CYS . 0.6 OUTLIER -79.07 11.65 2.65 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.499 178.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 45' ' ' GLN . 3.1 p-10 -157.12 10.66 0.21 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.114 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.1 m-85 -113.67 -45.34 3.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.598 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.04 155.14 38.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.666 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -44.77 150.12 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.771 2.314 . . . . 0.0 113.283 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 24.6 t -59.81 -46.14 98.35 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.023 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 52' ' ' SER . 46.1 Cg_exo -37.07 91.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 123.19 2.593 . . . . 0.0 114.602 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 7.0 p -169.26 111.12 0.49 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.659 0.742 . . . . 0.0 112.431 178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 56' ' ' SER . 1.8 pt20 45.11 -121.52 0.91 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.313 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 43.9 t -168.36 -80.42 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.635 0.255 . . . . 0.0 111.398 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.47 -172.99 29.57 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.288 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.747 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -117.15 90.62 3.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -26.71 109.68 0.21 Allowed Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.6 Cg_exo -47.15 168.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.126 2.55 . . . . 0.0 111.893 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -151.79 149.36 28.93 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.733 0.778 . . . . 0.0 112.457 -178.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.34 -8.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.273 -1.785 . . . . 0.0 115.112 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.909 ' HB2' ' CB ' ' A' ' 84' ' ' ALA . 1.9 t -88.82 34.61 0.77 Allowed 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.634 0.73 . . . . 0.0 109.462 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 49.46 55.85 12.36 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.805 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 164.58 -166.1 37.75 Favored Glycine 0 C--O 1.216 -1.011 0 CA-C-O 120.075 -0.292 . . . . 0.0 112.469 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.866 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 6.6 mmt180 -97.97 160.5 14.26 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 117.304 0.552 . . . . 0.0 111.95 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.747 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 6.8 t -72.79 51.04 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.748 0.785 . . . . 0.0 110.596 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.955 ' CB ' ' HB3' ' A' ' 74' ' ' CYS . . . -42.17 -98.06 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.642 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.805 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -66.53 -155.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -176.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.952 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -61.61 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 113.817 -1.538 . . . . 0.0 107.202 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.996 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 63.92 33.52 87.47 Favored Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 119.088 -1.53 . . . . 0.0 111.593 -177.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.054 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -94.67 150.26 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.895 ' CB ' ' HB3' ' A' ' 63' ' ' SER . 4.8 t -119.56 100.68 7.42 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.955 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -134.82 151.49 50.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 112.053 -2.339 . . . . 0.0 111.558 -172.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.007 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 50.0 m -119.38 -139.22 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.266 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.007 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 32.5 Cg_endo -92.84 -28.64 0.12 Allowed 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.618 1.614 . . . . 0.0 108.605 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.773 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.03 -56.94 9.03 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.151 -1.84 . . . . 0.0 111.394 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.0 152.33 21.84 Favored Glycine 0 C--N 1.343 0.931 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.106 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.619 ' CA ' ' HB2' ' A' ' 74' ' ' CYS . 2.3 m -114.86 142.14 46.96 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.482 0.658 . . . . 0.0 111.935 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 1.7 pt-20 -143.95 134.96 25.44 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.573 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.083 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -56.19 84.66 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 120.986 0.422 . . . . 0.0 111.074 -177.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 84' ' ' ALA . 40.5 m-20 -83.04 121.32 77.19 Favored Pre-proline 0 N--CA 1.406 -2.667 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.034 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -59.19 2.6 0.23 Allowed 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.656 2.904 . . . . 0.0 108.967 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.909 ' CB ' ' HB2' ' A' ' 63' ' ' SER . . . -76.83 -35.23 57.69 Favored 'General case' 0 N--CA 1.394 -3.239 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.013 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.996 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.1 m -112.7 -23.55 10.13 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.906 ' CB ' ' HA3' ' A' ' 71' ' ' GLY 0.293 6.1 t70 160.09 -17.44 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.748 0 N-CA-C 121.539 3.903 . . . . 0.0 121.539 -178.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.083 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 1.2 Cg_endo -94.71 -67.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.484 -1.995 0 CA-C-N 122.433 1.905 . . . . 0.0 112.313 -172.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.034 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.2 tt0 -77.75 -3.83 43.28 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.803 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.946 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -58.49 174.69 0.29 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 119.707 3.225 . . . . 0.0 119.707 -172.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.48 -158.45 0.67 Allowed 'General case' 0 N--CA 1.408 -2.551 1 CA-C-N 106.804 -4.726 . . . . 0.0 106.264 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -77.66 60.93 2.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.483 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.767 ' HB1' ' NH1' ' A' ' 8' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.712 0.292 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 9' ' ' THR . 27.4 m -96.09 132.33 40.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.97 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -111.92 161.76 16.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.755 ' HA ' ' HA ' ' A' ' 55' ' ' GLN . 14.5 t70 -86.22 -29.18 23.37 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.648 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -71.94 -104.11 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.697 -178.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.047 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.19 -14.74 0.3 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 5' ' ' LEU . 17.2 m -82.53 -7.93 11.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 119.372 -0.931 . . . . 0.0 112.455 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.97 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 89.6 mtt180 -149.43 125.16 10.45 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.535 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.789 ' O ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.33 156.5 16.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.712 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 11' ' ' LEU . 1.9 t -56.2 -93.06 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.463 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 2.9 tp -114.39 111.77 46.64 Favored Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 122.383 -0.198 . . . . 0.0 110.636 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.4 Cg_exo -47.86 170.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.051 1.834 . . . . 0.0 114.443 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 t -149.77 -160.19 1.14 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.695 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 53.15 -145.41 21.82 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.53 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 1.037 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 23.1 Cg_endo -84.85 78.81 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.704 2.936 . . . . 0.0 112.477 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.568 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 105.36 -62.4 0.34 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.136 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.662 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . -179.72 36.01 0.07 OUTLIER Glycine 0 CA--C 1.499 -0.915 0 CA-C-O 122.383 0.991 . . . . 0.0 111.426 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 1.037 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.85 -23.33 65.14 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 112.931 -1.634 . . . . 0.0 110.86 179.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -144.79 -149.25 5.0 Favored Glycine 0 N--CA 1.418 -2.511 0 CA-C-N 113.634 -1.621 . . . . 0.0 110.869 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.893 ' NH2' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -166.83 -178.05 4.11 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.147 -1.026 . . . . 0.0 110.252 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -103.68 129.04 50.94 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.842 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.3 m-85 -98.64 -2.78 37.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -177.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 151.47 -80.84 0.19 Allowed Glycine 0 C--N 1.338 0.654 0 C-N-CA 118.878 -1.63 . . . . 0.0 116.788 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.942 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.5 Cg_endo -99.13 90.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.966 1.778 . . . . 0.0 113.603 -175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.4 15.48 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.842 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -99.59 159.03 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 122.16 0.981 . . . . 0.0 113.591 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -154.16 145.45 22.96 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 113.378 -1.737 . . . . 0.0 109.655 -179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -144.46 125.15 14.13 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.86 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -113.58 167.17 12.24 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.531 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -72.64 -80.93 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 118.001 0.901 . . . . 0.0 108.764 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -1.08 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 122.203 1.002 . . . . 0.0 108.632 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD22 ' CZ ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.29 -20.29 20.55 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.807 -1.542 . . . . 0.0 113.788 -175.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.69 -160.83 53.19 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.004 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.827 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -114.71 140.21 49.05 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.129 -0.628 . . . . 0.0 112.303 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.001 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -131.73 154.64 48.82 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.432 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.666 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -140.28 113.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 109.802 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.14 9.79 17.29 Favored Glycine 0 C--N 1.318 -0.471 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.255 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 39' ' ' ALA . 16.6 m -83.43 178.86 7.84 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 110.81 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.698 ' H ' HG22 ' A' ' 38' ' ' THR . . . -58.66 -53.17 61.33 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.178 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CB ' ' CE2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -66.69 9.37 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.641 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 27' ' ' CYS . . . -126.22 -2.81 6.94 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.866 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.0 OUTLIER -63.42 -14.63 52.51 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 177.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.898 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.64 -13.15 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 m -64.69 -8.85 16.17 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.786 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.866 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -64.18 -26.42 68.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.776 ' OE1' ' HG3' ' A' ' 43' ' ' ARG . 52.3 mt-10 -73.25 -19.89 60.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.042 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.2 2.71 0.75 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 46' ' ' GLU . 5.3 p30 -53.28 -23.01 7.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.899 0.381 . . . . 0.0 110.855 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 92.8 m-85 -84.06 148.85 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.245 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 50' ' ' LEU . 2.0 mm? -105.37 74.29 0.27 Allowed Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 82.8 Cg_exo -54.32 -166.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.785 2.324 . . . . 0.0 112.625 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.795 ' OG ' ' HD3' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -152.41 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.227 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' OG ' ' A' ' 52' ' ' SER . 68.6 Cg_endo -98.9 117.56 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.943 2.429 . . . . 0.0 113.236 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.9 p -172.63 -162.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.859 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.893 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -78.43 -169.28 1.61 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.893 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.412 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 40.6 t 178.5 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.045 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.91 131.03 10.43 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.658 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.819 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -119.79 140.21 51.11 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -14.49 85.34 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 CA-C-O 122.382 1.087 . . . . 0.0 113.122 -174.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 52.9 Cg_exo -52.85 166.38 0.9 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 124.582 3.521 . . . . 0.0 117.316 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.7 p -158.17 162.5 37.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.351 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.01 22.6 11.48 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 113.937 -1.483 . . . . 0.0 115.681 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.058 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.7 t -104.14 37.51 2.06 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.25 8.26 64.66 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.666 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 159.75 -149.88 19.82 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.901 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.7 mmt-85 -93.39 -175.34 3.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 115.145 -0.527 . . . . 0.0 112.331 -173.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.73 48.78 0.71 Allowed 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.882 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.117 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -20.68 -66.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -160.09 144.44 14.54 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.523 -0.736 . . . . 0.0 110.83 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.064 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 15.44 67.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 124.318 1.012 . . . . 0.0 111.16 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.016 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 61.41 80.69 0.1 OUTLIER Glycine 0 N--CA 1.424 -2.143 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.117 HG22 ' HB3' ' A' ' 68' ' ' ALA . 1.1 mm -155.95 101.03 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.52 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.058 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 16.4 t -85.58 98.78 10.84 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.964 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.0 t -137.65 146.76 44.27 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -172.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.125 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 69.2 m -126.73 -138.68 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 112.53 -2.123 . . . . 0.0 107.885 176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.125 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 15.4 Cg_endo -91.42 -27.78 0.21 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 CA-C-N 121.676 1.634 . . . . 0.0 108.661 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.76 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -59.33 -52.44 65.65 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.055 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.76 155.29 19.4 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.045 173.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.829 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.9 m -110.11 142.06 42.11 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-O 121.906 0.86 . . . . 0.0 110.49 176.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.748 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.87 138.2 20.57 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.382 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.778 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -52.57 113.17 0.98 Allowed 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.1 p30 -99.21 101.8 13.87 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.127 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.106 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 63.4 Cg_exo -57.11 -14.48 14.99 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.697 2.931 . . . . 0.0 108.968 177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -67.79 -18.91 65.01 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-N 112.696 -2.047 . . . . 0.0 108.594 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.771 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -118.37 -31.62 4.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.155 2.279 . . . . 0.0 117.155 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.696 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 12.2 t0 168.3 -24.83 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.303 1 N-CA-C 122.109 4.114 . . . . 0.0 122.109 -177.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.064 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 8.7 Cg_endo -101.61 -68.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.478 -2.311 0 CA-C-N 122.057 1.77 . . . . 0.0 113.684 -171.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.106 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.1 tt0 -77.53 1.58 18.99 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 124.019 1.866 . . . . 0.0 106.39 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.985 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -68.52 -179.02 1.24 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 109.894 -3.321 . . . . 0.0 119.927 -173.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.71 -156.03 0.54 Allowed 'General case' 0 N--CA 1.424 -1.74 1 CA-C-N 107.468 -4.424 . . . . 0.0 107.089 175.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -78.14 55.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 9.2 t . . . . . 0 C--O 1.251 1.175 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.185 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.894 0.378 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -170.61 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.899 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.038 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -65.58 157.01 30.92 Favored 'General case' 0 N--CA 1.423 -1.799 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -178.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.856 ' HB3' HG23 ' A' ' 7' ' ' VAL . 27.8 t0 -63.75 -146.92 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.99 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.044 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -87.14 -107.66 0.06 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 121.633 -0.667 . . . . 0.0 111.061 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.044 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -84.45 -14.87 48.02 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.911 178.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.856 HG23 ' HB3' ' A' ' 4' ' ' ASP . 16.4 m -81.12 29.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.293 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.038 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 51.9 mtt85 -68.59 137.0 53.92 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.744 HG22 ' NH2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 43.63 72.94 0.16 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.999 0.904 . . . . 0.0 111.579 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.739 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 35.3 m -78.98 -79.01 0.14 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.243 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.853 HD13 ' OG ' ' A' ' 52' ' ' SER . 3.9 tp -75.64 102.98 0.83 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.327 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.777 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.3 Cg_exo -67.88 178.49 3.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.053 1.836 . . . . 0.0 113.071 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.777 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -141.7 -162.39 1.38 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.973 -179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 1.047 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 52.96 -148.26 13.56 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.942 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 25.4 Cg_endo -83.95 87.81 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.666 2.911 . . . . 0.0 112.678 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.93 -68.31 0.54 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.547 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.777 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -176.7 34.05 0.08 OUTLIER Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.338 0.965 . . . . 0.0 111.851 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.744 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.74 -26.69 67.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 113.182 -1.509 . . . . 0.0 111.585 -179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -136.81 -151.62 6.04 Favored Glycine 0 N--CA 1.415 -2.746 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.621 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.812 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.87 178.33 9.52 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.01 -1.095 . . . . 0.0 110.003 178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.2 m -100.97 128.75 46.86 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.887 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.5 m-85 -98.52 1.8 46.94 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.745 -177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.53 -69.9 0.45 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 119.059 -1.544 . . . . 0.0 116.9 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.1 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 39.9 Cg_endo -101.25 87.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.19 1.927 . . . . 0.0 113.781 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 t 51.75 22.03 1.56 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.746 0.308 . . . . 0.0 110.439 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.93 HD11 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -102.25 153.84 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -176.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 41' ' ' ALA . 2.2 m -142.02 134.56 28.18 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.01 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.601 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -136.01 115.61 12.86 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.837 ' HA2' ' HA2' ' A' ' 19' ' ' GLY . . . -108.09 163.98 12.86 Favored Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.39 -80.96 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.58 3.18 4.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.593 0.711 . . . . 0.0 109.213 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.2 OUTLIER -99.49 -21.63 15.86 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.661 ' HA2' ' HB3' ' A' ' 69' ' ' ALA . . . 80.86 -154.75 36.07 Favored Glycine 0 C--N 1.308 -1.013 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.895 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.819 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -133.39 113.24 12.32 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.988 ' HZ ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -111.24 157.19 20.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.838 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 26' ' ' ILE . 2.7 t -130.67 98.26 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.216 0.531 . . . . 0.0 109.793 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.52 -9.13 30.24 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.613 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.708 HG22 ' H ' ' A' ' 39' ' ' ALA . 10.4 m -57.09 179.03 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.478 0.18 . . . . 0.0 110.912 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' H ' HG22 ' A' ' 38' ' ' THR . . . -57.52 -55.65 32.13 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.1 10.95 0.24 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.919 0.39 . . . . 0.0 110.805 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -121.14 -5.64 9.47 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.91 -10.8 41.99 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.109 0.48 . . . . 0.0 110.553 176.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.812 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -49.57 -16.02 0.2 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.142 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -69.03 -13.69 62.6 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.249 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -24.34 67.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 28.0 mt-10 -75.14 -14.37 60.55 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.034 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.8 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -76.57 3.3 11.73 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.131 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.31 12.64 18.92 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.61 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 23.7 m-85 -99.03 -63.01 1.16 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 111.295 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.91 108.7 11.76 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.074 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -45.51 120.86 3.51 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.87 2.38 . . . . 0.0 113.137 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.853 ' OG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -155.77 51.0 0.52 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.829 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' HD3' ' N ' ' A' ' 52' ' ' SER . 5.1 Cg_exo -79.83 54.73 5.33 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.581 2.187 . . . . 0.0 111.785 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.848 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -100.6 109.19 21.25 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 122.98 0.512 . . . . 0.0 110.069 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.85 ' HA ' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER 161.6 -158.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.8 0.44 . . . . 0.0 110.651 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -179.7 -169.35 0.13 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.704 0.288 . . . . 0.0 111.156 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.01 156.0 25.88 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.368 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.796 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -121.1 160.81 22.9 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -11.35 85.15 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 126.032 1.733 . . . . 0.0 113.314 -174.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 53.1 Cg_exo -55.61 168.85 1.41 Allowed 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 123.983 3.122 . . . . 0.0 116.179 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' GLY . 2.3 p -161.75 164.36 29.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.292 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.57 23.47 19.21 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.001 -1.454 . . . . 0.0 115.472 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 1.014 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.8 t -104.85 35.49 2.76 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.59 59.38 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 114.837 -1.074 . . . . 0.0 115.123 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.593 ' HA3' ' OG ' ' A' ' 75' ' ' SER . . . 157.82 -147.61 15.85 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 115.815 1.086 . . . . 0.0 115.815 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.914 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.8 mmt180 -91.45 -175.78 4.33 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.981 -0.61 . . . . 0.0 112.279 -174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.02 54.31 1.58 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.374 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.962 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -16.4 -81.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB3' ' HA2' ' A' ' 33' ' ' GLY . . . -162.57 146.59 11.69 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 121.838 -0.539 . . . . 0.0 109.774 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.965 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 37.24 31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.622 0.769 . . . . 0.0 110.824 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.844 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 84.17 91.32 0.75 Allowed Glycine 0 N--CA 1.404 -3.478 0 CA-C-O 123.278 1.488 . . . . 0.0 110.843 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.039 HG12 ' HA ' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -157.59 119.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.003 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.014 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 11.4 t -91.31 100.68 13.44 Favored 'General case' 0 N--CA 1.388 -3.565 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.962 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.6 OUTLIER -135.69 139.98 44.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.051 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 67.8 m -127.44 -140.62 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.061 0 CA-C-N 112.736 -2.029 . . . . 0.0 108.3 175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HB3' ' HG3' ' A' ' 24' ' ' PRO . 17.7 Cg_endo -91.85 -28.87 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.731 1.654 . . . . 0.0 108.492 176.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -56.8 -52.06 66.51 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.966 -177.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.29 153.15 12.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.493 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.695 ' HB3' HG21 ' A' ' 72' ' ' ILE . 4.1 m -109.93 145.76 36.34 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.578 0.704 . . . . 0.0 109.975 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.722 ' H ' HG23 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -155.59 141.13 17.84 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.721 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 1.039 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -55.65 116.85 3.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.665 ' CB ' ' HB2' ' A' ' 73' ' ' CYS . 44.5 p30 -100.82 108.35 53.54 Favored Pre-proline 0 N--CA 1.416 -2.151 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.453 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.13 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 51.9 Cg_exo -58.28 -16.98 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.109 2.54 . . . . 0.0 109.364 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.29 -20.98 64.81 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 112.204 -2.271 . . . . 0.0 109.547 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.844 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.49 -30.53 4.52 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.1 t70 171.41 -27.05 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.652 1 N-CA-C 122.522 4.267 . . . . 0.0 122.522 -177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.965 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 7.8 Cg_endo -100.61 -68.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.486 -1.881 0 C-N-CA 122.377 2.051 . . . . 0.0 113.845 -171.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 1.13 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.1 tt0 -77.1 1.12 19.07 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.667 -2.061 . . . . 0.0 106.844 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.797 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.12 179.08 1.25 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.915 -3.311 . . . . 0.0 119.549 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -100.47 -156.78 0.57 Allowed 'General case' 0 N--CA 1.419 -2.001 1 CA-C-N 107.033 -4.621 . . . . 0.0 107.15 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -78.16 55.45 1.5 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.546 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-N 113.233 -1.803 . . . . 0.0 111.115 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 3' ' ' LEU . 2.6 t -62.44 163.68 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.422 . . . . 0.0 111.411 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.092 ' H ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -63.28 -154.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.622 1.201 . . . . 0.0 113.988 -177.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -141.14 -8.8 1.01 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.24 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.7 ' O ' ' HG3' ' A' ' 8' ' ' ARG . 5.1 tp -55.57 -160.36 0.0 OUTLIER 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 113.961 -1.472 . . . . 0.0 112.012 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -69.61 -20.66 63.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.692 HG23 HD13 ' A' ' 3' ' ' LEU . 2.8 m -84.91 32.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.6 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HG3' ' O ' ' A' ' 5' ' ' LEU . 34.3 mtt180 -64.96 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.451 0.7 . . . . 0.0 112.322 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.627 ' O ' HG22 ' A' ' 9' ' ' THR . 1.2 m 74.44 86.41 0.1 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.693 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 55' ' ' GLN . 94.8 m -78.75 -138.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.586 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.7 tp -68.71 138.12 90.66 Favored Pre-proline 0 C--O 1.231 0.118 0 CA-C-O 121.01 0.433 . . . . 0.0 111.572 -178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 12.9 Cg_exo -66.79 176.75 4.04 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.311 2.007 . . . . 0.0 113.514 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.717 ' HB2' ' N ' ' A' ' 20' ' ' ARG . 0.7 OUTLIER -139.28 -166.35 2.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.305 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.916 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 51.97 -144.49 17.7 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.916 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 22.6 Cg_endo -85.55 94.65 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.72 2.947 . . . . 0.0 113.173 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.65 -69.26 1.72 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.476 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.626 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . -178.59 37.63 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.954 0 CA-C-O 122.082 0.824 . . . . 0.0 112.033 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -67.51 -24.91 65.61 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.523 -1.339 . . . . 0.0 110.812 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -139.76 -150.18 5.46 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.06 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.717 ' N ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -158.78 171.38 20.18 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.268 -0.966 . . . . 0.0 109.742 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.1 m -99.18 128.91 45.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.784 ' HB2' HG21 ' A' ' 26' ' ' ILE . 3.3 m-85 -95.38 -2.73 48.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 144.69 -73.59 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 119.099 -1.524 . . . . 0.0 116.116 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 44.8 Cg_endo -100.53 98.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.538 2.159 . . . . 0.0 114.029 -176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 0.7 OUTLIER 39.25 32.11 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.964 0.411 . . . . 0.0 110.303 179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.784 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.2 tt -112.48 153.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.609 0.719 . . . . 0.0 112.699 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 7.1 m -144.39 139.17 28.27 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.438 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -136.22 118.66 15.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.72 ' HA3' ' CB ' ' A' ' 32' ' ' LEU . . . -113.09 165.54 12.05 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.69 -72.98 0.26 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -0.79 25.75 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HA3' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -97.48 -26.2 14.91 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.391 -1.277 . . . . 0.0 114.066 -175.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.26 -155.61 32.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.284 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.837 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -135.86 116.55 13.96 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 122.369 -0.489 . . . . 0.0 112.216 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.873 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -123.66 140.24 53.19 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.181 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.2 t -103.02 99.14 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.267 0.556 . . . . 0.0 110.456 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 69.38 9.94 62.06 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.854 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 3.8 m -72.21 163.76 27.39 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -40.0 -58.94 1.31 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.18 0.514 . . . . 0.0 110.655 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -73.71 8.99 1.6 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.154 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.873 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -130.24 2.18 4.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -65.75 -11.71 47.93 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.607 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.782 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 2.2 mpp_? -48.91 -19.33 0.37 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.746 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -74.52 -18.93 60.53 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.391 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.19 -21.43 66.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.1 mt-10 -75.11 -19.36 59.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.935 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -77.26 -0.03 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.102 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 49' ' ' TYR . 51.4 p30 -74.97 -5.67 45.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.048 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' HD22 ' A' ' 50' ' ' LEU . 56.6 m-85 -95.54 -16.51 22.12 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.134 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -138.09 80.53 29.08 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.281 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -44.97 166.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.096 2.531 . . . . 0.0 113.244 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.6 t 62.76 103.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.452 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -92.06 152.97 3.23 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.956 2.437 . . . . 0.0 112.014 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 p -118.92 -169.13 1.67 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.195 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' CG ' ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER 58.95 164.14 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.954 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.0 p -153.41 -159.07 0.94 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . -87.16 166.78 37.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.814 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.797 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -112.34 175.23 5.52 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.386 0.674 . . . . 0.0 111.692 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 58' ' ' GLN . 3.0 pttm -14.26 95.61 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.579 0 CA-C-O 122.958 1.361 . . . . 0.0 111.893 -174.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 51.1 Cg_exo -55.67 169.56 1.2 Allowed 'Trans proline' 0 C--N 1.351 0.697 1 C-N-CA 125.501 4.134 . . . . 0.0 117.279 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.552 ' O ' ' O ' ' A' ' 65' ' ' GLY . 1.4 p -157.21 159.42 37.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 112.888 -1.96 . . . . 0.0 111.926 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.99 29.49 8.0 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.905 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.5 t -110.02 35.67 3.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.93 0.16 48.44 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.07 -0.968 . . . . 0.0 114.33 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 61' ' ' CYS . . . 157.61 -143.36 9.41 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 -178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.928 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 10.4 mmt180 -94.7 -176.99 4.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.573 -0.813 . . . . 0.0 112.671 -173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 68' ' ' ALA . 45.1 t -78.62 50.28 0.96 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.894 0.378 . . . . 0.0 111.319 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.877 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -22.37 -67.95 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.561 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -160.58 147.34 15.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.347 0.976 . . . . 0.0 112.161 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.876 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 22.35 52.38 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.066 0 O-C-N 123.849 0.718 . . . . 0.0 109.775 -178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.904 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 68.13 83.97 0.13 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 119.163 -1.494 . . . . 0.0 110.456 -176.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.877 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -155.01 111.02 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.479 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.928 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 19.1 t -90.24 100.28 13.14 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 31.2 t -139.66 147.88 41.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 45.4 m -125.88 -137.54 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.958 -1.928 . . . . 0.0 108.066 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 83.8 Cg_endo -89.96 -29.88 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 120.901 1.357 . . . . 0.0 109.184 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.572 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -59.64 -51.88 67.92 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.176 -177.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.41 156.06 22.47 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.21 174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 8.3 m -111.92 139.92 47.0 Favored 'General case' 0 CA--C 1.486 -1.499 0 CA-C-N 117.848 0.824 . . . . 0.0 110.685 176.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.644 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -149.23 137.01 20.43 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.495 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.557 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -54.3 119.53 5.29 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 39.2 p30 -104.36 106.19 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.247 -177.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.675 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -55.45 -19.57 23.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.526 2.817 . . . . 0.0 108.508 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.64 -15.8 63.83 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 112.638 -2.074 . . . . 0.0 110.404 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -124.44 -27.8 3.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.809 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 16.8 t0 165.43 -21.77 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.145 0 N-CA-C 121.517 3.895 . . . . 0.0 121.517 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.876 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 13.6 Cg_endo -102.93 -68.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.688 0 CA-C-N 122.349 1.875 . . . . 0.0 113.68 -172.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 16.5 tt0 -79.33 4.64 14.62 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.446 -1.706 . . . . 0.0 106.747 178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.675 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -67.7 177.79 1.92 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.66 3.207 . . . . 0.0 119.66 -173.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -99.59 -154.82 0.48 Allowed 'General case' 0 N--CA 1.434 -1.264 1 CA-C-N 107.892 -4.231 . . . . 0.0 106.291 174.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.72 55.24 1.04 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 5.4 t . . . . . 0 C--O 1.249 1.026 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.104 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.766 0.317 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.99 129.09 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.952 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -73.25 153.66 40.53 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -75.35 -122.53 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.886 -1.507 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.87 ' CD1' HG22 ' A' ' 7' ' ' VAL . 1.5 pp -96.1 -135.75 0.23 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 117.894 0.315 . . . . 0.0 111.239 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.562 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.6 m-20 -79.58 -10.47 59.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.155 0.502 . . . . 0.0 111.405 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.87 HG22 ' CD1' ' A' ' 5' ' ' LEU . 27.8 m -96.74 46.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.053 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.618 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 70.0 mtt180 -67.76 154.1 42.26 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.699 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.619 ' O ' HG22 ' A' ' 9' ' ' THR . 96.2 m 60.2 37.55 20.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.735 0.779 . . . . 0.0 109.574 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 9' ' ' THR . 54.4 m 24.11 -150.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.042 -1.436 . . . . 0.0 113.36 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.63 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 tp -90.54 146.35 34.15 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 8.4 Cg_exo -64.13 176.76 2.34 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.567 2.178 . . . . 0.0 114.892 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.608 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 17.6 t -146.95 -161.38 1.32 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.869 -1.514 . . . . 0.0 111.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.702 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 56.66 -151.49 24.5 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.319 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -79.73 85.86 1.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.99 -70.7 0.21 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.561 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.726 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -179.56 33.22 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.777 0.654 . . . . 0.0 112.141 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -65.01 -59.77 3.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.191 -1.004 . . . . 0.0 108.857 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -94.13 -145.32 17.69 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.38 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.73 177.89 7.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.479 -1.36 . . . . 0.0 109.219 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.98 139.74 40.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.787 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 2.9 m-85 -110.9 -1.71 16.34 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.46 -81.53 0.24 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 118.928 -1.606 . . . . 0.0 116.96 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 76' ' ' PRO . 70.0 Cg_endo -96.57 97.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.3 2.0 . . . . 0.0 114.429 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER 47.98 18.93 0.16 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.787 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 4.9 tt -107.09 159.27 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -158.84 154.34 25.94 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.334 179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -143.57 107.84 4.78 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.966 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.78 159.13 20.26 Favored Glycine 0 N--CA 1.421 -2.358 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.147 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 32' ' ' LEU . 1.2 t70 -73.56 -73.01 0.23 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.98 1.67 17.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.022 0.915 . . . . 0.0 108.705 175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.966 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -106.25 -7.49 17.79 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.62 -1.627 . . . . 0.0 114.227 -174.258 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 77.58 -151.05 37.33 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.009 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -139.38 112.83 8.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.73 0.3 . . . . 0.0 110.353 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.782 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 2.5 m-85 -102.84 144.59 30.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.936 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.8 t -131.71 112.94 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.163 176.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 63.14 44.76 96.69 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.783 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.542 ' H ' ' HB3' ' A' ' 41' ' ' ALA . 5.6 m -134.2 162.11 33.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.478 0.311 . . . . 0.0 110.571 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -41.43 -52.9 3.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.306 0.574 . . . . 0.0 110.917 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -64.45 12.04 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.515 178.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -134.48 -2.01 2.78 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.78 -11.24 60.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.962 0.41 . . . . 0.0 111.158 177.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.729 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.98 -10.0 2.24 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 32.9 m -63.63 -11.55 26.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -22.46 66.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 1.3 pp20? -68.83 -25.0 64.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.218 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.9 mt-10 -80.14 6.24 12.2 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.518 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -105.01 -20.75 13.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.357 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 34.2 m-85 -65.91 -77.43 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.693 0.283 . . . . 0.0 110.616 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 tp -105.0 89.17 2.76 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.231 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 25.7 Cg_exo -40.68 92.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.077 2.518 . . . . 0.0 113.247 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.514 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 74.9 m -150.69 59.03 3.25 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.878 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 52' ' ' SER . 17.3 Cg_exo -65.88 82.02 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.372 2.048 . . . . 0.0 111.526 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.1 p -79.21 -174.07 3.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 9' ' ' THR . 5.7 tt0 39.54 82.72 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.257 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -87.87 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.92 151.71 17.28 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.714 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.15 122.73 47.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -22.14 92.28 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 76.6 Cg_exo -45.34 163.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.019 2.48 . . . . 0.0 110.979 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.572 ' O ' ' N ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -148.42 147.56 29.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.035 0.921 . . . . 0.0 112.654 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.01 -13.2 0.0 OUTLIER Glycine 0 CA--C 1.523 0.534 0 CA-C-N 112.954 -1.93 . . . . 0.0 115.9 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.688 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 21.5 t -90.71 38.9 0.96 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 118.302 1.051 . . . . 0.0 109.119 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 45.23 66.74 1.41 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 114.347 -1.297 . . . . 0.0 114.656 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 159.11 -161.15 31.8 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.66 -0.305 . . . . 0.0 112.473 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.01 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 15.2 mmt-85 -100.15 157.91 16.24 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.066 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 68' ' ' ALA . 50.2 t -73.52 43.54 0.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.32 0.581 . . . . 0.0 110.867 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -25.97 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.361 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.794 ' HB3' ' HB ' ' A' ' 72' ' ' ILE . . . -70.76 -159.88 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.88 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -70.34 94.33 0.93 Allowed 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 171.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.888 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.29 79.88 0.09 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 118.192 -1.956 . . . . 0.0 108.578 -175.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.001 HG22 ' HB3' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -157.32 116.62 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 177.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 1.01 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 2.9 t -100.83 98.69 9.17 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 3.6 t -139.17 161.73 36.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.357 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 1.002 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 44.6 m -123.84 -137.19 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 37.4 Cg_endo -90.22 -27.98 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.79 1.318 . . . . 0.0 109.458 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.547 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -66.91 -61.52 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.881 -1.509 . . . . 0.0 112.649 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.63 154.55 25.63 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.792 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.71 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.8 m -117.49 141.31 48.5 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.704 ' C ' HD13 ' A' ' 72' ' ' ILE . 5.5 pt-20 -140.65 126.25 19.04 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.816 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -48.81 121.05 4.27 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.816 0.341 . . . . 0.0 111.164 -176.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 37.6 p30 -100.98 100.8 13.81 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 121.861 0.838 . . . . 0.0 110.876 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.822 ' HB3' ' HA ' ' A' ' 89' ' ' ALA . 71.2 Cg_exo -53.83 -15.64 7.34 Favored 'Trans proline' 0 CA--C 1.504 -0.991 0 C-N-CA 124.079 3.186 . . . . 0.0 109.363 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -69.03 -32.02 71.23 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.516 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.764 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -104.55 -24.98 12.94 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.5 t70 173.07 -28.66 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 1 N-CA-C 122.177 4.14 . . . . 0.0 122.177 -178.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.888 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 15.0 Cg_endo -111.88 -73.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.357 0 CA-C-N 122.401 1.893 . . . . 0.0 115.152 -170.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.652 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 22.1 tt0 -67.34 -2.55 6.28 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.822 ' HA ' ' HB3' ' A' ' 83' ' ' PRO . . . -64.0 -176.46 0.2 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 119.683 3.216 . . . . 0.0 119.683 -174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -101.63 -162.47 0.93 Allowed 'General case' 0 N--CA 1.423 -1.821 1 CA-C-N 107.947 -4.206 . . . . 0.0 106.347 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.79 66.75 2.12 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.659 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.848 ' O ' ' HA ' ' A' ' 52' ' ' SER . 3.2 t -74.72 172.81 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.005 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.826 HD12 ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -70.99 178.27 3.28 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 52' ' ' SER . 4.2 t0 -75.79 -46.19 32.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.125 -177.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -89.13 -71.55 0.59 Allowed 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 122.5 1.143 . . . . 0.0 109.741 176.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.434 ' H ' ' CG ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -152.69 -65.36 0.16 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 112.811 -1.995 . . . . 0.0 109.046 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.638 ' HA ' HD23 ' A' ' 3' ' ' LEU . 31.4 m -116.7 -1.38 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 114.522 1.305 . . . . 0.0 114.522 -178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.822 ' HB2' HD21 ' A' ' 5' ' ' LEU . 49.2 mtt85 -119.78 131.59 55.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 118.222 0.465 . . . . 0.0 112.194 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.826 ' HA ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -58.8 141.23 53.69 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.999 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' N ' ' HB2' ' A' ' 4' ' ' ASP . 5.6 m 61.95 132.83 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.737 0.303 . . . . 0.0 111.703 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.776 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -111.87 136.53 21.19 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 10.6 Cg_exo -62.45 175.55 2.08 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.423 2.082 . . . . 0.0 113.99 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 43' ' ' ARG . 5.8 t -147.59 -160.33 1.15 Allowed 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.112 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.16 -145.75 33.76 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.421 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -81.84 86.95 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.944 3.096 . . . . 0.0 112.874 -178.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.93 -69.88 0.37 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.595 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.709 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . -177.47 31.41 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 121.659 0.588 . . . . 0.0 112.273 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.83 -57.52 8.66 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.446 -0.877 . . . . 0.0 109.058 -178.186 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -95.37 -147.37 22.53 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.426 178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.12 176.42 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 113.887 -1.157 . . . . 0.0 109.552 178.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -103.12 138.32 40.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.133 178.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.753 ' CE2' ' HG3' ' A' ' 58' ' ' GLN . 2.3 m-85 -106.2 0.36 25.22 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' SG ' ' A' ' 44' ' ' CYS . . . 145.95 -87.07 0.17 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 116.958 1.543 . . . . 0.0 116.958 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 76' ' ' PRO . 58.1 Cg_endo -97.92 101.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.433 2.089 . . . . 0.0 113.99 -176.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 46.8 20.26 0.11 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.88 0.372 . . . . 0.0 110.462 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 76' ' ' PRO . 4.7 tt -109.42 160.2 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -159.34 151.41 20.87 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.454 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -143.61 111.41 6.05 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 120.811 0.339 . . . . 0.0 111.61 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 1.033 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.04 152.89 21.2 Favored Glycine 0 N--CA 1.412 -2.925 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -71.14 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.976 1.388 . . . . 0.0 108.227 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -3.26 35.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.473 175.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.033 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -108.45 3.26 23.0 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.975 -174.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 61.91 -143.96 48.83 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.409 -0.9 . . . . 0.0 114.091 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -134.19 145.04 48.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.884 0.374 . . . . 0.0 111.999 -179.097 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 2.9 m-85 -133.16 113.33 12.58 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.851 177.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.665 HG11 ' O ' ' A' ' 76' ' ' PRO . 2.5 t -100.8 130.92 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.477 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 49.96 33.64 21.49 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.12 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -116.41 157.48 25.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 122.235 0.214 . . . . 0.0 111.126 -179.309 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' ALA . . . -46.82 -49.96 19.19 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.073 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.2 10.52 0.06 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.084 178.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -136.2 2.78 2.82 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -66.22 -12.44 56.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 178.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.46 -15.87 4.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -74.99 -12.28 60.3 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.38 -179.501 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' O ' ' CE2' ' A' ' 49' ' ' TYR . 3.2 mt-30 -67.02 -16.22 64.22 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.535 1.16 . . . . 0.0 108.337 176.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.776 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -77.02 -34.15 57.38 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.644 177.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HG2' ' NE2' ' A' ' 55' ' ' GLN . 4.1 tt0 -81.02 0.09 37.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.358 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -93.63 -9.81 36.71 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE2' ' O ' ' A' ' 45' ' ' GLN . 51.1 p90 -142.31 9.4 1.85 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.703 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -143.97 74.83 16.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 0.0 111.07 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -45.91 151.87 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.837 2.358 . . . . 0.0 112.394 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.3 OUTLIER -142.38 160.13 55.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.765 0.316 . . . . 0.0 111.178 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' HD3' ' HA ' ' A' ' 3' ' ' LEU . 2.9 Cg_exo -76.85 -43.72 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.571 2.181 . . . . 0.0 111.956 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' THR . 6.3 t -90.66 -38.72 12.91 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 122.323 -0.235 . . . . 0.0 111.057 -179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -24.86 123.06 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 p 68.41 138.15 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.839 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.6 87.59 0.27 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.278 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.753 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -131.35 93.08 3.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -32.36 110.36 0.32 Allowed Pre-proline 0 C--N 1.316 -0.878 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.93 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -47.67 171.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.154 2.569 . . . . 0.0 112.006 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.657 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -149.21 146.84 27.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.045 0.926 . . . . 0.0 112.171 -179.485 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -36.52 -10.6 0.0 OUTLIER Glycine 0 CA--C 1.528 0.905 0 CA-C-N 113.164 -1.835 . . . . 0.0 116.404 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' ' 84' ' ' ALA . 9.1 t -95.27 38.87 1.13 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 118.701 1.251 . . . . 0.0 109.496 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 48.82 62.24 4.68 Favored Glycine 0 CA--C 1.505 -0.54 0 CA-C-N 114.327 -1.306 . . . . 0.0 115.003 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 61' ' ' CYS . . . 163.38 -163.47 35.6 Favored Glycine 0 C--O 1.218 -0.852 0 CA-C-O 120.16 -0.244 . . . . 0.0 112.542 179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.93 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.1 mmt180 -98.91 160.77 14.03 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -71.03 44.56 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.956 0.408 . . . . 0.0 110.479 177.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.997 ' HB2' ' HB3' ' A' ' 74' ' ' CYS . . . -14.56 -95.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 29' ' ' GLY . . . -157.8 151.7 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.747 0.308 . . . . 0.0 110.18 -176.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.715 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . 54.04 32.77 16.21 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.885 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 73.97 30.9 60.61 Favored Glycine 0 N--CA 1.421 -2.303 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.12 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.897 HG12 ' HA ' ' A' ' 81' ' ' GLU . 1.6 mt -88.72 150.86 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.917 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 5.1 t -117.51 102.75 9.45 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.997 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.9 t -141.61 156.93 45.65 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.869 -173.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.887 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 36.6 m -119.07 -137.72 0.0 OUTLIER Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.887 ' HD3' ' HB3' ' A' ' 75' ' ' SER . 71.2 Cg_endo -90.69 -28.92 0.19 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.924 1.366 . . . . 0.0 109.245 176.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -65.87 -60.33 2.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.377 -175.157 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.84 151.8 22.99 Favored Glycine 0 C--N 1.344 1.007 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.947 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.752 ' HA ' ' HB2' ' A' ' 74' ' ' CYS . 3.7 m -115.77 141.17 48.44 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 117.584 0.692 . . . . 0.0 112.651 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.65 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.0 pt-20 -145.21 132.6 20.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.509 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.897 ' HA ' HG12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -53.06 85.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.198 0.523 . . . . 0.0 112.196 -177.463 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.65 ' OD2' ' O ' ' A' ' 80' ' ' GLU . 20.4 m-20 -86.49 123.5 71.05 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.361 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 1.001 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 31.7 Cg_exo -60.97 1.43 0.59 Allowed 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 123.857 3.038 . . . . 0.0 108.986 176.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 63' ' ' SER . . . -76.58 -30.14 56.89 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.28 178.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.885 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 49.7 m -119.02 -22.84 7.08 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -177.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.873 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.5 t70 156.69 -15.05 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.617 0 N-CA-C 120.681 3.586 . . . . 0.0 120.681 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 81' ' ' GLU . 5.2 Cg_endo -95.46 -66.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.492 -1.575 0 CA-C-N 122.811 2.04 . . . . 0.0 111.637 -174.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.671 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 26.4 tt0 -76.89 -4.49 44.03 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.001 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . . . -16.09 124.72 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 120.395 3.48 . . . . 0.0 120.395 -175.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 92' ' ' SER . . . -99.24 -138.44 0.31 Allowed 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 108.783 -3.826 . . . . 0.0 105.468 170.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.19 47.48 0.21 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.753 ' HB3' ' O ' ' A' ' 83' ' ' PRO . 2.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.508 -177.687 . . . . . . . . 1 1 . 1 stop_ save_